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Chapter 1. Introduction  
 Voltage-activated ion channels are a class of transmembrane proteins found in 
excitable cells. These channels are key to the rapid and accurate transmission of 
information among cells in vertebrates and invertebrates alike. They play a very 
important role in electrically excitable cells, allowing influx or efflux of ions in 
response to membrane potential change. There are three major types of voltage-
activated ion channels which are responsible for maintaining cell viability and 
physiological functions; calcium, potassium and sodium. Voltage-activated currents 
have been isolated in nematodes and are associated with depolarization (calcium 
channels) or recovery of the cell after the depolarization (potassium channels). 
Voltage-activated potassium channels play an important role in recovery of cells 
after depolarization. While the entry of extracellular calcium into muscle cells after 
ACh induced depolarization is essential to the contractile process. Entry of calcium 
is facilitated by voltage-activated calcium channels. Different subtypes of voltage-
activated calcium channels have been identified in vertebrates. In nematodes, 
advances in C. elegans genomics led to the identification of voltage-activated 
calcium channel subtypes. These subtypes show some homology to vertebrate 
calcium channels but are pharmacologically and physiologically different. The 
understanding of the physiology of these different voltage-activated channels is 
becoming increasingly important as we try to attenuate the development of 
resistance to present anthelmintics. Major classes of anthelmintics produce their 
effect by modulating neuromuscular system either indirectly or directly. Therefore, it 
is important for us to understand the physiology of these channels in the worms to 
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either identify novel drug target sites or understand the mechanism of the 
development of resistance. Recently a new class of anthelmintic compounds, cyclo-
octadepsipeptides, has been approved for animal use. Their modes of action include 
latrophillin receptors activation, PF1 like neuropeptide release and more recently 
demonstrated activation of voltage-activated calcium dependent potassium 
channels. It is known from previous work done in A. suum and C. elegans that there 
are voltage-activated channels on the muscle membrane. Electrophysiological 
recordings in A. suum and other nematodes have shown that these currents may be 
modulated by different anthelmintics. We used voltage-clamp and current-clamp 
techniques to study voltage-activated currents in the pig parasitic nematode A. suum 
somatic muscle cells. We were able to isolate two types of voltage-activated calcium 
currents and a type of outward potassium current. We have characterized these 
currents pharmacologically and kinetically. We also observed that these currents, if 
modulated, could potentiate the response of cholinergic anthelmintics. Further, we 
used different endogenous nematode neuropeptides to modulate these currents. 
Neuropeptides and their receptors offer novel drug targets, not only for the 
development of new anthelmintics, but also to increase the potency of existing 
drugs. We anticipate that our observations will increase the understanding of worm 
physiology and validate the potential for exploring neuropeptide receptors for 
anthelmintic chemotherapy.  
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1.1 Thesis Organization 
Within this thesis, an introduction is presented describing some of the reasons for 
studying voltage-activated currents and nematode neuropeptides. In chapter 2, I 
reviewed the work of researchers in related fields of nematode physiology and 
FMFRamide related peptides (FLPs). The following three chapters (Chapters 3,4, & 
5) are each manuscripts which are either published or submitted for publication 
explaining in detail the work done by the author and collaborators on the subject of 
this dissertation. The papers represent the majority of the work done by the author 
towards the characterization of voltage-activated currents in Ascaris suum.  In 
chapter 3, I describe the isolation of voltage-activated currents and their modulation 
by the endogenous neuropeptide, AF2. Chapter 4 explains the effects of PF1 and 
AF3 on the voltage-activated currents. In chapter 5, I describe the effects of a 
muscarinic agonist (5-methylfurmethiodide) on contraction and electrophysiology. I 
appear as first author in all the three papers. Chapter 5 is for the final paper 
(Trailovic et al., 2007), where I conducted the voltage-clamp and many of the 
current-clamp experiments. In chapter 6, the general discussion, I summarize the 
observations of my PhD studies and discuss the significance of the observations and 
future courses of action.  
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Chapter 2. Literature review 
2.1 Nematode parasites and model nematode 
Parasitism is a relationship between organisms of different species in which 
one organism (parasite) benefits from the association while the other (host) is 
harmed. Parasites are classified broadly as ectoparasites and endoparasites 
depending upon their location. Parasites are smaller than their host and usually 
show a high degree of species specificity. Most parasitic infections are not deadly 
but cause a tremendous burden on animals and humans due to high morbidity. 
These infections lead to poor growth, decreased immune functions, weight loss, 
anemia and impairment of cognitive skills in humans. In animals they cause serious 
loss in production due to poor growth, decreased immunity and poor weight gain 
beside chronic debilitation. Ectoparasites, as their name suggests, are associated 
with infections to the outer surface of the body. Whereas, endoparasites are the 
ones which live inside the host, in different tissues and organs. Ectoparasites include 
blood sucking arthropods, ticks, fleas, mites and lice. The ectoparasites attach or 
burrow into skin leading to different skin conditions. Endoparasites broadly include 
helminths and protozoa. Protozoa are microscopic, unicellular organisms which can 
be parasitic or free living.  Helminths are large, segmented multi-cellular organisms. 
The mature worms reside in the GI tract, circulatory system (blood & lymph) or 
subcutaneous tissues. The larval stages travel through different body systems 
inducing disease symptoms. The word helminth is derived from the Greek word for 
worms. Helminths fall under three main groups: flatworms (platyhelminths); thorny-
headed worms (acanthocephalans); roundworms (nematodes). Parasitic nematodes 
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include: roundworms (Ascaris lumbricoides, Ascaris suum, and Trichuris vulpis), 
hookworms (Ancylostoma caninum, Necator americanus), heartworms (Dirofilaria 
immitis), pinworms (Enterobius vermicularis), strongyles (Strongyloids spp.) and 
filarial worms (Wuchereria bancrofti, Brugia malayi). Nematodes have life cycles 
which include adult males and females, they reproduce sexually and eggs are laid 
by the female. Larvae develop in these eggs, hatch and progress through a series of 
developing larval stages until they reach adulthood as sexually mature males and 
females and the cycle begins again. Most nematodes follow this basic life cycle 
pattern, although some may also include variations and additional complexities. 
Figure 2.1 shows the phylogenetic tree representing evolutionary associations 
between vertebrates, nematodes and other animals (Dunn et al., 2008).  
  
 Figure 2.1 Phylogram of the 77-taxon RaxML maximum likelihood analyses  
  conducted under the WAG model. Modified from Dunn et al., 2008. 
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2.1.1 Ascaris  and ascariasis  
The Millennium Declaration of the World Health Organization included a 
group of 13 parasitic and bacterial infectious diseases listed as neglected tropical 
diseases (Hotez et al., 2007).  Ascariasis is the most common parasitic infection in 
the list, with an estimated 807 million people infected and 4.2 billion people at risk. 
Helminths are of economic and welfare concern in animals. Ascariasis in man is 
caused by Ascaris lumbricoides and a related species Ascaris suum causes 
infection in swine. Adult females (20-40 cm) are bigger than the male in size (15-30 
cm). Females are identified by the presence of large ovaries occupying the posterior 
~ 2/3rd of the worm. A row of small  teeth on the lips of Ascaris suum   separates the 
two species anatomically (Sen et al., 1963). Even though the two species are very 
similar and closely related, cross species infections are rare (Urquhart et al., 1987). 
Ascaris spp. has a worldwide presence but is more common in temperate climates. 
Adult A. lumbricoides and A. suum normally reside in the small intestine. The 
nematode life cycle involves six stages which includes the egg, four larval stages 
(L1, L2, L3, L4), and an adult stage.  The female A. suum/A. lumbricoides lays more 
than 200,000 eggs in a day which are passed in the feces of the infected host. 
Ascariasis follows the ingestion of infective fertile eggs contaminating food or soil. 
Eggs, upon reaching the small intestine hatch to release the larvae. These larvae 
then migrate through the intestinal wall reaching the lungs. In humans, larvae in the 
lungs induce host sensitization and lung inflammation. L3 larvae molt to the L4 stage 
in the lungs and migrate up the trachea and are swallowed. These L4 develop into 
adult worms in the small intestine. Serious complications arise in cases where larvae 
 7 
migrate into sensitive tissues like the brain or other vital organs forming abscesses. 
The most common symptoms of ascariasis include abdominal pain, nausea and 
disturbed gastrointestinal tract functions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.2 The lifecycle of A. lumbricoides. Adult worms live in the intestinal 
 lumen. Eggs laid by the female are passed with feces. Eggs embryonate and become 
 infective. Following ingestion of contaminated food and water, larvae hatch in the 
 host intestine. Larvae migrate through the intestinal wall to reach the lungs. L4 larvae 
 migrate to the trachea and are swallowed. Upon reaching small intestine L4 larvae 
 develop into adult worms. (http://www.dpd.cdc.gov/dpdx date: 05/31/08)  
 
2.2 Body wall muscle cell and neuromuscular junction in nematodes  
 Figure 2.3 shows a cross section of an adult Ascaris. From outside to inside it 
includes cuticle, hypodermis and muscle layer. The musculature of Ascaris  consists 
almost entirely of longitudinal muscles and these muscles are classified as obliquely 
 8 
striated (Rosenbluth, 1965a; Rosenbluth, 1965b; Stretton, 1976). Body wall muscles 
are divided by two lateral lines into ventral and dorsal layers (del Castillo et al., 
1989). Each half is innervated by individual nerve cords. Somatic muscle cells of 
Ascaris  have three parts (Figure 2.4, 2.5) : spindle region, which is the contractile 
region and anchors the muscle to hypodermis, cell body which is formed by a 
balloon like structure called the muscle belly, which contains the nucleus, and 
muscle arms arising from the base of the belly and extending finger like projections 
to the nerve cord. The different components of Ascaris  muscles are described in 
detail here.  
 
 Figure 2.3 (Thorn et al., 1987) Transverse section of Ascaris. The dorsal and 
 ventral nerve cords are indicated as well as the two small lateral nerve cords. The  two 
 lateral lines separate somatic muscles into ventral and dorsal layers. 
  
2.2.1 Belly  
 The belly or bag region of the Ascaris  muscle is in the body cavity or 
pseudocoele. The belly contains nucleus, fibrillar bundles of cytoskeleton and 
mitochondria (Debell et al., 1963). The belly serves as an endoskeleton and has only 
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basic internal structures. The belly is filled with glycogen granules which are 
depleted during starvation or exercise (Rosenbluth, 1965b). The main function of the 
belly is assumed to be as a store providing glycogen when the animal faces scarcity 
of food.  
 
 Figure 2.4 (Stretton, 1976) Diagram of short length of the body of Ascaris showing 
 relationship of the muscle cells to nerve cord. a, muscle arm; c, cuticle; d.c., dorsal 
 cord; h, hypodermis, l.l, lateral line; m, muscle cell; s.c., sublateral cord; v.c.,ventral 
 cord. 
 
2.2.2 Arm 
 The muscle belly gives rise to the arm, an innervation process which can 
originate from any part of the belly (Rosenbluth, 1965b). Some bellies give rise to 
more than one arm. The arm in proximity to the nerve cord becomes thinner and 
divides into several finger like processes, and forms a syncytium (del Castillo et al., 
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1989). The processes from an arm interdigitate with processes from other arms and 
form a cap of muscle fingers. The arms reach the nerve cord in bundles separated 
by ~400-500 µm gaps. The syncytium (cap of processes) forms synapses with the 
nerve cord for impulse conduction (Figure 2.5).  
 
 Figure 2.5 (Rosenbluth, 1965b) Schematic diagram of the muscle cell and the 
 neuromuscular junction. The muscle cell includes a spindle, a belly (or bag) and 
 arms. The neuromuscular junction is formed between the end of the arms (which
 forms a syncytium) and the nerve cord. n: nerve cord; h: hypodermis; c: cuticle. 
 
 There are two types of junctions in Ascaris for communication –
neuromuscular junctions (between nerve and muscle arm) and tight junctions 
(between the muscle arms). The tight junction between two muscle cells presumably 
have two functions: synchronization of electrical activity in group of muscle cells by 
forming a functional syncytium; and have better control over muscle cells which are 
not able to make direct contact with nerve cells (del Castillo et al., 1989). 
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2.2.3 The spindle 
 The contractile apparatus of the muscle cell is obliquely striated and is limited 
to the spindle region of the cell. The spindle is made up of U shaped fibers forming 
tube shaped structure which is attached to hypodermis. Fibers has two sections : the 
sarcoplasmic core which is continuous with the belly; and the cortex which contains 
the contractile apparatus (Rosenbluth, 1965a). The double array of thick and thin 
filaments interdigitate to form A, H and I bands. However unlike vertebrates their  is 
no Z line but Z  bundles and dense bodies (Rosenbluth, 1965a). Sarcoplasmic 
reticulum is virtually absent in Ascaris  somatic muscle cells which is probably the 
reason for slow speed of contraction (Rosenbluth, 1967).   
2.3. Nervous system in Ascaris suum 
 The nervous system in Ascaris is simple with 298 neurons (Stretton et al., 
1992). The neurons are classified broadly as sensory, interneuron and motor 
neuron. The neurons are also classified according to the neurotransmitter released 
by them: cholinergic, GABAergic etc. The motor nervous system in Ascaris is simple 
with each fiber sending a straight fiber with none to two branch points. The neurons 
have short spines (1-2 µm) where they make synapse to muscle (Stretton et al., 
1978). Neuromuscular contacts are made by muscle arms branching out to form 
synapse at the neuronal spines. 
2.3.1 Anatomy of Ascaris nervous system  
 The nervous system of Ascaris is composed of three major structural regions: 
(i) nerve ring and associated ganglia at the anterior end, (ii) major dorsal and ventral 
nerve cords and the smaller subventral and subdorsal cords which runs along the 
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animal to tail, and (iii) smaller caudal ganglia in the posterior region (del Castillo et 
al., 1989; Stretton et al., 1978). The anterior nerve ring is the primary target of 
sensory neurons and produces cephalic motor output. Dorsal and ventral nerve 
cords also arise from the nerve ring (Fig.2.6). 
 
 Figure 2.6 (Crompton et al., 1979) The anterior part of the nervous system in 
 Ascaris . The nerve ring receives the primary sensory input and gives rise to the
 cephalic muscle motor output. The two major nerve cords, dorsal and ventral, 
 originate from the nerve ring. 
 
 The connection commissures form a pattern along the length of the nematode 
body leading to the formation of five segments. Thus the motor nervous system is 
composed of five repeating subunits or segments and each unit is composed of 
eleven motor neurons. The morphological differences divide the eleven segmental 
motor neurons into seven types: one of DI, DE2 and DE3, two of DE1, VI, V1 and V2 
(Stretton et al., 1978) Table 2.1. The cell bodies of all the motor neurons are located 
in the ventral nerve cord and three form synapses with ventral muscle cells while the 
other four form synapses with dorsal muscles. There are six non-segmental 
interneurons with their cell bodies either in the anterior or posterior region. All the 
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segmental neurons are motor neurons as they form synapses either in the dorsal or 
ventral cord but not in both (del Castillo et al., 1989; Stretton et al., 1978).  
Ascaris  neuron 
type 
Neuro-muscular output 
region 
function in 
Ascaris  
DE3 Dorsal Excitatory 
DE2 Dorsal Excitatory 
DE1 Dorsal Excitatory 
DI Dorsal Inhibitory 
VI Ventral Inhibitory 
V-1 Ventral   
V-2 Ventral Excitatory* 
 Table 2.1  (Stretton et al., 1978) Ascaris  neuronal types and distribution.  
 *Function of V-1 and V- 2 neurons has not yet been fully elucidated. 
 
2.3.2. Nervous commissures in nematodes  
 As mentioned previously the nervous system of Ascaris  is characterized by a 
repeating pattern of neurons, called segments (Stretton et al., 1978).  The ventral 
cord sends out branches which travel across the body and form connections with the 
dorsal cord, Fig. 2.9. These connecting branches between dorsal and ventral cords 
are called “commissures”. The commissures are located in the hypodermis 
underneath the cuticle. There is bilateral symmetry in distribution of commissures in 
that for every left handed commissure there are six right handed commissures, Fig. 
2.7. Neuromuscular synapses are formed by four of the seven neuronal types in the 
dorsal cord, Fig. 2.7. In Ascaris females five copies of repeating segments are found 
with three pairs of left handed commissures anterior to the first segment. In males 
the difference is the presence of four extra left handed commissures at the caudal 
end (Stretton, 1976).  
 14 
 
 
 Figure 2.7 (Martin et al., 1996) Diagram of the dorsal and ventral nerve cord in  
 one segment of Ascaris . Seven anatomical types of motorneurons are present: 
 dorsal excitatory (DE1, DE2 and DE3), dorsal inhibitory (DI), ventral inhibitory 
 (VI), ventral excitatory (V1 and V2). 
 Inhibitory motor neuron 
 Excitatory motor neuron 
 Inhibitory output 
 Excitatory output 
 
 As observed in the model nematode C.elegans, there are two pairs of 
commissures in the head region, called right and left amphid and deirid 
commissures. There are three pairs of right and left commissures in the tail: lumbar, 
dorsorectal and dorsolateral. The pharyngeal ring is formed by an enlarged 
commissure with ~200 processes surrounding the bulb region of pharynx. The 
pharynx has two commissures: nerve ring and terminal bulb commissures. There are 
more that 40 commissures which grow out of ventral nerve cord and connect to the 
dorsal nerve cord across the length of the worm (Hedgecock et al., 1987; White et 
al., 1986).  
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 Figure 2.8  (Stretton et al., 1978) The seven types of segmental neurons and their 
 commissures.  
2.4. Physiology of the body-wall muscle cell in nematodes  
Nerves form synapses with fingers at the end of muscle arms to conduct 
impulses. Apart from the neuromuscular junction, the muscles also form connections 
between muscle cells through gap junctions. These connections are important to 
synchronize the activity of muscle cells in a region as all the muscle cells do not 
make contact with nerve cord. The action potential is induced in the muscle arms or 
near the nerve cord. Gap-junctions are the major means of initiating recruitment of 
neighboring muscle cells, which do not form direct connections with nerve (Debell et 
al., 1963; del Castillo et al., 1967).  Close to half of the muscle cells make contacts 
with more than one nerve (Rosenbluth, 1965b).  
 
 
 16 
2.4.1. Membrane potential of the muscle cell  
 The ionic mechanisms involved in the maintenance of the resting membrane 
potential in Ascaris are very different from vertebrate muscles. The striking 
difference is the relative insensitivity of the Ascaris muscle to changes in 
concentration of the extracellular ions, potassium and sodium (Brading et al., 1971; 
del Castillo et al., 1964a). The resting membrane potential of Ascaris  somatic 
muscle is ~ -30 mV (Debell et al., 1963).  The resting membrane potential decreased 
by only 1.5 mV with a 10 fold increase in the bath potassium concentrations. Similar 
results were obtained with sodium but the Ascaris muscles cell was found to be 
sensitive to changes in extracellular chloride although not as much as in vertebrates 
(Brading et al., 1964; del Castillo et al., 1964a).  del Castillo et al., (1964)  proposed 
the presence of a high resistance potassium and low resistance chloride battery in 
the cell membrane to explain the results. The hypothesis was later countered by 
Brading and Caldwell (1971). The insensitive nature of the resting membrane 
potential to sodium, potassium and chloride cannot be explained by the Goldman-
Hodgkin-Katz equation. It has been suggested that other ions are involved in 
maintaining the insensitive nature of the cell membrane. The results can be 
explained by a modified Goldman-Hodgkin-Katz equation:  
                   
Where pk[Na] etc. are product permeability constants and ionic concentrations and x 
& y represents the contribution of other ions. The contribution of the other ions (x 
and y) is much larger than the contribution of sodium, potassium or chloride (Brading 
et al., 1971). Brading and Caldwell (1971) proposed that the insensitivity of the 
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muscle membrane was due to the effects of an electrogenic pump. The sodium, 
potassium and chloride fluxes are smaller when compared with large fluxes of 
carboxylic acids across the Ascaris muscle membrane (Brading et al., 1971). It was 
proposed that the abnormal behavior is linked to electrogenic sodium pump in which 
outward movement of sodium ions is independent of another ion (Caldwell, 1973; 
Caldwell, 1972). The muscle belly has been found to posses ACh, GABA receptors 
(Martin, 1980; Martin, 1982). Thorn and Martin (1987) have also shown the presence 
of large calcium-activated chloride channel on the belly region. We have yet to come 
up with a satisfactory mechanism to explain the distinct membrane potential 
responses of Ascaris. The possible role of ACh, GABA and calcium-activated 
chloride channels in maintaining the membrane potential has not been elucidated, 
although it seems that the calcium channels have an important function. 
2.4.2 Spontaneous activity of muscle cell 
  The resting membrane potential in Ascaris is regularly superimposed upon 
by spontaneous depolarizations at 1.5-7 per second. Each spontaneous 
depolarization is composed of a slow wave with spikes superimposed (Debell et al., 
1963). Ascaris  muscles demonstrate three types of spontaneous activity: graded 
spike potentials (10-50 ms), slow waves (100-1000 ms) and long lasting modulatory 
waves (3-20 ms), Fig. 2.11 (Weisblat et al., 1976). The spike potentials are affected 
by the concentration of calcium in the bath solution, the lower the concentration, 
smaller the spikes. These observations coupled with the absence of effect of sodium 
suggest that spikes are in fact mediated by calcium ions. Also the spikes are blocked 
by lanthanum and cobalt (Weisblat et al., 1976). The slow waves on the other hand 
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are more complex and the involvement of both sodium and calcium has been 
proposed. Ion substitution experiments confirmed that both sodium and calcium can 
carry currents during slow waves (Weisblat et al., 1976). del Castillo et al., (1989) 
concluded that spontaneous electrical activity of the Ascaris  somatic muscle cells is 
myogenic in nature, originating from the syncytium. The syncytial membrane 
generates pacemaker potentials which give rise to spikes that traverse from arm and 
belly to the spindle region to activate contraction. The slow waves and spikes 
generated from the syncytium are modulated by the interaction of neurotransmitters 
including GABA and ACh (del Castillo et al., 1989). The voltage-dependent channel 
density is low in motor nerves and the somatic muscle cell membrane which is 
compensated by the increased excitability of the syncytial membrane. The syncytial 
membrane boosts the signals generated by the nervous system ensuring that there  
is no loss of signal strength at the spindle (del Castillo et al., 1989).  
 
 Figure 2.9  (Weisblat et al., 1976) Spontaneous activity of the Ascaris  somatic 
 muscle cells. a) Modulated spontaneous activity. b) Previous recording on expanded 
 scale to show slow waves and super imposed spikes. c) Slow waves and spikes.
 Scale, 10 mV x 12 s in a, 10 mV x 1 s in b and c.  
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2.5 Nematode neuropeptides and neurotransmitters  
 The metazoan nervous system possesses a significant peptidergic signaling 
system. Peptidergic neurotransmitters and peptidergic parasitic neurons are of early 
evolutionary origin as they are found in the major branches of metazoans, cnidarians 
and helminths and also in other invertebrates (Halton et al., 1994; Shaw, 1996), 
Table2.2.  The mode of synthesis is the biggest difference between the peptidergic 
transmitters and classical neurotransmitters. Classical neurotransmitters are 
synthesized and metabolized in nerve terminals. Peptides are genetically encoded 
and are synthesized in the cell bodies of neurons as peptide precursors that are then 
processed within vesicles, mature vesicles then are transported to nerve terminals 
along the axon (Shaw, 1996). 
2.5.1 FMFRamide like peptides  
Nematode neuropeptides are endogenous intercellular  signaling molecules. 
Most of the neuropeptides interact with G-protein coupled receptors on the cell 
surface and initiate intracellular transduction or cytosolic signaling cascades (Maule 
et al., 2001), some neuropeptides also evoke fast responses by directly acting on ion 
channels (Purcell et al., 2002). Peptidergic signaling molecules are very diverse in 
nature and have been isolated from helminths, arthropods and other invertebrates 
(Taussig et al., 1986), Table 2.2. FMRFamide-like peptides (FLPs) or FMFRamide-
related peptides (FaRPs) are the largest known family of invertebrate regulatory 
neuropeptides. The first neuropeptide of the FMFRamide (Phe-Met-Arg-pheNH2) 
family was isolated from the molluscan brain (Price et al., 1977). Later antibodies 
were used for immunohistochemical staining which revealed imunoreactivity to this 
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peptide in various nematode species. Most are small peptides (≤20 amino acids) 
which are not members of the neuropeptide Y family and posses a C-terminal 
RFamide motif, an aromatic residue a hydrophobic residue and are classified as 
FLPs. The FLP system in nematodes is very complex with 42 flp encoding genes 
identified in both free living and parasitic nematodes with each flp gene coding for at 
least one distinct peptide (Cowden et al., 1993a; Cowden et al., 1995; Keating et al., 
1995; McVeigh et al., 2005; Rosoff et al., 1992; Rosoff et al., 1993). More than 20 
FLPs have been structurally characterized in A. suum  so far (Cowden et al., 1993a; 
Cowden et al., 1995; Cowden et al., 1989; Davis et al., 1996). Some FLPs are active 
across species in invertebrates, arthropods and insects. Some neuropeptides 
isolated from Ascaris affect other nematodes (Maule et al., 2002; Mousley et al., 
2005a). PCR-based cDNA analysis of expressed sequence tag  database of 
parasitic nematodes have lead to identification of approximately 290 distinct FLPs in 
the nematodes (Mousley et al., 2005a). More than 200 peptidergic signaling 
molecules have been identified in arthropods (Mousley et al., 2004; Mousley et al., 
2005b).  
2.5.2 FLP distribution in Ascaris  
Immunocytochemistry and confocal scanning laser microscopy have lead to 
the identification of many structurally distinct FLPs. Their  is abundance of 
immunoreactivity to FMRFamide peptides in nematodes, infact more than 75% of 
neurons in Ascaris suum are immunpositive to FLP antiserum (Brownlee et al., 
1996; Cowden et al., 1993a; Cowden et al., 1995; Davenport et al., 1988).  Table 2.3 
shows in detail the immunopositive components of the A. suum nervous system.  
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FLP immunoreactivity has been identified in all neuronal components (central, 
peripheral and enteric) and subtypes including motor-, sensory- , and interneurons 
(Brownlee et al., 1993a; Brownlee et al., 1993b; Cowden et al., 1993a; Fellowes et 
al., 1999). FLP immunostaining is also widespread in all the nerve cords and more 
than half the ganglia of circumpharyngeal ring are FLP positive. FaRP 
immunopositive nerves have been identified in association with pharyngeal and 
vagina-vera muscles. Varicose nerve fibers with FLP immunoreactive dense core 
vesicles (120-160 nm) were identified around ovijector muscles. The peptidergic 
nerves are varicose in nature as they accumulate secretory vesicles (Fellowes et al., 
1999). Ascaris  pharyngeal innervation is complex and involves cholinergic, 
serotoninergic and peptidergic vesicles (120-160 nm)  
   
Table 2.2  (Maule et al., 2001) Localization of FMRFamide- like peptides  
 in helminths. 
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Table 2.3 (Maule et al., 2001) FLP immunoreactivity in Ascaris suum   
 nervous system.  
 
2.5.3 FLP distribution in other helminths 
The molecular characterization of nematode FLPs was pioneered by Rosoff 
et al. (1992). Completion of C. elegans  genome sequence  has lead to detailed 
study of FLPs in it’s neuromuscular system, which can be applicable to other 
nematodes (White et al., 1986). FLP imunoreactivity in C. elegans was found to be 
only 10% with 30 neurons being immunopositive for FLPs in contrast to widespread 
reactivity demonstrated in Ascaris  (Schinkmann et al., 1992). flp-1lacZ reporter 
constructs and in situ hybridization techniques have lead to the identification of 23 flp 
genes encoding 60 different FLPs in C. elegans (Li et al., 1999; Nelson et al., 1998b; 
Rosoff et al., 1992). Other than immunohistochemistry, expressed sequence tag 
(EST) analysis coupled with PCR-based cDNA analysis have lead to identification of 
novel flp-encoding gene homologues in four nematode clades (McVeigh et al., 2005; 
Mousley et al., 2005a).  Interestingly neuropeptide sequences are found to be 
conserved across free living and parasitic nematodes. So far 290 distinct FLPs have 
been identified across parasitic nematode ESTs.   
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Helminth FLPs also share similar motifs with FLPs found in organisms from 
some other phyla. FLPs have been identified by immunostaining in platyhelminths; 
cestodes, digeneans, monogeneans and turbellarians. Immunoreactivity has been 
seen in both peripheral and central nervous systems as well as in the reproductive 
system (Halton et al., 1994). FLP immunoreactivity has been identified throughout 
the nervous system in trematodes e.g. Fasciola hepatica and Schistosoma mansoni. 
Immunoreactivity was also seen in the somatic musculature and the muscles 
associated with egg laying flat worms (Day et al., 1999; Marks et al., 1995a). A role 
for RFamides and FLPs has also been proposed in egg formation in platyhelminths 
(Shaw et al., 1996). The platyhelminth  FLPs share the RFamide motif at the C-
terminal but they contain different N-terminal amino acid sequences. 
All the studies done so far have revealed that FLPs occur in all neuronal 
subtypes and the number and position of FLP positive neurons is very well 
conserved between diverse species not only in helminths but also in insects and 
arthropods.  
 2.5.4 Ascaris  FLPs  
 The first nematode neuropeptide isolated from Ascaris suum was AF1. It is a 
heptapeptide (Lys-Asn-Glu-Phe-Ile-Arg-Phe-NH2) which was isolated from methanol 
extracts of Ascaris  head  (Cowden et al., 1989). This was the first endogenous 
neuropeptide shown to have physiological role in Ascaris  neuromuscular system. 
So far 20 endogenous FLPs with different physiological actions have been isolated 
and characterized from Ascaris suum, Table 2.4. Since all these neuropeptides were 
isolated from Ascaris they were designated as Ascaris  FMRFamide-like peptides 
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(AF) and they were numbered in chronological order of their discovery. One of the 
peptides, AF17, included in the list of FLPs differs in C-terminal sequence, it 
possesses a HFamide sequence instead of RFamide. Multiple-copy neuropeptide 
genes identified in invertebrates is a feature of Ascaris FLP encoding genes. It has 
been shown that six FLPs isolated from A. suum are encoded on single gene afp-1 
(Edison et al., 1997). Three of the four transcripts of afp-1 differed only in the 
untranslated region but had similar protein coding sequence. It is assumed that 
single nematode neuropeptide gene can code for a range of related, but structurally 
unique neuropeptides. So far six afp genes has been identified in Ascaris suum  
(Edison et al., 1997; Mousley et al., 2005a).The most abundant of all FLPs is AF2 
which differs from AF1 by three amino acid substitutions (Cowden et al., 1993b). 
AF2 has also been isolated from Heamonchus contortus, C. elegans and 
Panagrellus redivivus (Marks et al., 1995b; Maule et al., 1996).  
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 Table 2.4 (Maule et al, 2001) Primary sequences of A. suum FLPs.  
 
2.5.5 Other nematode FLPs 
 Completion of the C. elegans genome sequencing project has lead to the 
identification of various flp genes. Table 2.5 shows the complete list of flp genes and 
their corresponding peptides identified to date. 29 flp genes are identified so far and 
expression of at least 15 genes is confirmed by PCR and other techniques (Li, 2005; 
Maule et al., 1997; Nelson et al., 1998a). 68 different peptides are encoded on 
different flp genes identified in C. elegans, their are 60 known C. elegans FLPs 
(McVeigh et al., 2005). Similar to Ascaris AF17, C. elegans also has two peptides, 
KPNFMRYG (flp-1) and EDGNAPFGTMKFG (flp-3), which do not have the 
characteristic RFamide motif at the C-terminal end. flp genes have also been 
identified in the related species C. vulgaris (Schinkmann et al., 1992). The gene Cv-
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flp-1 shares a strong sequence homology in the coding region with C. elegans flp-1. 
The neuropeptide precursor protein differs by four conservative amino acid changes 
and the RFantisera stained a similar subset of cells in both the species, suggesting 
that the function and regulation of these peptides is conserved between these two 
species (Schinkmann et al., 1994). Several other peptide encoding genes like flp-1, 
flp-6, flp-8, flp-11 and flp-14 have also been identified in other nematode species 
which suggest conservation of structures but the conservation of function of these 
peptides between different species has yet to be completely determined.  
 FLPs have been structurally and functionally characterized in other nematode 
species as well. Five FLPs have been identified in the free living nematode P. 
redivivus and three FLPs have been identified in Haemonchus contortus. Work done 
by Geary et al. (1992) lead to the identification of two novel FLPs from nematode P. 
redivivus: SDPNLRFamide (P. redivivus FLP-1, PF1) and SADPNFLRFamide (PF2). 
Since then more peptides: KSAYMRFamide (PF3/AF8) (Maule et al., 1994b); 
KPNFIRFamide (PF4) (Maule et al., 1995a); KHEYLRFamide (AF2) (Maule et al., 
1994a) ; and AMRNALVRFamide and NGAPQPFVRFamide (Maule et al., 2001) 
have been identified in P. redivivus. It was noted that except for PF4 all the PF 
peptides showed complete identity with C. elegans peptides. These observations 
again confirm the evolutionary conservation of neuropeptide sequences and possibly 
functions in nematodes. Two peptides isolated from H. contortus: KSAYMRFamide 
(PF3/AF8) and KHEYLRFamide (AF2) are found in all four nematode species 
studied extensively for FLPs (Keating et al., 1995; Marks et al., 1999). As in Ascaris,  
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AF2 is the most abundant neuropeptide in P. redivivus, C.elegans and H. contortus 
making it the most abundant FLP in the nematode phyla identified so far.  
 In platyhelminths FMRFamide immunoreactivity has been seen but the 
immunocytochemical staining pattern is virtually identical to another peptide family 
NPF (Neuropeptide-F). So far only three flatworm FLPs have been isolated from 
turbellaria, and the cestode family: Dugesia tigrina – GYIRFNH2 (Johnston et al., 
1996); Artiposthia triangulata – RYIRFNH2 (Maule et al., 1994c); and Moniezia 
expansa – GNFRFNH2 (Maule et al., 1993). The isolation of FLPs from trematodes 
has been unsuccessful so far. However, functional FLP receptors have been 
identified in Schistosoma mansoni muscles, where RYIRFamide isolated from 
flatworms demonstrated the highest potency compared to other FLPs (Day et al., 
1999; Day et al., 1994). The high degree of potency of the turbellarian FLP in 
inducing contractions in digenean muscles (S. mansoni) suggests that it is the most 
closely related endogenous ligand for the receptor. Interestingly turbellarians are the 
proposed evolutionary ancestors of parasitic digeneans (Shaw et al., 1996). Table 
7.1 (Appendix) shows the complete list of flp genes so far identified from different 
clades of the phylum Nematoda. Some of the genes as mentioned in the Table were 
characterized from EST’s due to unavailability of complete genome sequences for all 
the nematodes in different clades.  
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Table 2.5 (Maule et al., 2001) C. elegans flp genes and FLP  sequences. 
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2.5.6 Effects of nematode FLPs  
 We know of a large number of FLPs and flp genes in nematodes but the 
physiology of each of them has not been fully elucidated. There is a big gap between 
structural identification and physiological function of these peptides. A. suum is the 
most commonly used nematode for investigating the effects of these neuropeptides 
on the nematode neuromuscular system. Due to conservation of FLP sequence 
across nematode species, the information could be used for a foundation applicable 
across the phylum (Mousley et al., 2005a). Here we have to keep in mind that 
although FLP immunoreactivity has been demonstrated across the nematode 
phylum, we still don’t have the distribution pattern of individual FLPs. The functional 
studies in Ascaris  have been done in most detail using somatic body wall muscles 
(Cowden et al., 1993b), neurons, the ovijector (Brownlee et al., 1993a), and the 
pharynx (Brownlee et al., 1999).  
 Table 2.7 and 2.8 describes in detail the different flp genes, FLP peptides 
synthesized and effects of different peptides on the pharynx, somatic body wall 
muscles and nervous system of Ascaris suum. I will discuss here representative 
neuropeptides of different classes from Ascaris and other nematodes. 
 
KNEFIRFamide (AF1) and KHEYLRFamide (AF2)  
 These are hepta peptides isolated from A. suum. The two peptides have very 
similar pharmacology (Cowden et al., 1993b; Cowden et al., 1989). AF1 and AF2 
abolish locomotory waves at the injection site when injected in whole worms. On 
muscle strip preparations AF1 and AF2 induced a biphasic response, on initial 
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inhibitory phase followed by an extended period of excitatory contractions (Cowden 
et al., 1989; Maule et al., 1995a; Pang et al., 1995). AF2 was more potent than AF1 
in inducing muscle contraction, the threshold concentration of AF1 was 1 nM 
(Bowman et al., 1996) compared to 10 pM for AF2 (Cowden et al., 1993b). The 
effects of AF1 and AF2 were found to be dose-dependent, the inhibitory phase 
decreasing with increasing concentration of AF1 and at concentrations higher than 1 
µm the inhibitory phase was abolished. However, at concentrations <100 nM, the 
inhibitory phase was extended (Bowman et al., 1996; Pang et al., 1995). 
Experiments with denervated muscle strips showed that the excitatory and inhibitory 
responses were mediated by different receptors. The excitatory phase was 
abolished in denervated muscle strips, suggesting the excitatory receptors are 
neuronal while inhibitory receptors are muscular in location. Electrophysiological 
studies demonstrated the inhibition of dorsal and ventral inhibitory neurons with no 
effect on excitatory motor neurons. It also reversibly abolished the oscillatory 
responses. AF2 also increased the ACh induced excitatory junction potential. 
Structure-activity studies with AF1 and AF2 also demonstrated the probable  
presence of two different receptors for the two responses (Pang et al., 1995). 
Chimera studies with AF1 and AF2 have also shown that the two peptides act on 
different receptors, AF1 antagonist didn’t block the effects of AF2. It has also been 
postulated that AF2 acts both pre- and post-synaptically at the neuromuscular 
junction to elicit muscle responses. AF2 increased the excitatory junction potential in 
A. suum muscles treated with nicotinic antagonist. AF2 not only potentiated the ACh 
induced muscle contraction (Pang et al., 1995) but also it potentiated the ACh 
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induced depolarization of the A. suum muscles (Trailovic et al., 2005). AF2 has also 
been found to stimulate cAMP levels in A. suum body wall muscles (Thompson et 
al., 2003) but the cAMP does not seem to play a role in the AF2 induced excitability 
of muscle cells (Trailovic et al., 2005).  
 Effects of AF1 and AF2 have also been shown on the vagina vera of the A. 
suum. The vagina vera, unlike body wall muscles, is circular in structure. Both 
peptides inhibit the spontaneous contraction but only AF1 induced the biphasic 
response seen in somatic muscle cells (Fellowes et al., 1998). In sheep nematode 
H. contortus AF2 inhibited the ACh induced muscle contractions (Marks et al., 1999).  
AVPGVLRFamide (AF3) and GDVPGVLRFamide (AF4) 
            Six C-terminal PGVLRFamide peptides (AF3, AF4, AF10, AF13, AF14 and 
AF20, Table. 2.7) have been isolated from A. suum and have been shown to 
increase muscle tension, they are excitatory in nature (Davis et al., 1996). Both AF3 
and AF4 induced muscle contractions and like AF2 they increased the muscle cAMP 
levels. However, electrophysiological recording showed that the AF3 and AF4 
induced muscle depolarization was independent of ACh receptor activation or 
inhibition (Trim et al., 1997). Also cobalt was more effective at blocking the AF3 and 
AF4 induced depolarization of muscle membrane than those of ACh. These results 
confirm that AF3 and AF4 produce their effect without an effect on muscle nAChR’s 
(Trim et al., 1997), the effect on second messengers is yet to be completely 
understood. AF3 and AF4 had complex multiphasic effects on ovijector, initial 
contraction followed by relaxation and a period of inactivity. The effects of AF3 & 
AF4 are different from AF1 & AF2 suggesting that there are different receptors for 
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different peptides (Fellowes et al., 2000; Fellowes et al., 1998). AF3 and AF4 
produced similar responses in the related species, Ascaridia galli suggesting that the 
effects of these peptides are not limited to A. suum in nematodes (Trim et al., 1998).      
SDPNFLRFamide (PF1), SADPNFLRFamide (PF2)    
 PF1 and PF2 both have been isolated from the free living nematode P. 
redivivus (Geary et al., 1992) and C. elegans (Rosoff et al., 1993). Although they 
have not been identified in A. suum, both produce profound inhibitory effects in A. 
suum muscle (Maule et al., 1994b). Both PF1 and PF2 produced similar inhibitory 
effects on muscle cells: prolonged dose-dependent flaccid paralysis and slow 
hyperpolarization. PF1 relaxes ACh and levamisole contracted muscles and inhibits 
the excitatory peptides AF1 and AF2. The effects of PF1 and PF2 on muscle cells 
were nerve cord independent and Ca2+-dependent (Franks et al., 1994; Maule et al., 
1995a). It has been hypothesized that a NO (nitric oxide) pathway is responsible for 
the effects of PF1 and PF2 on muscles. Inhibitors of NOS (NO synthase), the 
enzyme responsible for NO generation, has been found to block the effects PF1 & 
PF2 on muscle cells. Also, the NO donor nitroprusside mimicked the PF1 induced 
muscle relaxation in A. suum muscle (Bowman et al., 1995). Interestingly, NOS 
activity was highest and NOS binding was most pronounced in the Ascaris 
hypodermal layer associated with muscles.  
 On the vagina vera preparation PF1 and PF2 produced circular muscle 
relaxation (shortening) and flaccid paralysis at high concentrations. But lower 
concentrations caused transient cessation of contractions which resumed after 
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addition of peptides, PF1 and PF2. PF2 produced measurably greater response  
compared to PF1 (Fellowes et al., 2000).   
 Other PF peptides also have effects on the Ascaris musculature (Table 2.7). 
KSAYMRFamide (PF3) was the first peptide demonstrated to have different effects 
on dorsal and ventral musculature; PF3 contracts ventral but relaxes dorsal muscles 
(Maule et al., 1995a). PF4 (KPFIRFamide) is the only neuropeptides shown to have 
a direct effect on ion channels (Purcell et al., 2002). PF4 has inhibitory effects on 
Ascaris body wall muscles, inducing nerve cord independent and Cl- dependent 
reversible relaxation. Electrophysiologically it also produced hyperpolarization of 
muscle cells (Maule et al., 1995a; Maule et al., 1995b). Table 2.7 and 2.8 gives a 
detailed summary of different peptides and their effects on nematode systems.  
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Nematode peptide 
(and abbreviation) 
Effects on neuromuscular system of 
Ascaris suum 
Effects on vagina 
vera  
KN6yEFIRFamide 
(AFI) 
Biphasic effects ≥ (1 nM) on muscle strips. 
Relaxation followed by increased muscle 
contractility. Small (1-2 mV) depolarization of 
muscle cells. Abolishes slow membrane 
potentials and increases input conductance’s 
of VI and DI inhibitory neurons. 
Biphasic effects (≥ 10 
nM) – profound 
contraction followed 
by period of 
relaxation. 
KHEYLRFamide 
(AF2) 
 
Qualitatively similar biphasic effects on 
muscle strips to those of AF 1 but much more 
potent (≥1 pM). Potentiates ACh-induced 
contraction, and increases the amplitude of 
EJPs; Stimulates cAMP levels. 
Reduces contraction 
frequency (0.1 µM) 
AVPGVLRFamide 
(AF3) 
Contraction of dorsal muscle strips (0.1 µM). 
Increases sensitivity of muscle to ACh but 
action is independent of ACh receptor; 
decreases cAMP levels.  
Multi-phasic  effects 
(≥1 mM) – transient 
contraction than 
relaxation and return 
of contractile activity 
GDVPGVLRFamide 
(AF4) 
Contraction of dorsal muscle strips (0.1 µM). Similar effects to AF3 
but less potent (3 nM) 
SDPNFLRFamide 
(PFI) 
Slow Ca2+ -dependent and nerve cord-
independent relaxation (≥1 nM) and flaccid 
paralysis of muscle strips. Decreases 
amplitude of EJPs. Effects may involve NO. 
Dose-dependent hyperpolarization (≤12 mV) 
of muscle cells. 
Induces a transient 
flaccid paralysis (≥ 3 
nM) 
SADPNFLRFamide 
(PF2) 
Similar effects to PFI (see above). Transient flaccid 
paralysis (≥ 1 nM) 
KSAYHRFamide 
[AF8 (PF3)] 
Nerve cord-dependent contraction of ventral 
(≥0.1 µM) and relaxation of dorsal (≥1 µM) 
muscle strips. Concentration-dependent 
inhibition of 5-HT-stimulated pharyngeal 
pumping. 
Reduces contraction 
frequency and 
amplitude (≥ 0.1 µm) 
KPNFIRFamide 
(PF4) 
Rapid Cl- dependent and nerve cord-
independent relaxation of muscle strips (≥ 1 
nM). Concentration-dependent 
hyperpolarization (4-6 mV) and increase in 
input conductance of muscle cells. 
Induces flaccid 
paralysis (≥ 10 nM) 
  
 Table 2.7 (Day et al., 1999; Maule et al., 1996) Effects of nematode FLPs on 
 Ascaris suum neuromuscular and reproductive system.  
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Gene Peptide 
Peptide 
title Behavioral effects  
Ascaris suum 
body wall 
muscle 
response type 
(bwRT) Pharynx  Electrophysiology  
flp-1 KPNFIRFa PF4 
C. elegans flp-1 
KO: uncoordinated 
movement, 
hyperactivity, 
defective nose touch 
response, osmotic 
avoidance and egg 
laying 
bwRT2 NE As PP  
 SADPNFLRFa PF2   ↓ Ce APF; As PP  
 SDPNFLRFa PF1  bwRT1 ↓ Ce APF; As PP  
 SDIGISEPNFLRFa AF11 As PI: ma bwRT1  
DE2↑Rin↓EPSP↑; 
DI↑Rin↓ 
flp-2 LRGEPIRFa      
 SPREPIRFa    ↑ Ce APF  
flp-3 SPLGTMRFa      
 SAEPFGTMRFa    ↓ Ce APF  
flp-4 ASPSFIRFa      
 SGKPTFIRFa AF5 As PI: ↓ movement bwRT3  DE2↑Rin↓EPSP↑; DI↓Rin↓ 
 AGPRFIRFa AF7 As PI: ↓ movement   DE2↓EPSP↑; DI↓Rin↓ 
 PTFIRFa    ↑ Ce APF  
flp-5 AGAKFIRFa      
 GAKFIRFa    ↑ Ce APF  
 APKPKFIRFa      
 FIRFa AF6 As PI: negligible  NE As PP DE2↑EPSP↑; DI↓Rin↓ 
flp-6 KSAYMRFa AF8/PF3 As PI: ma, ventral coiling 
Ventral: 
bwRT3 Dorsal 
bwRT1 
↑ Ce APF; ↓ As 
PP 
DE2↓Rin↓EPSP↓; 
DI↑↓Rin↓ 
flp-7 SPMERSAMVRFa      
 SPMQRSSMVRFa    NE Ce APF  
flp-8 KNEFIRFa AF1 As PI: ↓ bwRT4 ↑ Ce APF; ↓ As PP 
DE2↑Rin↓EPSP↑; 
DI↓Rin↓ 
flp-9 KPSFVRFa  
C. elegans flp-9 
KO: Reduced 
locomotion 
No effect ↓ Ce APF  
flp-10 QPKARSGYIRFa    NE Ce APF  
flp-11 AMRNALVRFa    ↓ Ce APF  
 NGAPQPFVRFa      
flp-12 RNKFEFIRFa    NE Ce APF  
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Gene Peptide Peptide title 
Behavioral 
effects  
Ascaris 
suum 
body wall 
muscle 
response 
type 
(bwRT) 
Pharynx  Electrophysiology  
flp-13 AADGAPLIRFa   bwRT1   
 AEGLSSPLIRFa AF19 As PI: ma   DE2↓Rin↓EPSPa↓; DI↓Rin↓ 
     ↓ Ce APF  
 APEASPFIRFa   bwRT1   
 ASSAPLIRFa      
flp-14 KHEYLRFa AF2/PF5 As PI: ↑ bwRT4 ↑ Ce APF; NE As PP DE2↑Rin↑↓; DI– Rin↓ 
flp-15 GPSGPLRFa      
 GGPQGPLRFa    ↓ Ce APF  
flp-16 AQTFVRFa AF15 As PI: ma  ↓ Ce APF DE2↑Rin↓EPSP↑; DI↑Rin↓ 
       
 GQTFVRFa      
flp-17 KSQYIRFa    ↑ Ce APF  
 KSAFVRFa    ↑ Ce APF  
flp-18 AVPGVLRFa AF3 As PI: ↑ bwRT3 NE As PP DE2↑Rin↑EPSP↑; DI– Rin↓ 
 GDVPGVLRFa AF4  bwRT3 NE As PP DE2↑Rin↑EPSP↓; DI↓Rin↓ 
 GFGDEMSMPGVLRFa AF10  bwRT3  DE2↑Rin↑; DI– Rin↓ 
    bwRT3  DE2↑Rin↑EPSP↑; DI↓Rin↓ 
 GMPGVLRFa AF20     
    bwRT3  DE2↑Rin↑; DI– 
 SDMPGVLRFa AF13     
    bwRT3  DE2↑Rin↑EPSP↑; DI↓Rin↓ 
 SMPGVLRFa AF14     
 SVPGVLRFa   bwRT3   
 EMPGVLRFa    ↓ Ce APF  
flp-19 ASWASSVRFa      
 WANQVRFa    ↓ Ce APF  
flp-20 AMMRFa    NE Ce APF  
flp-21 GLGPRPLRFa AF9 
C. elegans flp-21 
KO enhances 
social feeding, 
overexpression 
suppresses social 
feeding; As PI: ↓ 
bwRT3 ↓ Ce APF DE2↑EPSP↑; DI↓Rin↓ 
flp-22 SPSAKWMRFa    ↑ Ce APF  
flp-23 TKFQDFLRFa    NE Ce APF  
flp-24 VPSAADMMIRFa   No effecth   
flp-29 ILMRFa AF16 As PI: negligible  NE As PP DE2– EPSP↓; DI– 
 FDRDFMHFa AF17 As PI: ma bwRT3   
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 Table 2.8  Functional classes of nematode FLPs (McVeigh et al., 2006).   
 a In peptide sequences, a indicates amide. 
 b Peptide titles indicate the species from which peptides have been biochemically isolated: AF, A. 
 suum FLP; PF, P. redivivus FLP. 
 c ‘As PI’ denotes analysis of worm behavior following pseudocoelomic injection into adult A. suum; 
 ↑, increased movement; ↓, decreased movement; ma, movement abolished; negligible, negligible 
 effect. Only gross descriptions of effects, based on qualitative descriptions of Ref. Nelson et al., 
 (1998b), are given; for more detailed descriptions of behavioral effects, see Refs. Davis et al., 
 (2001) and Reinitz et al., (2000) 
 d bwRT denotes A. suum dorsal body wall muscle response types 1–4: 1, slow inhibitory; 2, fast 
 inhibitory; 3, excitatory; 4, biphasic; 
 e ovRT denotes A. suum ovijector response types 1–5: 1, inhibitory; 2, excitatory; 3, transient 
 contraction; 4, transient contraction followed by spastic paralysis; 5, relaxation followed by 
 increased activity. 
 f ‘As PP’ denotes effects on A. suum 5-HT stimulated pharyngeal pumping; Ce APF denotes effects 
 on C. elegans pharyngeal action potential frequency; NE, no effect. 
 g DE2 denotes a hyperpolarizing (↓), depolarizing (↑) or negligible (–) effect on A. suum DE2 
 motorneurons; Rin details an increase (↑), decrease (↓) or biphasic effect (↑↓) on neuronal input 
 resistance; EPSP denotes an increase (↑) or decrease (↓) on excitatory postsynaptic potential 
 frequency; EPSPa denotes changes in excitatory postsynaptic potential amplitude; DI denotes a 
 hyperpolarizing (↓), depolarizing (↑), biphasic (↑↓) or negligible (-) effect on A. suum DI 
 motorneurons; 
 h McVeigh, P., Marks, N.J., Maule, A.G., unpublished. Cited by McVeigh et al., 2006  
 a In peptide sequences, a indicates amide. 
 b Peptide titles indicate the species from which peptides have been biochemically isolated: AF, A. 
 suum FLP; PF, P. redivivus FLP. 
 c ‘As PI’ denotes analysis of worm behavior following pseudocoelomic injection into adult A. suum; 
 ↑, increased movement; ↓, decreased movement; ma, movement abolished; negligible, negligible 
 effect. Only gross descriptions of  
 
2.5.7 Nematode FLP receptors  
 Most nematode neuropeptides activate seven-transmembrane G-protein 
coupled receptors (GPCR’s) to induce their effects. Indirect data obtained from worm 
physiology, heterologous expression and reverse genetics has identified GPCR’s as 
potential target receptors of FLPs (Kubiak et al., 2007; Kubiak et al., 2003a; Kubiak 
et al., 2003b; Li et al., 1999; Reinitz et al., 2000; Thompson et al., 2003). Completion 
of the C. elegans genome sequence and preliminary data has lead to the 
identification of ~ 54 candidate for neuropeptide GPCR’s. There are close to ~ 60 
neuropeptide genes in C. elegans. Different spliced forms of C. elegans GPCR’s 
have also been cloned, sequenced and expressed in variety of systems but 
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functional consequences of this variation have yet to be determined (Komuniecki et 
al., 2004; Lowery et al., 2003). More recently deorphanization and cloning  of C. 
elegans GPCR’s as FLP receptors (Kubiak et al., 2007; Kubiak et al., 2003b) and 
their  functional expression has also confirmed the GPCR mediated effects of FLPs 
(Greenwood et al., 2005; Mertens et al., 2006; Mertens et al., 2005). Unlike the 
apparent promiscuous expression of FLPs in different tissues the cloned receptors 
are found to be relatively selective towards their ligand. The studies so far have 
provided data for potential ligand-receptor pairs but all the activating ligands have 
not been tested as yet. Also, most of the results obtained are in in-vitro experiments 
and in-vivo receptor ligand expression has yet to confirm the same. Unlike 
nematodes, no FLP receptors have been identified so far in flatworms. Although 
based on functional studies GPCR signaling systems have been implicated in the 
FLP responses, (McVeigh et al., 2005).  
Conclusion  
 From the identification of more than 60 nematode FLPs, it is apparent that the 
nematode signaling system is highly developed and plays an important role in worm 
physiology. It is also possible that FLPs, like neuropeptides, interact with other 
signaling pathways, not only modulating the different physiological systems, but also 
playing a role in the development of worms. Therefore they offer a potential target 
for the development of anthelmintic drugs. With the availability of different tools for 
investigation it is the right time to seriously consider them and their receptors as 
candidates for novel anthelmintics.  
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2.5.8 Nematode neurotransmitters  
 Acetylcholine (ACh) was the first molecule to be classified as a 
neurotransmitter in vertebrates. ACh and γ-aminobutyric acid (GABA) were the two 
neurotransmitters identified to modulate electrical activity in somatic muscles of A. 
suum   (del Castillo et al., 1964a; Stretton et al., 1978). We now have evidence to 
prove that serotonin, histamine, dopamine along with neuropeptides play important 
roles in the nematode neuromuscular system (http://wormbook.com). ACh is the 
major excitatory and GABA is the major inhibitory neurotransmitter in the A. suum 
nervous system (del Castillo et al., 1964a; del Castillo et al., 1964b; Stretton et al., 
1978). Originally, it was hypothesized that ACh and GABA were receptors located 
exclusively at the synaptic junction (del Castillo et al., 1964a; Norton et al., 1957) but 
this was proven otherwise with advances in the understanding of the 
electrophysiology of muscles. Now we know that apart from neuromuscular 
synapses, AChR’s and GABAR’s are present extra-synaptically on the muscle bag 
region (Brading et al., 1971; Martin, 1982).   
Acetylcholine (ACh) 
 
 
 
  
                            Figure 2.10 The chemical structure of acetylcholine. 
 ACh is one of the major neurotransmitter with more than a third of neurons in 
C. elegans releasing ACh. The stimulating action of ACh on A. suum muscle was 
first demonstrated by Baldwin and Moyle (1949) and later the excitatory nature of the 
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AChR was confirmed by Colquhoun et al., (1991).  In vertebrates there are two 
distinct AChR’s; nicotinic (activated by nicotine) and muscarinic (activated by 
muscarine). Nicotinic receptors (nAChR’s) are ionotropic in nature have five 
subunits, each unit is composed of four transmembrane domains, and belong to the 
group of ligand gated ion channels. Where as, muscarinic receptors (mAChR’s) 
have seven transmembrane domains and belonged to group of GPCR’s (Katzung, 
2003). Muscle contraction assays (Robertson et al., 2002) and single channel 
recordings (Qian et al., 2006) in Ascaris  have lead to the identification of three 
pharmacologically distinct nAChR’s; L-, N-, and B-type. As the name indicates they 
respond to ACh and nicotinic agonists such as levamisole, nicotine and bephenium. 
More recently ACh-gated chloride channels have been identified in C. elegans 
(ACC-1,-2, -3 and -4). The expression and function of these ion channels is not 
understood.   
 Muscarinic agonists were found to be weak or ineffective in modulating 
muscle contraction in A. suum (Natoff, 1969; Rozhkova et al., 1978) leading to the 
hypothesis that AChR’s in Ascaris are only the nicotinic type. However later, ligand 
binding studies in nematode C. elegans confirmed the presence of muscarinic 
receptors in nematodes (Culotti et al., 1983). Three genes coding mAChR’s have 
been identified in C. elegans; gar-1, gar-2 and gar-3 (Lee et al., 2000; Park et al., 
2003; Park et al., 2000). Among the three mAChR’s (GAR-1,-2 and -3) GAR-3 
isoform appears most similar to mammalian mAChR’s. Interestingly, mAChR’s 
(GAR’s) can undergo alternative splicing which plays a significant role in maintaining 
molecular diversity in ACh GPCR’s in C. elegans. In A. suum, like C. elegans genes 
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coding for gar-1, gar-2 and gar-3 have been identified in genomic sequences. GAR-
1 mAChR in A. suum have been cloned, it has two isoforms 1A and 1B. These 
isoforms are similar to GAR-1 isoforms found in C. elegans ( M. Kimber and T. Day, 
pers. comm.). 
γ-amino butyric acid (GABA) 
 
 Figure 2.11 The chemical structure of GABA.  
 
 GABA is an amino-acid neurotransmitter and is synthesized from glutamate 
(Bazemore et al., 1956). GABA is an inhibitory neurotransmitter in Ascaris (Martin et 
al., 1991).  Although the pharmacology of GABA receptors in C. elegans differs from 
vertebrates, two types of GABA receptors are identified in C. elegans based on 
sequence similarity, GABAA and GABAB. GABAA receptors are associated with 
chloride channels and are inhibitory in nature (Parri et al., 1991). GABAB is a Gi/o 
coupled receptor and its activation inhibits either voltage-gated calcium channels or 
activates potassium channels in vertebrates (Campbell et al., 1993). Most of the 
vertebrate GABAA agonists are active on the A. suum receptor (Holden-Dye et al., 
1989; Holden-Dye et al., 1988). The GABA neurons are well conserved in different 
nematodes. In C. elegans 26 neurons use GABA as a neurotransmitter (Guastella et 
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al., 1991; Johnson et al., 1987). GABA inhibits foraging and muscle contractions but 
contracts enteric muscles during defecation in C. elegans   (McIntire et al., 1993). 
Glutamate  
 A glutamatergic pathway has been shown to play a significant role in Ascaris 
locomotion and pharyngeal functions (Davis, 1998). The DE2 motor neuron is the 
primary target in the A. suum nervous system. Ionotropic ligand-gated GluR’s have 
been found to mediate excitatory and inhibitory neurotransmission in C. elegans 
(Brockie et al., 2003). Out of 10 excitatory GluR subunits identified in C. elegans, 
GLR-1 – GLR-8 are similar to vertebrate non-NMDA receptors. NMR-1 and NMR-2 
have similarity with NMDA receptors.  GluCl receptors are also identified in C. 
elegans, Ascaris and H. contortus (Cully et al., 1996; Forrester et al., 1999; 
Jagannathan et al., 1999; Portillo et al., 2003) these receptors are the target site of 
ivermectin (Cully et al., 1994; Martin, 1996).  GluCl channels are expressed in 
pharyngeal muscles and neurons (Dent et al., 2000; Laughton et al., 1997; Vassilatis 
et al., 1997b). 
Serotonin  
 Serotonin (5-HT) receptors have been identified in Ascaris  pharynx and 
ventral cord motor neurons in the tail region of males (Johnson et al., 1996). Eight 
type of neurons are found to be immunopositive for 5-HT in C. elegans. Application 
of serotonin (Horvitz et al., 1982; Waggoner et al., 1998) or serotonin knockout 
worms (Loer et al., 1993; Waggoner et al., 1998) show locomotory defects with 
increased rate of egg laying. G-protein coupled serotonin receptors (SER-1, SER-4 
and SER-7) have been identified in C. elegans. These receptors are expressed in 
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pharyngeal neurons and muscles (Hamdan et al., 1999; Hobson et al., 2003; 
Hobson et al., 2006; Olde et al., 1997). 
Dopamine  
 Some evidence of dopaminergic signaling has been shown in A. suum   
(Sulston et al., 1975). In C. elegans there are eight neurons which use dopamine as 
neurotransmitter. Dopamine signaling is linked to environmentally based behavior in 
C. elegans. It has been shown that dopamine signaling helps in learning and 
memory in worms (Bettinger et al., 2004; Colbert et al., 1995). DOP-1 –DOP-4 are 
four dopaminergic receptors identified in C. elegans (Suo et al., 2002) 
2.6 Voltage-activated currents  
2.6.1 Voltage-activated calcium currents  
 Ca2+ channels mediate Ca2+ influx in response to membrane depolarization in 
many different cell types and especially in excitable cells. Ca2+ entry in to cells 
through voltage-gated calcium channels (VGCC’s) acts as second messenger of 
electrical signaling and initiates intracellular events such as, muscle contraction, 
neurotransmitter release secretion, gene expression and cellular differentiation. 
Their activity is essential to couple electrical signals on the cell surface to 
physiological events inside cells. High levels of Ca2+ entry can lead to toxicity as 
these events are based on a balanced entry of Ca2+ into the system. The importance 
of regulation of Ca2+ entry in cells is reflected by the presence of several subtypes of 
Ca2+ channels in vertebrate system, Table 2.14. Each of these channels is distinct in 
their location, kinetics, pharmacology and distribution. The first evidence of different 
channel types was found  in starfish eggs (Hagiwara et al., 1975) and then  in 
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mammalian neurons (Carbone et al., 1984; Fedulova et al., 1985) These channels 
are  protein complexes with four or five distinct subunits. The biggest subunit α1 is 
the most common site of channel regulation as it contains the conduction pore, 
voltage sensor and gating apparatus of the channel thus, α1 determines the 
pharmacological and electrophysiological diversity of the channel. The α1 subunit is 
composed of four homologous domains (I-IV), with six transmembrane segments in 
each. The S4 segment serves as the voltage sensor and the pore loop between S5 
& S6 determines ion conductance and selectivity (Catterall et al., 2005). There are 
ten α1 channel types associated with six different classes of calcium channels.  In 
addition to the α subunit there are three auxiliary subunits: α2-δ, β and γ, which are 
also responsible for modulation of the channel complex, Figure 2.14.  
 L-type calcium currents are high-voltage-activated (strong depolarization), 
long lasting currents which are blocked by calcium channel antagonists, like 
dihydropyridines (DHP), phenylalkylamines, and benzothiazepines. They are the 
major calcium carrying currents in muscles and endocrine cells. L-type low-voltage-
activated calcium currents are also identified in neurons and pacemaker cells.  
 The dihydropyridine insensitive high voltage-activated currents are of three 
types, N-, P/Q-, and R-type. These currents are blocked by different peptide toxins 
but not by L-type calcium channel blockers, Table 2.9. N-types are neuronal channel 
types (Nowycky et al., 1985), whereas P-type were first isolated from purkinje cells 
(Hillman et al., 1991), Q-type arise from the same molecular entity as P-types so are 
combined together (Randall et al., 1995). N-and P/Q-type calcium channels are the 
main subtypes responsible for synaptic transmission and are located at 
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neuromuscular junctions. The residual calcium currents which are resistant to 
dihydropyridines and the N and P/Q channel toxins are classified as R-type calcium 
currents (Randall et al., 1995).   
 Figure 2.12  (Dolphin, 2006) Structure of voltage-gated calcium channels, there are 
 five components (α1, α2, β, δ and γ). Calcium channel dendrogram, showing the 
 percent identity between different  calcium channel types.  
 
  The low-voltage-activated calcium channel currents which can be 
activated by small depolarizations of cell membrane are grouped as T-type 
channels. These channels are responsible for low threshold spikes which in turn 
modulate sodium channels. Three T-type channels have been cloned recently 
(Perez-Reyes, 2003). T-type channels are activated at lower voltages, inactivate 
quickly and are poor conductors of barium. Different T-type calcium channels are 
pharmacologically separated on the basis of their response to nickel and selective 
block by lower concentration of mibefradil (Perez-Reyes et al., 2006).  
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Channel Current Localization Specific Antagonists Cellular Functions 
CaV1.1  L  Skeletal muscle; transverse tubules  
Dihydropyridines; 
phenylalkylamines; 
benzothiazepines  
Excitation-contraction 
coupling 
CaV1.2  L  
Cardiac myocytes; smooth 
muscle myocytes; endocrine 
cells; neuronal cell bodies; 
proximal dendrites  
Dihydropyridines; 
phenylalkylamines; 
benzothiazepines  
Excitation-contraction 
coupling; hormone release; 
regulation of transcription; 
synaptic integration 
CaV1.3  L  
Endocrine cells; neuronal cell 
bodies and dendrites; cardiac 
atrial myocytes and 
pacemaker cells; cochlear hair 
cells  
Dihydropyridines; 
phenylalkylamines; 
benzothiazepines  
Hormone release; regulation 
of transcription; synaptic 
regulation; cardiac 
pacemaking; hearing; 
neurotransmitter release 
from sensory cells 
CaV1.4  L  
Retinal rod and bipolar cells; 
spinal cord; adrenal gland; 
mast cells  
Dihydropyridines; 
phenylalkylamines; 
benzothiazepines  
Neurotransmitter release 
from photoreceptors 
CaV2.1  P/Q  
Nerve terminals and 
dendrites; neuroendocrine 
cells  
ω-Agatoxin IVA  
Neurotransmitter release; 
dendritic Ca2+ transients; 
hormone release 
CaV2.2  N  
Nerve terminals and 
dendrites; neuroendocrine 
cells  
ω-Conotoxin-GVIA  
Neurotransmitter release; 
dendritic Ca2+ transients; 
hormone release 
CaV2.3  R  Neuronal cell bodies and dendrites  SNX-482  
Repetitive firing; dendritic 
calcium transients 
CaV3.1  T  
Neuronal cell bodies and 
dendrites; cardiac and smooth 
muscle myocytes  
None Pacemaking; repetitive firing 
CaV3.2  T  
Neuronal cell bodies and 
dendrites; cardiac and smooth 
muscle myocytes  
None Pacemaking; repetitive firing 
Cav3.3 T Neuronal cell bodies and dendrites None Pacemaking; repetitive firing 
 
 Table 2.9   (Catterall, 2000) Different classes of vertebrate calcium channels.  
 
 In the parasitic nematode A. suum, modulation of the spike potential has been 
attributed to voltage-activated calcium currents (Martin et al., 1992; Weisblat et al., 
1976). Voltage-activated currents were isolated from somatic muscles cells of A. 
suum which are pharmacologically and kinetically similar to vertebrate P/Q-type 
currents (Verma et al., 2007). In the absence of a complete genome sequence for A. 
suum the isolation of calcium currents is based mainly on pharmacology and 
kinetics. Completion of the genome sequence of C.elegans has paved the way for 
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identification of calcium channel homologues, functionally and genetically. All the 
major types of calcium channel have been identified in C. elegans: EGL-19 (L-type); 
UNC-2 (N-, P/Q- & R-type) and CCA-1 (T-type).  
 egl-19 encodes for α1 subunit L-type voltage-activated calcium channel which 
is expressed in body wall muscles and pharyngeal muscles (Lee et al., 1997). Patch-
clamp studies and egl-19 mutants of C. elegans confirmed that this channel is 
dihydropyridine sensitive and exhibit calcium dependent inactivation, characteristics 
of vertebrate L-type calcium currents. EGL-19 in C. elegans controls body wall 
muscle functions and also modulates pharyngeal action potentials (Jospin et al., 
2002; Shtonda et al., 2005) . 
 The C. elegans unc-2 gene encodes for a α1 subunit structurally related to 
mammalian dihydropyridine insensitive- high-voltage-activated channels. The   unc-2 
gene has greatest similarity to vertebrate Cav2.3 subunits (R-type current), but is 
also similar to Cav2.1 and Cav2.2 subunits (N- and P/Q-type currents) (Mathews et 
al., 2003; Schafer et al., 1995). In C. elegans the cca-1 gene is expressed in 
pharyngeal muscles and encodes protein CCA-1 which has around a 70% similarity 
to mammalian Cav3 subunits (T-type current) (Steger et al., 2005). CCA-1 T-type 
currents improve excitatory effect of synaptic inputs and modulate pharyngeal 
contraction (Shtonda et al., 2005).  Two more channels identified in C. elegans, nca-
1 and nca-2, are not similar to any mammalian calcium channels. NCA-1 and NCA-2 
are similar to one another and to a channel in yeast Schiozosaccharomyces pombe 
(Bargmann, 1998). These channels are found in the nervous system and ventral 
cord and are recently associated with neuronal transmission in C. elegans (Yeh et 
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al., 2008). Figure 2.15 shows the different calcium channels identified in C. elegans 
and its percent homology with vertebrate calcium channels.  
 
 Figure 2.13 (Mathews et al., 2003) Phylogenetic comparison of C. elegans and 
 vertebrate calcium channel α1 subunits.  
 
  Functional voltage-gated calcium channels have also been identified in 
platyhelminths. The first indication of voltage-activated currents was reported by 
Blair and Anderson (1994) in muscle fibers of a parasitic flatworm, B. candida. Later 
on calcium currents were also recorded from Dugesia tigrina (Cobbett et al., 2003) 
and S. mansoni (Day et al., 2000; Day et al., 1993). Currents from S. mansoni were 
pharmacologically characterized and found to be associated with body wall muscle 
contraction (Mendonca-Silva et al., 2006). Interestingly, in schistosomes three high 
voltage-activated α1 calcium channel subunits have been identified. Based on 
sequence similarity to mammalian calcium channels two α units loosely resemble 
non-L-type α1 subunits and one is related to L-type α1 (Kohn et al., 2001b). Along 
with α subunits two Cavβs subunits also have been cloned from S. mansoni and  S. 
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japonicum (Kohn et al., 2001a). β subunits in Schistosoma are functionally and 
structurally different from mammalian β subunits. Unlike in mammals, β subunits  
modulate sensitivity of α subunits in schistosomes (Jeziorski et al., 2006).  Voltage-
gated calcium channels are assumed to be the target site of anthelmintic 
praziquantel in schistosomes (Greenberg, 2005). 
2.6.2 Voltage-activated potassium currents  
 Voltage-gated potassium channels comprise the largest and most diverse 
group of transmembrane ion channels in mammals. These channels are crucial for 
bringing the cell to resting phase after depolarization. There are 40 known genes in 
mammalian genome representing them. They maintain the potassium ion dependent 
component of the membrane potential and are critical to many physiological 
processes. The first potassium channel gene was the Drosophila voltage-gated 
shaker channel.  α subunits form the ion conducting pore as is the case in voltage-
gated calcium channels. The voltage-activated potassium channels are divided into 
twelve families based on the α subunit, KV1-12  (Gutman et al., 2005). Voltage-gated 
potassium channel group also include calcium-activated (KCa), inward-rectifying 
(KIR), and two pore (K2P) families; these families are classified separately and 
numbered according to their discovery. All the voltage-activated potassium channels 
are composed of six/seven segments with S4 being the segment conferring voltage 
sensitivity (Gutman et al., 2003).  
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 Figure 2.14 (Gutman et al., 2005) Phylogenetic trees of the KV Channels  
 Neuronal activity in mammals is maintained by different KV channels. KV 
channels are involved in action potential threshold frequency and the burst duration 
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of action potentials. Drsosophila mutants of KV channels demonstrate abnormal 
hyper excitability.  
 KIR has a long cytoplasmic pore and negatively charged amino acids on the 
wall for inward rectification. These channels play an important physiological role in 
function of many organs, including brain, kidney, ears, retina and endocrine cells. 
Changes in channel proteins have been described in different disease conditions in 
humans (Kubo et al., 2005).  
  
 Figure 2.15  (Kubo et al., 2005) Phylogenetic trees of the KIR Channels  
  KCa channels are the second major group of the voltage-gated 
potassium channels. These channels are modulated by entry of calcium and 
changes in the membrane potential of the cell. They include three small 
conductance KCa channels (KCa 2.1, 2.2 and 2.3); intermediate conductance 
channels KCa 3.1 and KCa Slo (1.1, 4.1, 4.2 and 5.1) channels, Fig. 2.16. The first 
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two groups are voltage insensitive and are activated by low concentration of calcium 
while the KCa 1.1 channel is activated by both membrane depolarization and internal 
calcium. Both small and intermediate conductance channels play important role in 
calcium dependent signaling in excitable and non excitable cells. They do not bind 
calcium but detect calcium by calmodulin binding and the resulting conformational 
changes (Rang, 2003; Wei et al., 2005). SLO-1 channels of this group are the most 
studied channels and were first identified in Drosophila “slowpoke” mutants. SLO-1 
channels are calcium dependent very high conductance potassium channels, “Big K” 
or “Maxi K channels” (Ghatta et al., 2006).  
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 Figure 2.16  (Wei et al., 2005) Phylogenetic trees of the KCA Channels 
 
  Figure 2.17 represents the structure of a SLO-1 channel as first 
identified in C. elegans: S9 and S10 segments determine the calcium sensitivity of 
the channels and a series of highly conserved negatively charged residues on the 
S10 domain forms the “calcium bowl” responsible for calcium binding  (Wei et al., 
1994). Coupling between calcium binding and channel activation as well as 
molecular characterization of other domains has not been completely resolved in C. 
elegans. There are two slo (1 &2) genes in C. elegans (Wang et al., 2001). slo-1 is 
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expressed in both motor neurons and body wall muscle, but transgenic animal 
studies have shown that SLO-1 produces its effect by neural signaling. In the 
pharynx slo-1 is expressed in neurons and regulates feeding. More recently forward 
genetic screens in C. elegans have also demonstrated that slo-1 mutants are 
resistant to the novel anthelmintic emodepside (Guest et al., 2007). SLO-1 offers an 
exciting target for the development of novel anthelmintics.  
 
 Figure 2.17 (Ghatta et al., 2006) Structure of the BK (SLO-1) Channel.   
  Outward potassium currents have been described in the parasitic 
nematode A. suum (Martin et al., 1992). These currents are sensitive to potassium 
channel blockers; 4-AP, and TEA. It has been assumed that potassium currents 
contribute to slow waves and modulation waves in electrophysiological recordings in 
A. suum (Weisblat et al., 1976). Recently Trailovic et al., (2007) have shown that 
depolarizing effect of cholinergic agents can be potentiated by potassium channel 
blockers.  
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2.7 Anthelmintics  
 The drugs used to control helminth parasitic infections are called 
anthelmintics. Anthelmintics offer a very important and successful method to control 
and treat parasitic helminth infections in animals and humans. Antinematodal drugs 
currently available in market are very helminth specific and have little effect on 
vertebrate physiology at recommended doses. The Following section discusses the 
major anthelmintics classes and their mode of action.  
2.7.1 Nicotinic agonists  
  
   Figure 2.18 Nicotinic agonists 
 There are four different groups of drugs which acts as nicotinic receptor 
agonists to produce their effects. These are the imidazolethiazoles (levamisole, 
 56 
tetramisole); the tetrahydropyrimidines (pyrantel, morantel and oxantel); the 
quaternary ammonium salts (bephenium and thenium) and the pyrimidines 
(methyridine)  (Robertson et al., 1993). These compounds are selective agonist of 
nematode nAChR’s (Janssen, 1976; Martin et al., 2007). They produce contraction 
and spastic paralysis and subsequent expulsion of worms from the host animal. The 
AChR’s are present on somatic muscles cells and depolarization leads to entry of 
calcium and contraction. Electrophysiological recordings in nematode parasites A. 
suum and O. dentatum using levamisole and its analogues induces depolarization, 
contraction and increase in spike frequency (Aceves et al., 1970; Martin et al., 1997; 
Robertson et al., 1993). The levamisole sensitive nAChR has been identified at the 
single channel level in, A. suum, O. dentatum and C. elegans (Richmond et al., 
1999; Robertson et al., 2002; Robertson et al., 1993). Levamisole induced 
contraction was found to be irreversible which could not be inhibited by atropine, 
tubocurarine, hexamethonium or piperazine (Coles et al., 1975; Coles et al., 1974).  
 Amino-acetonitrile derivatives (AAD’s) are a novel class of anthelmintics 
which act on nAChR’s. AAD’s response is mediated by ACR-23, which belongs to 
nematode specific DEG-3 group of nAChR’s (Kaminsky et al., 2008).  
2.7.2 Glutamate gated-chloride channel modulators 
 This group includes group of complex 16-membered macrocyclic lactones, 
avermectins, isolated from the fermented mixture of Streptomyces avermitlis  
(Chabala et al., 1980). This group includes ivermectin, abamectin, doramectin, 
milbemycin D and moxidectin. These compounds are structurally similar to 
macrolide antibiotics but they don’t have any antibiotic or antifungal properties. 
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Avermectins are highly efficacious against ectoparasites as well as endoparasites in 
man and animals (Campbell, 1985). The target site for ivermectins is glutamate-
gated chloride channels in nerve and muscles. The ivermectins interact selectively 
with parasitic GlCl channels preventing their closure, increasing chloride 
permeability. Chloride influx leads to hyperpolarization, decreasing or inhibiting 
neuronal transmission and this leads to paralysis of somatic muscles, inhibition of 
pharyngeal pumping and death of worms (Geary et al., 1993; Õmura, 2002; Omura 
et al., 2004). Glutamate-gated chloride channels are found only in nematodes, 
insects and ticks. Glutamate gated receptors in mammals are located in CNS where 
as in arthropods and nematodes they are located in peripheral nervous system 
making avermectins very safe and effective anthelmintics (Duce et al., 1985). GluCl 
channels have been identified in C. elegans and Xenopus oocytes (Cully et al., 
1994; Cully et al., 1996; Vassilatis et al., 1997a). Also the location of avermectin 
sensitive GluCl channel has been identified in pharyngeal muscles of the parasitic 
nematode A. suum (Martin, 1996) 
 Figure 2.19 (Omura et al., 2004) Avermectin. Structure of eight different 
 compounds isolated from fermentation. 
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2.7.3 Benzimidazoles  
 
 This class of drugs falls under category of drugs which interact selectively 
with nematode β-tubulin (Borgers et al., 1975). The list of compounds includes 
thiabendazole, fenbendazole, mebendazole, albendazole and prodrugs: febantel, 
thiophanate and netobimin. Benzimidazoles interaction with β-tubulin compromises 
the worm cytoskeleton. In A. suum pronounced degenerative changes were seen in 
cell cytoplasm with loss of glycogen, formation of autophagic vacuoles and decrease 
in number of microvilli (Borgers et al., 1975). In C. elegans benzimidazoles impairs 
locomotion, reproduction and inhibit oocyte development. In C.elegans the sensitivity 
is mediated by single gene ben-1 (Driscoll et al., 1989), the isolation of this gene is 
being exploited to understand benzimidazole resistance in H. contortus (Kwa et al., 
1994).  
 
Fenbendazole 
  Figure 2.20 Chemical structures of benzimidazole derivatives. 
 
 2.7.4 Cyclo-octadepsipeptides  
This group includes emodepside a semi-synthetic derivative of PF1022A, a 
fermentation product isolated from the fungus Mycelia sterilia. It is a broad spectrum 
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anthelmintic effective against worms resistant to all the other groups of drugs due to 
its novel mode of action (Harder et al., 2002). In A. suum emodepside caused 
muscle relaxation and inhibition of ACh or neuropeptide induced muscle contraction. 
The response was found to be dependent on calcium and potassium, mimicking the 
effects of the neuropeptides PF1 and PF2 (Willson et al., 2003). RNAi knockouts of 
latrophillin genes, lat-1 and lat-2, in C. elegans showed involvement of latrophillin in 
mode of action emodepside (Bull et al., 2007; Willson et al., 2004). But studies later 
demonstrated that lat-2 mutants are insensitive to emodepside suggesting that 
latrophillin receptors are not the primary targets (Guest et al., 2007). Forward 
genetic screens have very recently identified mutants of the slo-1 gene which are 
resistant to emodepside (Guest et al., 2007). SLO-1 is a calcium-activated 
potassium channel; it is expressed in the C.elegans nervous and muscular system 
but not in pharyngeal muscles (Holden-Dye et al., 2007). A SLO-1 mediated mode of 
action also supports the calcium and potassium dependent effects of emodepside.  
 
  
 
 
 
 
 
 
    
   Figure 2.21 Chemical structure of emodepside.   
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2.7.5 Other anthelmintics 
  This group includes important anthelmintics which have different mode of 
action than as any of the previous classes; piperazine and praziquantel. Piperazine 
is a GABA agonist and acts on ligand-gated chloride channel on synaptic or extra 
synaptic membrane (Martin, 1980; Martin, 1982). Piperazine exposure increases the 
opening of chloride channel on muscle membrane causing hyperpolarization, 
increased conductance and leading to spastic paralysis. Electrophysiologically 
piperazine activated single channel chloride channel currents have been recorded in 
A. suum (Martin, 1985; Martin, 1987). 
Praziquantel is a selective anthelmintic for schistosomes (Andrews et al., 
1983). Anthelmintic effects of praziquantel are mediated by increase in calcium 
permeability of parasitic muscle and / or tegument (Blair et al., 1994; Mehlhorn et al., 
1983). Increased calcium influxes across calcium induce calcium release (CICR) 
channels in tegument membrane have been implicated in the effects of praziquantel 
on schistosomes (Bennett et al., 1997; Day et al., 1992).   
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2.8 Hypothesis 
It is clear from the review preceding that there are a number of interesting and 
unanswered questions. In this thesis I investigated the following hypotheses:  
1. Entry of calcium from extracellular sources is responsible for muscle contraction 
in A. suum somatic muscle cells. It is assumed that spikes and slow waves 
induced under current clamp in A. suum muscles are calcium dependent. These 
spikes are potentiated by the excitatory neuropeptide, AF2. Our first hypothesis 
was that spiking is due to the opening of voltage-activated calcium channels. AF2 
increased the spiking and therefore the hypothesis was that AF2 will positively 
modulate the voltage-activated calcium currents.  
 
2. There are two distinct calcium currents in A. suum somatic muscle cells. The two 
currents are pharmacologically different. The second hypothesis was that both of 
the two currents can be modulated, negatively and positively, by FLPs. We 
investigated the effects of excitatory (AF3) and inhibitory (PF1) neuropeptide FLPs 
on the two calcium currents.  
    
3. The third hypothesis was aimed at investigating the role of muscarinic receptors 
in muscle contraction. Our hypothesis was that muscarinic receptors play some 
role in somatic muscle contraction and muscarinic AChR’s in nematodes modulate 
voltage-activated currents in the somatic muscle cells of A. suum. Colquhoun et al, 
(1991) tested effects of different mammalian cholinergic agonists including 
furtrethonium, muscarine, pilocarpine, arecoline, McN A343, bethanecol and 
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oxtremorine, on A. suum somatic muscle cells. They found that furtrethonium was 
the most potent. We therefore selected 5-methylfurmethiodide (MFI), which is a 
potent muscarinic agonist for further study on muscle contraction in A. suum. We 
studied the effect of the muscarinic agonist, MFI along with levamisole and 
acetylcholine on contraction and electrophysiology of the somatic muscle cells in 
A. suum.  
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increases voltage-activated calcium currents in Ascaris suum 
muscle. 
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3.1 Abstract 
 
Background and purpose: Resistance to all the classes of anti-nematodal drugs 
like the benzimidazoles, cholinergic agonists and avermectins, has now been 
recorded in animals and/or humans. The development of novel anthelmintics is an 
urgent and imperative need.  Receptors of nematode neuropeptides have been 
suggested to be suitable target sites for novel anthelmintic drugs.  
Experimental approach: To investigate the effect of AF2 on calcium-currents in 
Ascaris suum somatic muscle cells we employed the two-micropipette current-clamp 
and voltage-clamp techniques. 
Key Results: Here we report the isolation of voltage-activated transient inward 
calcium currents. These currents are similar in characteristics to C. elegans UNC-2 
type currents, non-L-type calcium currents. Following a 2-minute application of 1 µM 
AF2 , there was a significant long-lasting increase in the transient inward calcium 
current; AF2 increased the maximum current (from  - 84  nA to -158 nA) by shifting 
the threshold in the hyperpolarizing direction (V50 changed from -7.2 to -12.8 mV) 
and increasing the maximum conductance change from 1.91 to 2.94 µS.  
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Conclusion and Implications: These studies demonstrate a mechanism by which 
AF2 increases the excitability of the neuromuscular system by modulating calcium 
currents in nematodes. A selective small molecule ligand agonist of the AF2 receptor 
is predicted to increase the contraction and act synergistically with cholinergic 
anthelmintics and could counter resistance to these compounds.   
3.2 Introduction 
Nematode parasites have a diverse biology and infect plants, insects, animals 
and humans.  In most cases, they cause significant damage to their host.  Chemical 
agents (anthelmintics) that have a selective toxic effect on the parasites have been 
developed to control and treat these infections.   In most cases, these drugs were 
produced for domestic animal use, before they were developed for human use. This 
can be explained by the fact that the market for antiparasitic drugs in animals ($ 11 
billion U.S. world sales) is bigger than the market for human treatment ($ 0.5 billion 
U.S. world sales).   Regrettably, resistance to all the classes of anti-nematodal drugs 
like the benzimidazoles, cholinergic agonists and avermectins, has now been 
recorded in animals and/or humans (Dent et al., 2000; Geerts and Gryseels, 2001; 
Wolstenholme et al., 2004; Geary 2005; Martin et al., 2005).  The development of 
novel anthelmintics is an urgent and imperative need.   
Beginning with AF1 and AF2, a series of more than 20 novel neuropeptides 
have been isolated from the parasitic nematode Ascaris suum (Stretton et al., 1991). 
Receptors of nematode neuropeptides have been suggested to be suitable target 
sites for novel anthelmintic drugs (Greenwood et al., 2005; Mousley et al., 2005). 
Neuropeptides, known as FMRFamide-like peptides or FLPs, possess a C-terminal 
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motif usually comprising of an aromatic residue, a hydrophobic residue and an Arg-
Phe-amide (Maule et al., 2002). These neuropeptides modulate neuromuscular 
function. The neuromuscular system is a recognized target for the nicotinic and 
avermectin anthelmintics.  Evidence has also been gathered (Mousley et al., 2005) 
that shows that FLPs have activities in an extensive range of nematode parasites 
and even activities in arthropods.  Although initially, it was considered that FLP 
receptors were not present in vertebrate hosts (Geary et al., 1999), it has now been 
recognized that a number of FLPs have physiological effects in vertebrates, 
including modulation of food intake (Dockray, 2004), anti-nociception (Pittaway, et 
al., 1987) and increased blood pressure (Thiemermann et al., 1991).  Despite the 
possibility that there are FLP receptors in vertebrates, there is still optimism that 
selective small ligands may be found and developed for antiparasitic use (Mousley 
et al., 2005, Greenwood et al., 2005).   
AF2 is the FLP that has been recovered in the greatest quantities from 
Ascaris suum (Cowden and Stretton, 1993), C. elegans (Marks et al., 1995), 
Haemonchus contortus (Marks et al., 1999), and Panagrellus redivivus (Maule et al., 
1994).  AF2 has pronounced effects on muscle contraction of nematodes. At 
concentrations > 1 µM, AF2 produces excitatory responses in nematodes (Cowden 
and Stretton, 1993).  The abundance of AF2 in very diverse nematodes and the 
effects on the nematode neuromuscular system suggest that AF2 receptors should 
be suitable targets for novel broad-spectrum anthelmintics. Consequently, we have 
continued the exploration of the effects of AF2 and found that it potentiates the 
contractile effects of acetylcholine on Ascaris suum muscle strips (Trailovic et al., 
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2005). We have also observed that it increased spike frequency in 
electrophysiological experiments suggesting effects on voltage-activated currents.   
 We have now tested this hypothesis using voltage-clamp to examine these 
currents in muscle cells of the parasitic nematode Ascaris suum. Here we report 
effects of AF2 on voltage-activated currents in Ascaris suum muscle.  We found that 
following application of AF2 there was a long-lasting increase in the transient inward 
calcium current. These studies are important because they demonstrate a 
mechanism by which AF2 increases the excitability of the neuromuscular system of 
nematodes.  A selective small molecule ligand of the AF2 receptor is predicted to 
increase contraction and act synergistically with cholinergic anthelmintics and could 
counter development of resistance to these compounds. 
3.3 Materials and Methods 
Collection of worms 
Adult Ascaris suum were obtained weekly from the IBP pork packing plant at 
Storm Lake City, Iowa. Worms were maintained in Locke’s solution [NaCl (155mM), 
KCl (5 mM), CaCl2 (2 mM), NaHCO3 (1.5 mM) and glucose (5 mM)] at a temperature 
of 32◦C. The Locke’s solution was changed daily and the worms were used within 4 
days of collection. 
Muscle preparation 
1 cm muscle tissue flaps were prepared by dissecting the anterior part of the 
worm, 2-3 cm caudal to the head. A body muscle flap preparation was then pinned 
onto a Sylgard™-lined 3 ml Petri-dish. The intestine was removed to expose the 
muscle cells. The preparation was continuously perfused, unless otherwise stated,  
 84 
with a calcium-Ringer containing 4-aminopyridine to reduce potassium currents with 
the following composition (mM) : NaCl 23, Na-acetate 110, KCl 24, CaCl2 6, MgCl2 5 
, glucose 11 , HEPES 5 and 4-aminopyridine 5; NaOH was used to adjust the pH to 
7.6. The preparation was maintained in the experimental chamber at 34◦C using a 
Warner heating collar [DH 35] and heating the incoming perfusate with a Warner 
instruments (TC 324B) in line heating system (Hamden, CT, USA). The perfusate 
was applied at 4-6 ml/min through a 19- gauge needle placed directly over the 
muscle bag recorded from. Calcium substitution experiments were performed using 
a  magnesium-Ringer (composition in mM: NaCl 23, Na-acetate 110, KCl 24, MgCl2 
11, glucose 11, HEPES 5, 4-aminopyridine 5mM, and EGTA 0.5; NaOH was used to 
adjust the pH to 7.6). The sodium  and calcium substitution experiments were 
conducted using NMDG-Ringer (composition in mM : NMDG Cl 23, NMDG-acetate 
110, KCl 24, MgCl2 11, glucose 11, HEPES 5 and 4-aminopyridine 5; CsOH was 
used to adjust the pH to 7.6).  AF2 (1µM), verapamil (100 µM), nickel (30 µM) and 
cobalt (10 mM) were applied in calcium-Ringer as described in results. 
Electrophysiology 
Two-micropipette voltage-clamp and current-clamp techniques were 
employed to examine the electrophysiological effects in the Ascaris muscle bag 
region (Fig.1). Borosilicate capillary glass (Harvard Apparatus, Holliston, MA, USA) 
micropipettes were pulled on a Flaming Brown Micropipette puller (Sutter Instrument 
Co., Novato, CA, USA) and filled with 3 M potassium acetate or mixture of 1.5 M 
potassium acetate and 1.5 M cesium acetate. The cesium acetate was included in 
pipette solution to block outward potassium currents. Current–clamp micropipettes 
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and the voltage-sensing micropipettes for voltage-clamp had a resistance of 20-30 
MΩ; the current-injecting micropipette for voltage-clamp had a resistance of around 
4 MΩ. The recordings were obtained by impaling the bag region of the Ascaris 
muscle with both micropipettes. All experiments were performed using an Axoclamp 
2B amplifier, a 1320A Digidata interface and pClamp 8.2 software (Axon 
Instruments, CA). All data were displayed and analyzed on a Pentium IV based 
desktop computer.  
Current-clamp experiments were performed by injecting a hyperpolarizing 
pulse of 40 nA for 500 ms at 0.28 Hz frequency through the current-injecting 
micropipette and the other micropipette recorded the change in membrane potential. 
Cells with stable resting membrane potentials over a period of 30 minutes and input 
conductance of less than 2.5 µS were used for analysis. 
For voltage-clamp, the amplifier gain was set to more than 100 for all 
recordings. We also took extra care to keep the resistance of the current-injecting 
micropipette low (4 MΩ) and keeping the amplifier gain high. The phase lag was set 
to 1.5 ms in all the experiments to limit oscillation. In addition, muscles closer to the 
nerve cord were impaled for experimental study, as they were rounder muscle cells 
with short arms to keep the space-clamp effective. Muscle cells close to the nerve 
cord were also found to posses larger calcium currents.  
For activation of calcium currents, muscle cells were held at -35mV during the 
voltage-clamp experiments and stepped through a series of voltage-steps that 
increased by 5mV and lasted 130 ms. The protocol had step potentials of -25 mV, -
20 mV, -15 mV, -10 mV, -5 mV, 0 mV, +5 mV, +10 mV, +15 mV, and +20 mV. In 
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separate experiments, we studied the steady state inactivation kinetics of the 
calcium current. We used conditioning prepulses of 130 ms that were applied before 
the step potential 0 mV. To investigate outward-currents, step potentials of: -25 mV, 
-15 mV, -5 mV, +5 mV, +15 mV, and +25 mV were used lasting 200 ms. The holding 
potential again was -35 mV. The currents displayed were leak-subtracted using five 
1 mV depolarizing steps that were scaled by the pClamp 8.2 software. Drugs were 
applied initially under current-clamp before effects on voltage-activated currents 
were tested under voltage-clamp. Cells with uniform membrane potentials more 
negative than -25 mV over a period of 40 minutes and resting conductance of less 
than 3µS over the course of experiment were selected for the voltage-clamp studies.  
Drugs  
An AF2 (Sigma, Genosys) 3mM stock solution was prepared every week and 
kept in Ependorf tubes at -12 ºC. The AF2 stock solution was thawed just before use 
to make up the 1 µM AF2 for the experiments. A 100 µM verapamil solution was 
prepared fresh for each experiment. 100 mM cobalt chloride stock was prepared 
every week. Fresh 30 µM nickel and 1 µM acetylcholine solution was prepared for 
every experiment. All drugs were obtained from Sigma-Aldrich, St. Louis, MO. All the 
stock solutions were made using double distilled water. 
Statistical Analysis 
Currents were plotted against the function of step potential to determine 
current-voltage relationships. For the inactivation curve, peak-current values were 
plotted against the prepulse potentials. All the statistical analysis was done using 
Graph Pad Prism software (version 4.0, San Diego, CA, USA).  Paired t-test was 
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used to test significant difference in peak current response in control and test 
recordings; significance levels were set at p <0.05. 
3.4 Results 
AF2 increases the frequency of small-waves and large-spikes  
In a sample of 18 muscle cells from different preparations 12 cells were active 
and showed depolarizing small-spikes and large-spikes (Weisblat et.al., 1976). In 
the other 6 quiet cells, the membrane potential showed no depolarization. The effect 
of a 2-minute application of 1µM AF2 on the resting membrane potential and input 
conductance of the 12 active muscle cells was a small but statistically significant 
(p=0.03) depolarization without a noticeable effect on input conductance. In these 12 
experiments, before the application of AF2, the resting membrane potential was 31.6 
± 2.1 mV and the input conductance was 2.66 ± 0.14 µS (means ± S.E.); after 
application of AF2, the membrane potential was 29.5 ± 1.6 mV with an input 
conductance of 2.68 ± 0.12 µS (mean ± S.E.).  In the other 6 quiet preparations, AF2 
had no detectable effect on membrane potential or input conductance.   
In 5 of the 12 active preparations, AF2 produced an increase in the frequency 
of small-spikes and large-spikes that returned towards control levels following AF2 
washout; in 7 of the 12 active preparations, the increased spiking was maintained 
even after washout, Fig 2A.  The large-spike frequency increased from 0.03 spikes 
per second before AF2 to 0.1 spikes per second after AF2; and the small-spikes 
frequency increased from 0.08 spikes per second to 0.15 spikes per second after 
AF2, Fig. 2B.  In 5 of the 12 active preparations, there was no noticeable effect of 
AF2 on small-spikes or large-spikes.  AF2 also produced an increase in the rate of 
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rise of the potential of the small-spikes and the large-spikes, suggesting that AF2 
can increase the inward current producing these depolarizations.  In Fig. 2C, the rate 
of rise of the large-spikes ranged between 1.2 to 1.4 Vs-1 before AF2: after AF2, the 
rate of rise increased to 1.3 to 1.7 Vs-1.  In the experiment illustrated in Fig 2, the 
small-spike rate of rise was 0.05 to 0.06 Vs-1 before AF2 and 0.08 to 0.09 Vs-1 after 
AF2.  The amplitudes of the large-spikes and small-spike were also increased after 
AF2 application.  The large-spikes increased from 28.6 ± 0.4 mV before AF2, to 31.5 
± 0.14 mV after AF2 application, Fig 2C; the amplitude of small-spikes increased 
from 3.7 ± 0.2 mV before AF2 to 6.9 ± 1.8 mV after AF2 application, Fig 2B. These 
effects on small-spikes and large-spikes together with their increased rate of rise, 
suggested that AF2 increases voltage-activated inward currents. Consequently, we 
explored the effects of AF2 under voltage-clamp as described in the experiments 
below.  
 
 Effects of AF2 on voltage-activated currents 
we investigated effects on voltage-activated currents by switching the 
recording system to the voltage-clamp mode.  Fig. 3A shows initial records of total 
voltage-activated currents. These currents possessed: 1) an initial transient inward 
current, more visible at a step potential of 0mV;  and 2) a larger sustained outward 
potassium current, more visible at a step potential of +25mV (Thorn et al., 1987).  
Effects of AF2 on voltage-activated currents were not observed during 
application of AF2 but increased in a time dependent manner after AF2 application.  
Fig. 3 shows effects of a 2-minute application of 1µM AF2 after a delay of 4 minutes.  
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AF2 produced a small reduction in the peak outward current but a larger increase in 
the transient inward current, Fig. 3A & B.   The outward peak current at the +25 mV 
voltage-step was 315 ± 81 nA, mean ± S.E., in 5 preparations: this decreased 
significantly to 304 ± 77.2 nA, mean ± S.E., (p =0.04 paired t-test).  The small effect 
of AF2 on the current-voltage plot of the outward peak currents is shown in Fig 3C.   
When we examined the peak transient inward current at 0mV, we found that it 
increased significantly from -224 ± 24  nA  to -260 ± 26 nA, mean ± S.E. in 5 
preparations (p= 0.016, paired t-test).  Thus, we observed the effects of AF2 on the 
two currents and that the effect on the transient inward current was proportionately 
bigger than on the outward current.   
Our next step was to separate the transient inward current from the outward 
current. We did this by using cesium in the recording electrodes and adding 5 mM 4-
AP to the bathing solution to block potassium currents.  Also, we changed the 
voltage protocol to examine the activation of the inward current, in more detail: we 
increased the number of depolarizing voltage-steps to every 5 mV and shortened the 
length of the voltage-steps from 200 ms to 120 ms. 
 
Activation of the transient inward currents  
The muscle cells were held at -35 mV.  Fig. 4A is a representative recording 
of the voltage-activated inward currents where the outward potassium currents were 
blocked by 5mM 4-AP applied in the bath and cesium in the recording micropipettes. 
The currents were characterized by a large transient inward current and a small-
sustained inward current that was < 10 % of the peak.    
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Fig 4B shows that the peak inward current was induced by a step potential to 
0 mV. A similar observation was made in 16 preparations. The peak current-voltage 
relationship was extrapolated to predict the reversal potential (Erev) for each 
experiment. In the experiment shown in Fig. 4C, we used linear regression and 
extrapolation to estimate the reversal potential (+42 mV) and then the calculated 
conductance changes from the peak inward currents and driving forces (Erev – V) to 
obtain the activation curve, Fig 4C.  The activation curve was then fitted by the 
Boltzmann equation: 
G = Gmax / {1 + exp [(V50 -V)/Kslope]}; 
Where G is the conductance change, Gmax is the maximum conductance change, 
V50 is the half-maximum step-voltage, V is the step-voltage and Kslope is the slope 
factor.  For the experiment in Fig 4C, V50 was -11.3 ±0.8 mV (mean ± S.E.), Gmax 
was 4.5 ± 0.1µS (mean ± S.E.) and the slope factor was 5.5 ± 0.7 mV.  In 8 similar 
experiments, V50 ranged between - 13.3 mV to - 7mV, Gmax ranged between 1.7 µS 
to 4.5 µS and the slope factor ranged between 4.5 to 7.5 mV.  We discuss the 
characteristics of different calcium currents later.   
 
Effect of AF2 on transient inward currents 
Fig 5A shows a representative experiment of effects following a 2-minute 
application of 1 µM AF2 on the peak transient inward current. We followed the same 
analytical approach as before to prepare the activation curves and to test the effect 
of AF2 on the transient inward currents.  Fig. 5A, B, C & D show that AF2 increased 
the current by shifting the activation curve to the left and increasing the maximum 
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conductance change.  The peak current at the 0 mV step increased from -84 nA in 
the control to -158 nA after AF2 application, Fig. 5 A &B.  The control activation 
curve had a V50 of -7.2 ± 0.4 mV and a Gmax of 1.91 ± 0.02 µS.  After AF2, V50 was -
12.8 ± 0.4mV and the Gmax was 2.94 ± 0.03 µS, Fig 5C.  Thus, there was an 
hyperpolarizing shift of 5.4 mV in V50 and a 52% increase in Gmax in this experiment. 
The slope factor for the curve changed from the control 7.0 ± 0.4 mV to 4.4 ± 0.3 mV 
after application of AF2. 
 It was clear from the experiment described in Fig. 5 A-C and from similar 
observations in 10 other experiments that AF2 increased the transient inward 
current.  We were interested in determining the time-dependent nature and duration 
of this effect.  To do this we measured the % increase in the inward peak current at 
the 0 mV step-potential and followed this every 4 minutes. We found that the 
potentiation took at least 8 minutes to reach a maximum and lasted for more then 
twenty minutes after washing the AF2. Fig. 5 D shows the mean ± S.E. % increases 
from 11 experiments.   The average potentiation for the 11 recordings after 17 
minutes was 29 ± 8%. There was wide variation ranging between 15 % - 89%.  In 
addition, we also examined the effect of the AF2 on the small sustained inward 
current and found it to be without significant effect (9 preparations) illustrating the 
fact that AF2 had its major effect on the transient inward current.  
 
AF2 did not affect inactivation of transient inward currents 
The inactivation of the transient inward currents (Figure 6) was tested by 
using a pre-pulse protocol. The muscle cells were held at -35 mV, then taken to 
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different pre-pulses for 130 ms to allow inactivation, and then finally stepped to a 
test-voltage of 0 mV. The pre-pulses were from -45 to 0 mV. The inactivation curves, 
produced by plotting the peak inward currents against the pre-pulse potentials, were 
fitted by the Boltzmann's equation; example pre-AF2 treatment and post-AF2 
treatment inactivation curves are shown in Figure 6b. Overall, Imax had a value of -
81.0 18.8 nA, before AF2 application and was -97.3 21.3 nA, after AF2 application 
(no significant change, P>0.05, n=6). V50 before AF2 application was -21.1 1.3 mV, 
and after AF2 application was -22.3 1.6 mV; no significant change, (P>0.05, n=6). In 
addition, the slope factor was not significantly different in the control, 6.4 0.7 mV, as 
compared to after AF2 application, 8.0 0.9 mV (P>0.05, n=6). These experiments 
showed that the exposure to AF2 did not affect the inactivation characteristics of the 
inward current. 
 
The transient inward current is calcium dependent 
We performed calcium substitution experiments to test effects on the transient 
inward current. Fig. 7A shows representative recordings, where the amplitude of the 
transient inward current was reduced, reversibly, by removing calcium and bathing 
the preparation in a magnesium-Ringer solution for 10 mins.  The current returned 
towards normal on wash.  
Fig. 7B shows the current-voltage plots for this particular experiment. In 6 
experiments, the peak current at 0 mV in the absence of calcium was significantly 
reduced from -123.3 ± 11.7 nA, mean ± S.E., to -21.7 ± 13.7 nA mean ± S.E., in the 
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magnesium-Ringer solution.  The inward current recovered to -80.8 ± 13.4 nA mean 
± S.E., after perfusion with the control, calcium-Ringer solution for 10 min.    
Fig.7C shows a bar chart (mean ± S.E., n = 6) of the peak currents at the step 
potential of 0 mV as a % of the control.  These experiments showed that removal of 
the calcium reduced the inward current by 83% and suggested that most of the 
transient current is carried by calcium.   In these experiments, we were not able to 
reversibly abolish all of the transient inward current despite bathing the preparations 
in calcium-free Ringer for more than 20 minutes.  The remaining current suggests 
that a small proportion of the inward current is carried by other ions.   
 
Effects of sodium and calcium substitution on the transient inward current 
To examine the effect of sodium substitution on the transient inward current 
we substituted both sodium and calcium with N-methyl D-glucamine (NMDG), as a 
non-permeant cation.  In the NMDG-Ringer we found that there was only a small 
residual inward current and found that the addition of sodium could produce a 
modest increase in the amplitude of the inward current. However, only addition of 
calcium produced a large and significant increase in the transient inward current.  
The Fig. 8A1 is a representative trace of the current in NMDG-Ringer; Fig. 8A2 
is a representative trace of the current trace following the addition of magnesium-
Ringer (sodium present); and Fig. 8A3 is the current trace following the addition of 
sodium and calcium when the muscle cell was in normal calcium-Ringer solution. 
The current-voltage relationship for this experiment is shown in Fig. 8B.  The peak 
inward current at 0 mV in NMDG-Ringer was -26 nA; it increased to -39 nA following 
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the addition of sodium; and increased to -73 nA when sodium and calcium were 
present (calcium-Ringer).   
In 6 experiments, the peak transient inward current in NMDG-Ringer at 0 mV 
was -13.8 ± 5.3 nA (mean ± S.E.). This current was -23.8 ± 3.1 nA (mean ± S.E.) in 
magnesium-Ringer (sodium present) and it increased to -37.2 ± 2.4 nA (mean ± 
S.E., n = 6) in calcium-Ringer. Fig. 8C shows a bar chart of the currents expressed 
as a % of the control (NMDG-Ringer). The increase in the transient inward currents 
in calcium-Ringer was 260 ± 69 % and was significant (p<0.01, paired t-test, n = 6). 
These experiments demonstrated that in the absence of sodium and calcium there 
was a small voltage-activated inward current.  However, only the addition of calcium 
produced a large voltage-activated current.  Sodium did not substitute for calcium. 
Subsequently we refer to this inward current as the voltage-activated calcium 
current.  
 
Effect of some calcium channel antagonists on the transient voltage-activated 
calcium current 
We have seen that most of the transient inward current is carried by calcium 
and that it is increased following AF2 treatment. We were interested to determine 
effects of some calcium channel antagonists, to see if the current had 
pharmacological properties that resembled mammalian calcium currents.  
We tested effects of 10 mM cobalt on the voltage-activated calcium current, 
Fig. 9.  Fig 9A shows representative traces of the reversible inhibition of the calcium 
current.  In this particular experiment, the current at 0 mV decreased from -78.3 nA 
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(control) to – 6.2 nA in the presence of 10 mM cobalt; the current recovered to -78.0 
nA after 25 minutes wash. Fig 9B shows the current-voltage plots from this 
experiment.  Fig 9C shows a bar chart of normalized currents obtained from 7 
preparations before, during and at different times following wash.   All of these 
experiments showed that 10 mM cobalt was effective at inhibiting the calcium 
current.   
We also tested effects of 30 µM nickel, a T-type calcium channel antagonist, 
and 100 µM verapamil, a non-selective calcium channel antagonist, Fig 10.  Both of 
these agents were without effect.  These observations suggested that the 
pharmacology of the calcium current is different to that of vertebrates.   
 
Effect of acetylcholine on the transient calcium current 
There is evidence of muscarinic receptors present on Ascaris muscle 
(Colquhoun et al., 1991).  We tested for the effects of 1µM acetylcholine in 6 
preparations and found no effects suggesting that muscarinic receptors do not 
modulate calcium currents in Ascaris muscle.   
3.5 Discussion 
Spikes in Ascaris 
Ascaris muscle is capable of producing full action potentials as well as partial 
spikes (DeBell et al., 1963).   The spikes are suggested to start at the 
neuromuscular-junction (syncytium) and then to travel to the bag region of the 
muscle via the arms of the muscle cell.  We can see here that the bag region, from 
where we recorded, is capable of conducting voltage-activated currents to support 
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spikes.   The electrical activity and modulation of the spikes seen in Ascaris has 
been modeled by Turner (2001) who has shown that a combination of voltage-
activated calcium currents, voltage activated potassium currents (Martin et al., 1992) 
and a calcium-activated chloride currents (Thorn and Martin, 1987) can produce 
repeating bursts of spikes in an oscillatory mode that is observed in fresh 
preparations (Weisblat et al., 1976). An increase in the calcium entry is predicted to 
change the pattern of this oscillation (Turner, 2001). In this manuscript, we have 
explored the effects of the neuropeptide, AF2, on the calcium currents. 
 
AF2 
Cowden and Stretton, (1993); Pang et al., (1995); Reinitz et al., (2000); Maule 
et al., (2002) and Trailovic et al., (2005) have described how brief application of AF2 
to Ascaris suum muscle strips produces a long-lasting increase in the contractility 
and electrical excitability.  Trailovic et al., (2005), have also observed that brief 
application of AF2 results in a long-lasting potentiation of depolarizing responses to 
acetylcholine applied to Ascaris suum muscle cells.  This latter observation showed 
that AF2 has direct excitatory effects on Ascaris suum muscle and contrasts with 
earlier observations involving cut-nerve-cord experiments (Maule et al., 1995) that 
suggested that AF2 has post-synaptic inhibitory effects on Ascaris muscle.   We 
have described, here, how AF2 increases the amplitude and frequency of small-
spikes and large-spikes.  When we applied AF2 for a 2-minute period to the muscle 
cells, we found that there was an increase in the transient inward current that lasted 
for more than 20 minutes after washout. AF2 produced an increase in the maximum 
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and the threshold shifted in the hyperpolarizing direction.   The increase in this 
inward current suggests it was responsible for the change in spontaneous 
depolarizations observed under current-clamp.  The small effect of AF2, Fig. 3, on 
the total outward current suggests that the decreased outward current is not the 
primary cause of the increased excitability of the muscle cells.   
The transient inward current is carried by calcium 
We can say that the current producing the muscle spikes is mediated by 
voltage-activated calcium channels for the following reasons: the amplitude of 
Ascaris muscle spikes are reduced in low-Ca Ringer solutions (Weisblat et al., 
1976); the transient inward current is blocked by 1mM lanthanum (Martin et al., 
1992); removal of calcium reduces the amplitude of the transient inward current, Fig. 
7; removal of sodium and calcium in the NMDG-Ringer abolishes the transient 
inward current; addition of calcium, but not sodium, allowed the transient current to 
reappear, Fig. 8; and addition of cobalt, Fig. 9 abolished the transient current. All of 
these observations are consistent with calcium being the major, but not necessarily 
the exclusive charge carrier of the current.  The reversal potential of the current in 
this series of experiment was estimated by extrapolation and was around +45 mV.   
The predicted Nernst calcium potential with 6 mM extracellular calcium and 1 µM 
intracellular calcium is +110 mV, some 65 mV more positive than we observed. 
Despite the prediction of a more positive reversal potential for calcium, others have 
made similar observations for the C. elegans L-type EGL-19, calcium channels 
(Jospin et al., 2002); and for the calcium channels in vertebrate preparations 
(Nowcyky et al., 1985). Collectively, these observations suggest that the calcium 
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channel in nematode and mammalian preparations is not exclusively permeable to 
calcium, but may also be permeable to other monovalent ions including sodium and 
potassium. Although we replaced all cations with NMDG we found that a residual 
inward current remained in some preparations, Fig. 8. This remaining inward current 
is not likely to be carried by cations (no permeable cations in NMDG-Ringer) so it 
may be produced by closing of outward calcium-dependent chloride channel current 
(Thorn and Martin, 1987) which is present in Ascaris bag cells.  We did not 
investigate this current in NMDG further.  
 
Comparison of voltage-activated calcium currents in mammals and C. elegans 
Voltage-gated calcium channel currents in vertebrates can be divided into three 
major groups (Catterall, 2000).   
1) There is the T-type or transient calcium channel current that is activated at 
relatively negative potentials, positive to -70 mV (V50 -51 mV, K 7.0 mV; Fox 
et al, 1987).  It inactivates with a time constant in the 20-50 ms range at 
potentials more positive than -60mV. The different types of calcium channels 
are built around a transmembrane ion-channel protein that is known as the α1 
subunit.  CaV3 protein subunits are the α1 subunit for the T-type channels 
(Perez-Reyes et al., 1998).   A similar current has been described in the 
nematode C. elegans pharyngeal muscle, coded for by the gene cca-1 that 
has around 70% similarity to mammalian CaV3 subunits (Mathews et al., 
2003; Shtonda et al., 2005).  
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2) There are the N-, P-, Q, and R-types of calcium currents that are activated at 
potentials positive to -30 mV (N- type: V50 -6.5 mV, K 6.5 mV; Fox et al, 1987) 
and that inactivate in the 50-80 ms range. The N-type current is resistant to 
block by nickel and nifedipine. Cloned CaV2.2 subunits conduct N-type 
currents (Dubel et al., 1992); cloned CaV2.1 subunits (Mori et al, 1991) 
conduct P-/Q-type currents; cloned CaV2.3 subunits conduct R-type currents 
(Randall and Tsien, 1995).  The unc-2 gene of the nematode C.elegans has 
the greatest similarity to the CaV2.3 subunits (R-type current) but is also 
similar to CaV2.1 & CaV2.2 α1 subunits (N- & Q/P-type currents).   
3) There is the L-type current that is activated by making bigger depolarizing 
steps to potentials positive to -10 mV (V50 +16.5 mV, K 5.5 mV; Fox et al, 
1987).  This current inactivates slowly with a time constant > 500 ms.  The L-
type calcium current is mediated by the CaV1 family of α1 subunits, inhibited 
by nifedipine, verapamil and potentiated by Bay K 8644. In C. elegans body 
muscle and pharyngeal muscle a current similar to the L-type current is 
conducted through a channel formed by an α1 subunit coded for by the egl-19 
gene (Shtonda and Avery, 2005).   
In the nematode, C. elegans, genes coding for α1 calcium channel subunits are: cca-
1, unc-2 and egl-19 (see above) and nca1 and nca2.  nca1 and nca2 are outliers, 
similar to one another, and to a channel in the yeast Schiozosaccharomyces pombe 
(Bargmann, 1998). They are found in the nervous system and ventral cord in C. 
elegans but their electrophysiological properties have not yet been described.  
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Membrane potential, activation of Ascaris and C. elegans calcium currents, and 
propagation distances 
The C. elegans body muscle has a resting membrane potential averaging -
19.7 mV so it is not surprising that there is only an L-type calcium (EGL-19) current 
present that requires potentials positive to -20 mV to activate it (V50  +0.95 mV, K 4.6 
mV and Erev +51mV) (Jospin et al., 2005).   The C. elegans L-type current is only 
partially blocked by a high (1 µm) concentration of nifedipine so it behaves differently 
to the mammalian L-type current.  The C. elegans body wall muscle sometimes 
displays small-spikes or overshooting action potentials (Jospin et al., 2005).   In C. 
elegans, the pharyngeal muscle has a more negative equilibrium membrane 
potential of -53.6 mV (Shtonda and Avery, 2005) and it has both T-type (CCA-1) and 
L-type (EGL-19) currents. These currents support the large overshooting action 
potential of the pharynx.   The more negative resting membrane potential allows 
activation of the T-type current.  
The resting membrane potential of Ascaris muscle cells is around -35 mV, 
and displays both small-spikes and overshooting action potentials along with slow 
waves.  The voltage-activated current we observed has some but not all of the 
properties of the T-type and L-type currents: it inactivated but required a relatively 
depolarized potential for activation and was not inactivated at a holding potential of -
35 mV.  The Ascaris calcium current was not inhibited by 30µM nickel or 100 µM 
verapamil and is therefore pharmacologically different to T- and L-types of current 
(Fox et al., 1987; Jospin et al., 2005; Shtonda and Avery, 2005).  The Ascaris 
calcium current has properties similar to the N-, P/Q- and R-types and was unlike 
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currents carried by C. elegans EGL-19 and CCA-1.  Sequence comparisons show 
that phenylalkylamine (verapamil) binding sites in C. elegans in the EGL-19 L-type 
homologue (Snutch et al., 1991; Frøkjær-Jensen et al., 2006) but not in other C. 
elegans non-L-type calcium channel homologues. The Ascaris calcium current was 
most like the currents expected to be carried by UNC-2.  The need for propagated 
spike activity in body muscle cells may be more important in a large nematode like 
Ascaris suum where electrotonic conduction may not be sufficient to carry 
depolarizations over the larger distances as compared to much smaller C.elegans.   
 
Significance of AF2 effects 
A number of authors (Wolstenholme et al., 2004; Geary 2005; Martin et al., 
2005) have raised concerns about the development of resistance to existing 
anthelmintics. Our approach has been to investigate the actions of cholinergic 
anthelmintics (levamisole), to understand better the mode of action of these drugs 
and to develop a pharmacological strategy for countering resistance to these 
compounds.  AF2 is found in different nematode species and its potency on the 
nematode neuromuscular system makes AF2 (FLP) receptors an attractive target for 
the development of novel anthelmintic drugs.  In muscle strips of Ascaris suum, AF2 
potentiates the contractile responses to acetylcholine and levamisole (Marks et al., 
1999; Kubiak et al., 2003) increases spiking, post-synaptic neuromuscular potentials 
(Pang et al., 1995; Brownlee and Walker, 1999) and depolarizing potentials in 
response to acetylcholine (Trailovic et al., 2005).   These properties suggest that a 
synthetic AF2 ligand could be used to potentiate the effects of cholinergic 
 102 
anthelmintics like levamisole and so counter effects of resistance to these 
compounds.  In this paper, it is clear that AF2 could potentiate contractions induced 
by cholinergic anthelmintics, at least in part, by increasing the entry of calcium 
through voltage-activated channels. Other mechanisms by which AF2 may 
potentiate muscle contraction remain to be investigated.    
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3.8 Figures and Legends  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Electrophysiological techniques. A: Diagram of the location of two micropipettes 
for making current-clamp and voltage-clamp recordings from bag region of Ascaris suum 
somatic muscle. The current-injecting pipette and the voltage-sensing pipette are shown. B: 
Current-clamp recording showing membrane potential change (lower trace) in response to 
0.5 sec, 40nA, current pulses (upper trace). Input conductance 3.7µS. C: Voltage-clamp 
recording showing current responses (leak subtracted lower trace) in response to depolarizing 
potentials from a holding potential of  -35mV. Note the presence of the voltage-activated 
transient inward current and a sustained current.  Sustained currents were not prominent in all 
cells.  
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Figure 2. Effect of AF2 under current-clamp. Brief application of AF2 increases 
frequency of small and large spikes. A: Membrane potential record of somatic muscle in 
current clamp before, during and after application of 1µM AF2. B: The large spike frequency 
increased from 0.03 spikes per second before AF2 to 0.1 spikes per second after AF2; the 
small spike frequency increased from 0.08 spikes per second to 0.15 spikes per second.  C: 
Represents the increase in the amplitude and rate of rise of large-spike before and after 
application of 1 µM AF2.  
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Figure 3.  Effect of 2-minute application of 1µM AF2 on voltage-activated currents.      
A: Control voltage-activated currents; peak total outward currents (O); peak inward currents 
(I) under K current block. B: Voltage-activated currents following AF2 treatment.  Note the 
slight decrease in the peak outward current and the increase in the peak inward current.  C: 
Current-voltage plot of the peak outward currents, the peak inward currents before, and 
following the 2-min application of 1µM AF2. ■: Control peak outward current. □: post AF2 
peak outward current. Δ Control peak inward current. ▲: post AF2 peak inward current.  
Note that proportionately, the biggest effect was on the peak inward current 
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Figure 4. Activation curve of transient inward currents. A: Voltage-clamp records 
following depolarizing steps.  Cell was held at -35 mV, and depolarizing steps from -35 mV 
to   + 20 mV were made. Top trace: voltage steps.  Lower trace: leak subtracted current 
records. B: Peak-inward-current vs. step-potential plot from same cell as A. Step potentials:-
25 mV, -20 mV, -15 mV, -10 mV, -5 mV, 0 mV, +5 mV, +10 mV, +15 mV, and +20 mV. 
The current-voltage relationship was extrapolated to predict reversal potential, +42mV. C: 
Activation curve for experiment shown in A and B, fitted to Boltzmann equation (V50 = 4.46 
mV, Gmax = -11.26 µS, Kslope = 5.5 mV).  
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Figure 5. Transient inward currents show long-lasting potentiation after a 2-minute 
application of 1µM AF2. A: Voltage-gated transient-inward currents recorded before and 9 
minutes after AF2 application. Note the increase in the amplitude of the peak inward 
currents. V: voltage steps; I: control currents; I`: currents after AF2. B: Peak-current step-
voltage relationship for experiment shown in A. Control (□). 9 minutes after AF2 application 
(■). Last three current points of each plot were extrapolated to obtain the reversal potential, 
59mV. C: Activation curve showing decrease in Gmax and hyperpolarizing shift in V50 after 
AF2. Control (□). After AF2 application (■). Gmax increased from 1.91 µS in control to 2.94 
µS after AF2. V50 shifted from = -7.2 mV (control) to -12.8 mV after AF2, Kslope increased 
from 7.0 mV to 4.4 mV after AF2. D: Long-lasting potentiation of the % change of the peak 
transient inward current after AF2 application (paired t-test, n=12 preparations from separate 
worms,** significance <0.01,* significance <0.05). 
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Figure 6.  Effect of 1µM AF2 on the inactivation of the transient inward current. The 
transient inward currents were activated by a test pulse of 0 mV following 130 ms pre-pulses 
of 45 mV, -40 mV, -35 mV, -30 mV, -25 mV, -20 mV, -15 mV, -10 mV, -5 mV and 0 mV. 
A1: Shows the trace of control transient inward currents at 0 mV step potential after the pre-
pulses. A2: Depicts the transient inward currents at 0mV step potential after the pre-pulses 
and following AF2 perfusion. B: Shows the plot of peak current against the pre-pulse 
potential the points were fitted to the inactivation curve as described by Boltzmann equation. 
(n = 6). ○: Control before AF2 Imax was -161.9 ± 3.4 nA; V50 was -16.8 ± 0.8 mV; K was 
7.3 ± 0.7 mV; ■: After 1µM AF2. Imax was -189 ±4.  nA; V50 was -16 ± 1 mV; Kslope was 
7.7 ± 0.8 mV. No significant changes 
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Figure 7. Calcium substitution decreases the amplitude of transient inward current.        
A: Changes voltage-gated transient inward currents before and after calcium substitution.  
B: current voltage relationship (I-V) plot from the same experiment. ○ Circles representing 
control (Calcium 6mM), □ Ca-free solution and ■ wash. C: Calcium substitution 
significantly suppressed the inward current and the effect was reversible (paired t-test, n = 6, 
p< 0.01).  
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Figure 8.  Effects of addition of sodium and calcium to NMDG bath solution.               
A1: Represent the trace of inward currents in the absence of sodium and calcium (NMDG 
Solution). A2: Represent the trace of inward currents in presence of sodium (sodium & 
calcium -free solution), same preparation. A3: Transient inward current in presence of 
calcium-Ringer, same preparation. Note that only calcium produced a transient inward 
current. All currents are at – 5 mV voltage step. B: Current voltage relationships for the 
inward currents, ■ in absence of both sodium and calcium, □ in presence of Na, and ○ when 
both sodium and calcium present (APF). C: Percent change in the transient inward current 
with presence of calcium in the solution. The inward currents for NMDG were used for 
normalization for each preparation. Only the addition of Ca produced a significant increase in 
Normalized transient inward currents (paired t-test, n=6, p<0.01)). 
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Figure 9. Cobalt blocked the transient inward currents. A: an experiment representing 
effect of cobalt on transient inward current at 0 mV. B: Current voltage relationships for the 
inward currents Control □; after 10 mM cobalt ■ application and; ○ wash. C: Cobalt 
application significantly suppressed the peak transient inward currents (paired t-test, n=7, ** 
significance <0.01,*** significance <0.001).  
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Figure 10. Lack of effect of nickel, verapamil and acetylcholine on transient inward 
current. Representative traces showing that application of A: Nickel (30 µM); B: Verapamil 
(100 µM), and; C: Acetylcholine (ACh 1 µM) did not affect the transient inward current. 
 
Verapamil 
50
 n
A
 
5 ms 
Control 
Control 
Control 
Nickel 
Acetylcholine 
A 
B 
C 
 116 
Chapter 4. Effects of SDPNLRF-amide (PF1) on voltage-activated 
currents in Ascaris suum muscle. 
(Submitted for publication in International Journal of Parasitology) 
S Verma, AP Robertson and RJ Martin 
Department of Biomedical Science, Iowa State University, Ames, IA, 50010, USA 
 
Key words: PF1; AF3; Ascaris suum; voltage-activated currents; calcium currents; 
potassium currents. 
4.1 Abstact 
Helminth infections are of significant concern in veterinary and human medicine. The 
drugs available for chemotherapy are limited in number and the extensive use of 
these drugs has led to the development of resistance in parasites of animals and 
humans (Geerts and Gryseels, 2000; Kaplan, 2004; Osei-Atweneboana et al., 2007). 
The cyclooctadepsipeptide, emodepside, belongs to a new class of anthelmintic that 
has been released for animal use in recent years. Emodepside has been proposed 
to mimic the effects of the neuropeptide PF1 on membrane hyperpolarization and 
membrane conductance (Willson et al., 2003). We investigated the effects of PF1 on 
voltage-activated currents in A. suum muscle cells. The whole cell voltage-clamp 
technique was employed to study these currents. Here we report two types of 
voltage-activated inward calcium currents: transient peak (Ipeak) and a steady-state 
(Iss). We found that 1 µM PF1 inhibited the two calcium currents. The Ipeak decreased 
from -146 nA to -99 nA (p= 0.0007) and the Iss decreased from -45 nA to -12 nA (p= 
0.002). We also found that PF1 in the presence of calcium increased the voltage-
activated outward potassium current [from 521 nA to 628 nA (p=0.004)]. The effect 
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on the potassium current was abolished when calcium was removed and replaced 
with cobalt; it was also reduced at a higher concentration of PF1 (10 µM). These 
studies demonstrate a mechanism by which PF1 decreases the excitability of the 
neuromuscular system by modulating calcium currents in nematodes. PF1 inhibits 
voltage-activated calcium currents and potentiates the voltage-activated calcium 
dependent potassium current. The effect on a calcium-activated-potassium channel 
appears to be common to both PF1 and emodepside (Guest et al., 2007). It will be of 
interest to investigate the actions of emodepside on calcium currents to further 
elucidate the mechanism of action. 
4.2 Introduction 
 There is a group of 13 parasitic and bacterial infectious diseases listed as 
neglected tropical diseases in the Millennium Declaration of the United Nations 
(Hotez et al., 2007).  Ascariasis is the most common parasitic infection in the list, 
with an estimated 807 million people infected and 4.2 billion people at risk (de Silva 
et al., 2003; Bethony et al., 2006). Helminth infections are also a welfare and 
economic concern in animals (Coles, 2001; Wolstenholme et al., 2004).  
Chemotherapy is widely used to control these parasitic infections. The drugs 
available for chemotherapy are limited in number and the extensive use of these 
drugs has led to the development of resistance in parasites of animals and humans 
(Geerts and Gryseels, 2000; Kaplan, 2004; Osei-Atweneboana et al., 2007). The 
cyclooctadepsipeptide, emodepside, belongs to a new class of anthelmintic that has 
been released for animal use in recent years (Harder et al., 2003). Emodepside has 
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been proposed to mimic the effects of PF1 (Willson et al., 2003), an inhibitory 
FMRFamide like neuropeptide (FLP) in nematodes (McVeigh et al., 2006) .  
  FLP’s have been isolated from both free living and parasitic nematodes 
(Geary et al., 1992; Geary et al., 1999; Husson et al., 2005; Li, 2005; McVeigh et al., 
2006). There are more than 31 nematode flp genes that have been identified and 
found responsible for the synthesis of more than 90 FLP’s (McVeigh et al., 2005). 
FLP’s are associated with all the major neuronal systems in nematodes (Stretton et 
al., 1991; Brownlee et al., 1996; Brownlee and Walker, 1999; Geary and Kubiak, 
2005). PF1 (SDPNFLRFamide) is a peptide that was originally isolated from an 
acetone extract of Panagrellus redvivius (Geary et al., 1992). PF1 has marked 
paralytic and hyperpolarizing effects on A. suum muscles (Franks et al., 1994; 
Bowman et al., 2002). Although PF1 has not been recovered from A. suum, Yew et 
al, (2005) have isolated related peptides with the C-terminal PNFLRFamide from A. 
suum. PF1 has been reported to antagonize the effects of acetylcholine and 
levamisole induced contractions (Franks et al., 1994; Geary et al., 1999).  The 
effects of PF1 appear to be mediated by nitric oxide in A. suum (Bowman et al, 
1995). The hyperpolarizing effect of PF1 is abolished by a combination of potassium 
channel antagonists and nitric oxide synthase (NOS) inhibitors. It has been shown 
that nematode NOS is partially dependent on calmodulin and completely dependent 
on calcium (Bowman et al., 1995; Bowman et al., 2002). These effects suggest a 
role for calcium for the mode of action of PF1. 
 Voltage-gated calcium channels play a major part in regulation of calcium 
entry from extracellular sources  in nematodes (Jeziorski et al., 2000). Entry of 
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calcium through ion channels plays an important role in the physiological processes 
of contraction, secretion, synaptic transmission and signal transduction pathways 
(Catterall et al., 2005). Voltage-gated calcium channels are modulated positively and 
negatively by G-protein coupled receptors in many species (Tedford and Zamponi, 
2006) including neuropeptide receptors in A. suum (Verma et al., 2007). 
 In this manuscript we investigate the effects of PF1 on voltage-activated 
calcium and potassium currents in A. suum muscle cells. We found that PF1 
reduced peak and steady state inward calcium currents as well as increased 
voltage-activated potassium currents. These observations show that the inhibitory 
effects of PF1 also include effects on voltage-activated calcium currents. If PF1 does 
in fact mimic emodepside (Willson et al., 2003), our observations suggest that  
emodepside will also affect voltage-activated calcium and potassium currents (Guest 
et al., 2007).  
4.3 Methods 
Collection of worms 
 Adult A. suum were obtained weekly from the Tyson’s pork packing plant at 
Storm Lake City, Iowa. Worms were maintained in Locke’s solution [Composition 
(mM): NaCl 155, KCl 5, CaCl2 2, NaHCO3 1.5 and glucose 5] at a temperature of 
32◦C. The Locke’s solution was changed daily and the worms were used within 4 
days of collection. 
Muscle preparation 
 1 cm muscle tissue flaps were prepared by dissecting the anterior part of the 
worm, 2-3 cm caudal to the head. A body muscle flap preparation was then pinned 
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onto a Sylgard™-lined 2 ml Petri-dish. The intestine was removed to expose the 
muscle cells (Trailovic, et al., 2005). The preparation was continuously perfused, 
unless otherwise stated, with APF-Ringer composition (mM): NaCl 23, Na-acetate 
110, KCl 24, CaCl2 6, MgCl2 5, glucose 11, and HEPES 5; NaOH was used to adjust 
the pH to 7.6. To study inward currents calcium-Ringer solution was prepared by 
adding 4-aminopyridine (4-AP) (5mM) to APF-Ringer solution to reduce potassium 
currents and adjusting the pH to 7.6 by NaOH. The preparation was maintained in 
the experimental chamber at 34◦C using a Warner heating collar [DH 35] and heating 
the incoming perfusate with a Warner instruments [SH 27B] in line heating system 
(Hamden, CT, USA). The perfusate was applied at 4-6 ml/min through a 19- gauge 
needle placed directly over the muscle bag recorded from. The calcium substitution 
experiments were conducted using cobalt-Ringer, composition (mM): NaCl 23, Na-
acetate 110, KCl 24, CoCl2 6, MgCl2 5, glucose 11, HEPES 5 and 4-aminopyridine 5; 
NaOH was used to adjust the pH to 7.6.  PF1 (1µM) and AF3 (1µM), were applied in 
APF-Ringer, calcium-Ringer or cobalt-Ringer as described in Results. 
Electrophysiology 
 Two-micropipette voltage-clamp and current-clamp techniques were 
employed to examine the electrophysiological effects in the A. suum muscle bag 
region (Fig.1A). Borosilicate capillary glass (Harvard Apparatus, Holliston, MA, USA) 
micropipettes were pulled on a Flaming Brown Micropipette puller (Sutter Instrument 
Co., Novato, CA, USA) and filled with 3 M potassium acetate or a mixture of 1.5 M 
potassium acetate and 1.5 M cesium acetate. The cesium acetate was included in 
the pipette solution to block outward potassium currents when recording calcium 
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currents. Current–clamp micropipettes and the voltage-sensing micropipettes for 
voltage-clamp had a resistance of 20-30 MΩ; the current-injecting micropipette for 
voltage-clamp had a resistance of 3-4 MΩ. The recordings were obtained by 
impaling the bag region of the A. suum muscle with both micropipettes. All 
experiments were performed using an Axoclamp 2B amplifier, a 1320A Digidata 
interface and pClamp 8.2 software (Molecular Devices, Sunnyvale, CA). All data 
were displayed and analyzed on a Pentium IV based desktop computer.  
Current-clamp experiments were performed by injecting a hyperpolarizing pulse of 
40 nA for 500 ms at 0.30 Hz through the current-injecting micropipette and the 
voltage sensing micropipette recorded the change in membrane potential (Fig.1B). 
Each set of experiments were repeated on preparations from separate worms to get 
the desired number of observations. 
 For voltage-clamp, we kept the resistance of the current-injecting micropipette 
low (3-4 MΩ) and the amplifier gain high (>100). The phase lag was set to 1.5 ms in 
all the experiments to limit oscillation. In addition, muscles closer to the nerve cord 
were selected for experimental study, as these were spherical cells with short arms 
which help to keep the space clamp effective. Muscle cells close to the nerve cord 
were also found to possess consistently bigger calcium currents.  
 For activation of calcium currents, muscle cells were held at -35mV during the 
voltage-clamp experiments and stepped through a series of voltage-steps of 5mV 
each: to -25 mV, -20 mV, -15 mV, -10 mV, -5 mV, 0 mV, +5 mV, +10 mV, +15 mV, 
and +20 mV (Fig. 1C) and lasted 40 ms. The currents displayed were leak-
subtracted, by steps 1/10th of the test step with opposite polarity, using pClamp 8.2 
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software. The inward calcium currents were recorded at the peak (Ipeak) of the 
currents and the steady state currents were recorded as an average at 25, 30 and 
35 ms. Potassium currents were recorded as an average of the current values at 20, 
35 and 40 ms for +20 mV voltage step in the plateau phase. 
Drugs were applied initially under current-clamp before effects on voltage-activated 
currents were tested under voltage-clamp. Cells with uniform membrane potentials 
more negative than -25 mV over a period of 40 minutes and resting conductance of 
less than 2.5 µS over the course of an experiment were selected for the voltage-
clamp and current-clamp studies.  
 We used linear regression and extrapolation to estimate the reversal potential 
for different experiments. Then we calculated conductance changes from the inward 
currents and driving forces (Erev –V) to obtain the activation curve (Verma, et al., 
2007). The activation curve was then fitted by the Boltzmann equation. 
Drugs  
 PF1 (SDPNFLRFamide) and AF3 (AVPGVLRFamide) [98% purity, EZBiolab, 
Westfield, IN] 10 mM stock solutions were prepared in double distilled water every 
week and kept in Ependorf tubes at -12 ºC. PF1 and AF3, stock solutions were 
thawed just before use to make up the 1 µM or 10 µM working solutions. All other 
chemicals were obtained from Sigma-Aldrich, St. Louis, MO.  
Statistical Analysis 
 Currents were plotted against the step potential to determine current-voltage 
relationships. All the statistical analysis was done using Graph Pad Prism software 
(version 4.0, San Diego, CA, USA).  Paired t-tests were employed to test the 
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statistical significance of the change in current responses in control and test 
recordings; significance levels were set at p <0.05. 
4.4 Results 
Hyperpolarizing effect of PF1   
 Fig. 2A, shows a typical recording of the effects of PF1 on membrane 
potential and input conductance; in this cell the resting membrane potential was -32 
mV and input conductance was 2.3 µS. Application of 1µM PF1 produced a 
hyperpolarization of 5 mV and conductance increase of 0.1 µS. The effect did not 
wash off within 25 minutes. 
 Similar results were obtained in a total of 7 preparations. Fig. 2B summarizes 
the effects on membrane potential. The effect of 1µM PF1 on membrane potential 
was statistically significant and the mean hyperpolarization was 5.0 ± 0.8mV (p = 
0.004). When we applied a higher concentration of PF1 (10µM), the mean 
hyperpolarizing effect on membrane potential 6.2 ± 0.7 mV (n=6).  
 Previous studies (Maule et al., 1995; Walker et al., 2000) have suggested that 
PF1 mediates its effects on membrane potential via a potassium conductance. We 
tested the effects of a high concentration of 4-AP. We found, Fig. 2B, that 5 mM 4-
AP reduced but did not abolished the effects of 1µM PF1 on membrane potential: 
3.0 ± 0.4 mV (p= 0.01, n=11). 4-aminopyridine however, does not block all types of 
potassium channels in A. suum (Martin et al, 1992). In order to further investigate 
the effects of PF1 we pursued our investigation of effects of PF1 on voltage-
activated currents using voltage-clamp. 
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 Effects of PF1 on voltage-activated potassium and calcium currents 
 Fig. 3A shows currents activated by voltage-steps from the holding potential 
of    -35 mV to 0 mV and +20 mV. The step-potential of 0 mV (Fig. 3A) shows 
activation of the transient calcium current, Ipeak (Verma et al., 2007). The step 
potential to +20 mV (Fig. 3A) shows activation of the outward potassium current, O 
(Thorn and Martin, 1987).  
 1 µM PF1 produced an effect on the currents that increased slowly over a 
period of 10 minutes. In the representative recording, Fig. 3A, PF1 increased the 
potassium current from 241 nA to 310 nA and the calcium transient current 
decreased from -100 nA to -72 nA. Despite 20 minutes of continuous wash, the 
potassium current continued to increase to 445 nA but in contrast, the calcium 
transient current (Ipeak) returned towards control values, -84 nA after 20 mins. 
  Fig 3B shows the effect of PF1 on the current-voltage plot of the potassium 
currents. Fig. 3C shows the effect of PF1 on the current-voltage plot of calcium 
transient currents. Notice again that the effect on the potassium currents is not 
reversed on washing but the effect on the calcium current is partially reversed on 
washing. This difference in wash-out suggests different regulation of the two 
currents. Fig. 3D & E summarizes the time-dependent effects on the potassium 
currents and the calcium currents in 6 different preparations. It can be seen by 
comparing Fig. 3D & E that the percentage increase in the potassium currents for 
the 6 recordings after 8 minutes application of PF1, 14 ± 4 % (p=0.02, n=6), was 
smaller than the percentage decrease of the calcium currents, 38 ± 17 % (p=0.001, 
n=6).  We can also see that during the wash period the potassium current continues 
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to increase; but the decrease in the calcium currents is not maintained. Thus, we 
observed the effects of PF1 on the two currents and the effect on the calcium 
currents was proportionately bigger than on the potassium currents.   
 
Effect of PF1 on transient inward and steady-state currents 
  Because there was a larger percentage effect on the calcium currents, we 
decided to investigate effects of PF1 on calcium currents in isolation. We did this by 
using cesium in the recording electrodes and 4-AP in the bath solution to block 
outward potassium currents (Verma et al., 2007). 
  Fig. 4A is a representative recording showing the calcium current at -5 mV. 
The current is characterized by the presence of a transient peak (Ipeak) and a steady-
state component  (Iss). Fig 4A also shows effects of 1 µM PF1 on these two 
components. The Ipeak decreased from -132 nA to -112 nA and the Iss decreased 
from -48 nA to -24 nA.  Fig. 4B & C show effects of 1 µM PF1 on the current voltage 
plots from the same experiment. Note that maximum Ipeak is seen at 0 mV whereas 
the maximum Iss is seen at +5 mV suggesting they are two distinct currents. Also 
notice in the I-V plot that proportionately, PF1 has a bigger effect on Iss than on Ipeak. 
Similar observations were made in 10 other experiments. Fig. 4D shows that the 
decrease for Ipeak was 35 ± 6% (p=0.001, n=10). Fig. 4E shows that the decrease in 
the Iss was 66 ± 6% (p<0.001, n=10). Despite a long period of washing for more than 
20 minutes, we found that the effects of PF1 were not completely reversible. 
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Effect of PF1 in the presence of cobalt on the outward voltage-activated potassium 
current 
We have seen effects of PF1 on isolated calcium currents. Our next step was 
to examine effects of PF1 on the potassium currents isolated from the calcium 
currents. To accomplish this we bathed the preparation in solutions where 
extracellular calcium was replaced by cobalt.  
 Fig 5A shows representative traces of the effect of PF1 on the potassium 
current.  In this particular experiment, the current plateau slightly increased from 901 
nA to 947 nA after PF1 application. Fig 5B shows the current-voltage plots from this 
experiment.  Fig 5C shows a bar chart of peak outward currents obtained from 6 
preparations before, during and at 20 min post-wash following PF1 application. It is 
evident that the increase produced by PF1 does not reach statistical significance in 
the absence of calcium. This is in contrast with the significant increase seen in the 
presence of calcium, Fig.3. 
 
Effects of high concentrations of PF1 on calcium and potassium currents 
 We also investigated the effect of higher concentrations of PF1 on the 
calcium and potassium currents. In order to look at effects on these currents we 
again used APF-Ringer (calcium present but lacks 4-AP). Fig. 6A, shows a 
representative trace of the effects of 10 µM PF1. PF1 produced an inhibitory effect 
on the Ipeak calcium current: at -5 mV, the current decreased from -70 nA to -46 nA. 
The Ipeak currents continued to decrease to -41 nA throughout the 20-minute post-
wash period. The current voltage plot, Fig 6C shows the effect of PF1 on the Ipeak 
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calcium currents.  The calcium currents consistently failed to return towards control 
levels when this higher concentration of PF1 was used, Fig. 6E. 
 The effect of 10 µM PF1 on the potassium current was small, Fig. 6B & D. 
The average increase in potassium currents for the 5 recordings after 9 minutes was 
3 ± 2 % (p=0.2, n=5) this contrasts with the more dramatic decrease in the calcium 
current which averaged 40 ± 11 % (p=0.003, n=5), Fig. 6D & E. Thus   10 µM PF1 
compared to 1 µM PF1 produced a smaller increase in the potassium current but a 
bigger decrease in calcium current (Ipeak). 
 
AF3 reverses the effects of PF1 on calcium currents 
 Fig. 7 shows a summary of the effects of 1 µM AF3 on voltage-activated 
inward currents. Fig. 7A shows a representative trace of effects on currents 
activated at -5 mV. Ipeak increased from -113 nA in the control to -158 nA after AF3 
application. The Iss increased from -22 nA to -39 nA.  Fig. 7B & C shows current-
voltage plots for Ipeak and Iss: notice that the peaks of these plots occur near ~0 mV 
for Ipeak and ~+5 mV for Iss. When the percentage increases were averaged over 9 
preparations, it was clear that the biggest effect was on the steady-state current.  
The average potentiation was 21 ± 7% (p=0.03) for Ipeak and the average potentiation 
for Iss was 48 ± 8% (p=0.0003). The effects of AF3 washed off gradually over a 
period of 20 minutes.  
 We described earlier the inhibitory effects of PF1 on calcium currents and 
how they failed to reverse on washing. In order to test the maintained viability of the 
preparation we followed application of PF1 with application of AF3, Fig. 8. We found 
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that AF3 reversed the inhibitory effects of PF1 on Ipeak and Iss. Fig 8A shows a 
representative recording, at -5 mV, of the effects of PF1 on the control calcium 
currents and its reversal by AF3. The effects on the current voltage plots of Ipeak and 
Iss are shown in Fig. 8B & C. 
 Fig. 8D & E summarizes the effects of PF1 and then AF3 application on Ipeak 
and Iss. The average decrease in Ipeak from 5 experiments after application of PF1 
was 26 ± 7 % (p=0.02) which recovered to 89 ± 6% (p=0.0005) after AF3 
application. These effects were statistically significant. The average decrease in Iss 
after PF1 application was 60 ± 10 % (p=0.001) which recovered to 104 ± 28 % (p= 
0.04) after AF3 application.  
 Fig. 9A & B shows the activation curves for the experiment shown in Fig. 8. 
The activation curve was obtained using the Boltzmann equation: 
                                G = Gmax / {1+ exp [(V50 – V)/ KSlope]} 
Where G is the conductance change, Gmax is the maximum conductance change, 
V50 is the half maximum step-voltage, V is the step voltage and KSlope is the slope 
factor. Fig. 9A represents the activation curve for Ipeak currents. The control 
activation curve had a Gmax of 3.6 ± 0.04 µS; V50 of -20.8± 1.5 mV and KSlope of 3.2 ± 
0.6. During PF1 application, Gmax was 3.0 ± 0.05 µS; V50 was -19 ± 0.8 mV and KSlope 
was 3.04 ± 0.5. Following AF3, Gmax was 4.9 ± 0.03 µS; V50 was -25.6 ± 0.5 mV and 
KSlope was 4.7 ± 1.1.  
 Fig. 9B is the activation curve for Iss currents. The control activation curve had 
a Gmax of 4.2 ± 0.06 µS; V50 was -0.7 ± 0.2 mV and KSlope was 3 ± 0.2. During PF1 
application, Gmax was 2.9 ± 0.1 µS; V50 was - 0.9 ± 0.4 mV and KSlope was 3.1 ± 0.3. 
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Following AF3, Gmax was 6.4 ± 0.1 µS; V50 was – 4.4 ± 0.3 mV and KSlope was 3.8 ± 
0.3. For 4 averaged recordings the effect of PF1 and AF3 on Gmax of Iss was 
statistically significant, Table 1 & Fig. 9D.  The effect of AF3 but not PF1 on Gmax   of 
Ipeak was statistically significant, Table1 & Fig. 9C. The effect of PF1 and AF3 on V50 
of Ipeak but not the V50 of Iss was statistically significant, Table 1. The effect of PF1 on 
Gmax of Iss but the lack of effect on Gmax of Ipeak suggests that the two currents are 
separate with different kinetic properties.  
4.5 Discussion  
PF1 mechanism of action 
  PF1 was first  recovered and identified from P. redivivus (Geary et al., 1992) 
and then from C. elegans (Rosoff et al., 1992). In A. suum four PNFLRFamides  
(AQDPNFL/IRFamide, ATDPNFL/IRFamide, APKPNFL/IRFamide and 
ENEKKAVPGVLTRFamide) have been proposed (Yew et al, 2005). 100 nM – 100 
µM PF1 produces a long lasting flaccid paralysis of A. suum body-wall muscle strips 
and a 3 mV hyperpolarization (Franks et al., 1994; Bowman et al., 1995; Maule et 
al., 1995).  The hyperpolarization is independent of extracellular chloride and is 
blocked by a combination of potassium channel antagonists and NOS inhibitors: 4-
AP, tetra-ethyl-ammonium (TEA) and 7-nitroindazole (Bowman et al., 2002). During 
an investigation of the effects of PF1, Bowman et al., (1995) noted the complete 
dependence of A. suum NOS activity on calcium. Bowman et al., (2002) suggested 
that a possible explanation for the requirement for a combination of 4-AP, TEA and 
7-nitroindazole to block PF1 hyperpolarizations is that PF1 opens a calcium channel 
in the nematode muscle membrane which activates the calcium sensitive NOS; the 
 130 
NO produced gates a membrane potassium channel to cause the hyperpolarization 
and relaxation. 
 In our studies we examined the effects of PF1 on voltage-activated calcium 
currents. However, we found that the PF1 did not increase the calcium currents but 
actually inhibited them (Fig. 4). We also found that PF1, in the presence of calcium, 
increased the voltage-activated potassium current (Fig. 3). Interestingly, the effect 
on the voltage-activated potassium current was abolished when calcium was 
removed and replaced with cobalt and was reduced at a higher concentration of PF1 
(Fig. 5 & 6). Our observations support the requirement for the presence of calcium 
for effects of PF1. Fig. 10 is a summary diagram of the effects of PF1 on the calcium 
and potassium currents.   
 
Two type of calcium currents A. suum  
 The presence of voltage-activated calcium currents has been demonstrated in   
A. suum muscle cells (Martin et al., 1992; Verma et al., 2007). Here we have 
investigated the effects of the neuropeptides, PF1 and AF3, on transient (Ipeak) and 
steady-state (Iss) calcium currents. In C. elegans, several genes coding for calcium 
channels have been identified. There are low voltage-activated channels [CCA-1; T-
type, Shtonda et al., (2005)] and high voltage-activated channels [UNC-2; R-type; 
Schafer et al., (1995) and EGL-19; L-type; Jospin et al., (2002)]. Different classes of 
calcium channels have not been genetically identified in A. suum.  
 Ipeak in A. suum is most like (Verma et al., 2007) C. elegans UNC-2 type 
currents (Schafer et al., 1995); they are activated by potentials – 30 to + 30 mV and 
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inactivated in the 50-80 ms range. Verma et al., (2007) demonstrated that AF2, an 
excitatory neuropeptide, produces an increase in the Ipeak current. Removal of 
calcium and addition of cobalt abolishes the Ipeak in A. suum muscles, indicating that 
calcium is the major charge carrier of this current. 
  egl-19 encodes the L-type calcium channel in pharynx and body wall muscles 
in C. elegans (Lee et al., 1997) . L-type calcium currents in C. elegans have a fast 
and a slow component but the components are not pharmacologically separate 
(Jospin et al., 2002). The Iss current in A. suum is similar to the L-type calcium 
current as it has a high voltage threshold for activation (peaks ~ +5 mV) and is long 
lasting in nature (~ 30 ms). The Iss current is abolished by cobalt and the absence of 
calcium, consistent with calcium being the major charge carrier.  
 
Effects of AF3  
 The neuropeptide AF3 was first recovered from A. suum by Cowden et al., 
(1995) and found to stimulate contraction of A. suum muscle strips (Trim et al., 
1997). We used AF3 to study voltage-activated currents and found that it increased 
Ipeak and Iss calcium currents. Previous investigations of the action of AF3 have 
demonstrated that it exerts a depolarizing effect which is blocked by cobalt (Trim et 
al., 1997; Brownlee and Walker, 1999), an action consistent with our observations 
on the voltage-activated calcium currents. We exploited the stimulatory effects of 
AF3 on the calcium currents to counter the actions of PF1 which are not otherwise 
easily reversed on washing (Franks et al., 1994). Our concern was to confirm that 
the calcium currents had not declined because of failing viability of the preparation. It 
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is interesting to note that AF3 had its biggest percentage effect on the Iss but the 
neuropeptide AF2 has its biggest effect on the Ipeak (Verma et al., 2007).  The 
different actions by these two neuropeptides, on Ipeak and Iss, imply that they can be 
modulated separately and that the two currents have separate origins and 
physiological functions. It is possible that Iss currents are similar to C.elegans EGL-
19 L-type calcium currents that have been found in body wall, enteric, egg laying 
and pharyngeal muscles (Lee et al., 1997; Jospin et al., 2002). EGL-19 has been 
demonstrated to maintain the plateau phase of action potentials of pharyngeal 
muscles (Shtonda and Avery, 2005). The UNC-2 type calcium currents in C. elegans 
have similarities to the Ipeak current and are associated with neurotransmitter release 
and calcium dependent action potentials in pharyngeal muscles (Schafer and 
Kenyon, 1995; Mathews et al., 2003). We do however caution, that we have not 
conclusively separated the Ipeak and Iss calcium currents in A. suum and there is a 
possibility that the two currents are due to the same channel with different levels of 
inactivation as described by Dick et al., (2008).  
 
Emodepside and PF1 
 Emodepside, a semisynthetic derivative of PF1022A, is a novel cyclo-
octadepsipeptide anthelmintic (Harder et al., 2003; von Samson-Himmelstjerna et 
al., 2005). Emodepside has potent paralytic effects on A. suum body wall muscles 
(Willson et al., 2003) and has a wide range of effects on C. elegans inhibiting 
development, locomotion, egg laying and feeding (Bull et al., 2007).   
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Martin et al., (1996) demonstrated that PF1022A does not produce its effect on A. 
suum muscles by mimicking the inhibitory neurotransmitter GABA or by antagonizing 
nicotinic receptors.  It has been demonstrated that the parent compound PF1022A, 
interacts with latrophilin receptors (Saeger et al., 2001). The latrophilin receptors are 
G-protein coupled receptors involved in the regulation of transmitter release from 
dense core vesicles (Davletov et al., 1998). It has been suggested that emodepside 
induces latrophilin mediated release of transmitters by a pathway that involves UNC-
13 dependent vesicle priming in C. elegans (Willson et al., 2004).  
 Another proposed mechanism of action of emodepside has been to mimic the 
effects of PF1 or to induce the release of PF1 (Willson et al., 2003). Both PF1 and 
emodepside produce relaxation, slow hyperpolarization and a small change in input 
conductance of A. suum muscle cells (Bowman et al., 2002; Willson et al., 2003). It 
has also been shown that the effects of PF1 in A. suum muscles are calcium 
dependent (Franks et al., 1994; Bowman et al., 1995) as are the effects of 
emodepside (Harder et al., 2003). Potassium channel blockers reduce 
hyperpolarization induced by both PF1 and emodepside (Harder et al., 2003).  
 We found that the PF1 did not increase the voltage-activated calcium currents 
but inhibited them. Our observations also demonstrated the importance of entry of 
calcium for an effect on voltage-activated potassium currents. Fig. 10 is a summary 
diagram showing the actions of PF1: PF1 cannot stimulate the potassium channel 
unless sufficient calcium is present in the cell. At high concentrations of PF1, 
calcium entry may be so reduced, preventing the effect of PF1 on the potassium 
currents. We have shown that PF1 inhibits voltage-activated calcium currents and 
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potentiates voltage-activated potassium currents. The action of emodepside in C. 
elegans has been shown to depend upon the SLO-1 pathway. SLO-1 is a calcium-
activated-potassium channel (Guest et al., 2007). The effect on a calcium-activated-
potassium channel appears to be common to both PF1 and emodepside. It will be of 
interest to investigate the actions of emodepside on calcium currents to further 
elucidate the mechanism of action of emodepside.  
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4.8 Legends 
 
Figure 1.  A: Diagram of the location of two micropipettes for making current-clamp 
and voltage-clamp recordings from bag region of Ascaris suum somatic muscle. The 
current-injecting pipette and the voltage-sensing pipette are shown 
B: Current-clamp recording showing, 40nA, 0.5 sec, current pulses (upper trace) 
inducing change in membrane potential (lower trace).  
C: Voltage-clamp recording showing depolarizing step-voltage from a holding 
potential of -35mV to 0 mV (upper trace) producing a current response (leak 
subtracted lower trace). Note the presence of the voltage-activated transient inward 
current (Ipeak) and a sustained inward current (Iss).   
 
Figure 2. Effect of PF1 under current-clamp. 
A: Representative trace showing change in membrane potential record of somatic 
muscle cells in current clamp before, during and after application of PF1 (1µM).  
B:  Shows a bar chart of the mean ± S.E.M. membrane potential responses 
observed from different preparations. There was a significant hyperpolarization after 
PF1 application in all experimental conditions; the comparisons were made between 
the membrane potential before and after application of PF1 under different 
conditions. The comparison to responses between different conditions was not 
significant. PF1 (1 µM, n=6) -5.0 ± 0.8 mV; PF1 (10 µM, n=6) -6.25 ± 0.7 mV; PF1 (1 
µM, n=5) in the presence of cobalt (6mM) -6.4 ± 1.0 mV and PF1 (1µM, n=10) in 
presence of 4-AP (5mM) -3.2 ± 0.4 mV, respectively. (paired t-test,  ** p ≤ 0.01,   * p 
≤ 0.05). 
 
Figure 3.  Effect of PF1 on voltage-activated currents. 
A: Representative traces showing voltage-activated currents in control, during PF1 
(1 µM) application and post-wash. Two currents observed outward potassium 
currents (O) and transient inward calcium current (Ipeak). Note the increase in the 
plateau of outward current and the decrease in the Ipeak current.  (APF-Ringer no 
calcium or potassium channel block).  
B: Current-voltage plot of the mean potassium current before, during and after PF1 
(1 µM) application. Control:  . PF1 (1 µM):  . Post-wash:  .   
C: Current-voltage plot of the calcium transient inward current (I) before, during and 
after PF1 (1 µM) application. Control:  . PF1 (1 µM):  . Post-wash: D: 
Long-lasting potentiation of the mean (O) potassium current before, during and after 
PF1 (1 µM) application (paired t-test, n=6, ** p ≤ 0.01,* p ≤ 0.05). 
E: Inhibition of the peak calcium transient inward current (Ipeak) before, during and 
after PF1 (1 µM) application (paired t-test, n=6, ** p ≤ 0.01,* p ≤ 0.05). 
 
Figure 4.  Effect of PF1 on voltage-activated calcium currents. 
A: Voltage-activated inward currents, control and during the application of PF1 (1 
µM) (red); peak inward currents (Ipeak) and steady state current (Iss). Note decrease 
in the Ipeak and the Iss currents. Recordings were made in calcium-Ringer solution 
with cesium acetate in recording micropipettes.  
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B: Current-voltage plot of the Ipeak before, during and after PF1 (1 µM) application. 
Control:  . PF1 (1 µM):  . Post-wash:  .   
C: Current-voltage plot of Iss before, during and after PF1 (1 µM) application. Control: 
 . PF1 (1 µM):  . Post-wash:  .   
D: Inhibition of the Ipeak current during and after PF1 (1 µM) application (paired t-test, 
n=10, ** p ≤ 0.01,* p ≤ 0.05). 
E: Long-lasting inhibition of the mean Iss current during and after PF1 (1 µM) 
application (paired t-test, n=9, ** p ≤ 0.01,* p ≤ 0.05). 
 
Figure 5. Lack of effect of PF1 (1µM) in presence of cobalt. 
A: Representative traces showing the effect of PF1 (1 µM) on voltage-activated 
outward currents in cobalt-APF. There was no change in the voltage-activated 
(outward) potassium currents during and after PF1 application. Recordings were 
made in cobalt-Ringer solution no potassium channel blockers. 
B: Current-voltage plot of the mean (O) potassium currents before, during and after 
application of PF1 (1 µM). Control:  . PF1 (1 µM):  . Post-wash:  .   
C: There was no change in mean potassium current during and after PF1 (1 µM) 
application in presence of cobalt (paired t-test, n=6, ** p ≤ 0.01,* p ≤ 0.05). 
 
Figure 6. Effect of higher concentration of PF1. 
A: Representative traces showing voltage-activated currents; mean potassium 
currents (O); peak inward currents (Ipeak). Voltage-activated currents: control, during 
PF1 (10 µM) application and post-wash.  Note the increase in the peak outward 
current and the decrease in the Ipeak.  Recordings were made in APF-Ringer.  
B: Current-voltage plot of the mean potassium currents (O) during and after 
application of PF1 (10 µM). Control:  . PF1 (1 µM):  . Post-wash:  .     
C: Current-voltage plot of the Ipeak currents during and after application of PF1 (10 
µM). Control:  . PF1 (1 µM):  . Post-wash:  .  The biggest effect is on the 
Ipeak current. 
D: No significant potentiation of the mean (O) potassium current during and after 
PF1 (10 µM) application  
E: Significant inhibition of the Ipeak current after PF1 (10 µM) application (paired t-
test, n=5, ** p ≤ 0.01,* p ≤ 0.05). 
 
Figure 7. Effect of AF3 on voltage-activated inward currents. 
A: Voltage-gated transient-inward currents recorded before  and 9 minutes after AF3 
application. Note the increase in the amplitude of the Ipeak and the Iss current. 
Recordings were made in calcium-Ringer solution with cesium acetate in recording 
micropipettes. 
B: Ipeak current-voltage relationship for the experiment shown in A. Control:  . 
AF3 (1 µM):  . Post-wash:  .   
C: Iss current-voltage relationship for the experiment shown in A. Control:  . AF3 
(1 µM):  . Post-wash:  .   
 D: Potentiation of the Ipeak current after AF3 (1 µM) application (paired t-test, n=9, ** 
p ≤ 0.01,* p ≤ 0.05). 
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E: Long lasting potentiation of the Iss current after AF3 application (paired t-test, n=9, 
** p ≤ 0.01,* p ≤ 0.05). 
 
Figure 8. AF3 triggers the recovery of PF1-inhibited currents. 
A: Voltage-activated inward currents records: control; PF1 (1 µM) (red) and; AF3  (1 
µM). Note the decrease in amplitude of the Ipeak and the Iss currents after PF1 
application and recovery of currents after AF3 application. Recordings were made in 
calcium-Ringer solution with cesium acetate in recording micropipettes. 
B: Ipeak current step-voltage relationship for the experiment shown in A. Control: 
. PF1 (1µM): . AF3 (1µM) : . Post-wash: .  
C: Iss current step-voltage relationship for the experiment shown in A. Control: . 
PF1 (1µM):  . AF3 (1µM) : . Post-wash:  .  
D: Inhibition of the Ipeak current after PF1 and recovery after AF3 application (paired 
t-test, n=5, ** p ≤ 0.01,* p ≤ 0.05). 
E: Inhibition of the Iss current after PF1 application and recovery after AF3 
application. Note that AF3 potentiated the Iss current (paired t-test, n=5, ** p ≤ 0.01,* 
p ≤ 0.05). 
 
Figure 9.  Activation curves for Ipeak & Iss.  
A: Activation curves for Ipeak currents before and during application of PF1 & AF3.  
Control:   . PF1 (1µM):  ..  AF3 (1µM):  .  
B: Activation curves for Iss currents before and during application of PF1 & AF3. 
Control:   . PF1 (1µM):  ..  AF3 (1µM):  . 
C: Change in Gmax of Ipeak currents after AF3 application.  
D: Change in Gmax of Iss  currents after AF3 application.  
 
Figure 10.  Summary diagram of the effects of PF1 and AF3 on voltage-activated 
currents. PF1 inhibits the opening of voltage-activated calcium channels (Ipeak & Iss) 
and stimulates opening of potassium channels (K) but only in the presence of 
calcium.  AF3 stimulates opening of voltage-activated calcium channels (Ipeak & Iss). 
Calcium is required to allow the inhibitory effect of PF1 on potassium currents.  If 
sufficient calcium is not present (for example due to the presence of cobalt in the 
bathing solution or if a high concentration of PF1 is used inhibiting the voltage 
activated currents) the effect of PF1 on voltage-activated potassium current is 
prevented.  
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4.9 Figures  
 
Figure 1.  A: Diagram of the location of two micropipettes for making current-
clamp and voltage-clamp recordings from bag region of Ascaris suum somatic 
muscle. The current-injecting pipette and the voltage-sensing pipette are 
shown 
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Figure 2. Effect of PF1 under current-clamp. 
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Figure 3.  Effect of PF1 on voltage-activated currents. 
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Figure 4.  Effect of PF1 on voltage-activated calcium currents. 
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Figure 5. Lack of effect of PF1 (1µM) in presence of cobalt. 
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Figure 6. Effect of higher concentration of PF1. 
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Figure 7. Effect of AF3 on voltage-activated inward currents. 
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Figure 8. AF3 leads to recovery of currents inhibited by PF1. 
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Figure 9.  Activation curves for Ipeak & Iss.  
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Figure 10.  Summary of the effects of PF1 and AF3 on voltage-activated 
currents. 
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  Peak current Steady-state current 
  Control PF1 AF3 Control PF1 AF3 
Gmax (µS) 2.8 ± 0.3 2.8 ± 0.2 3.9 ± 0.4* 3.5 ± 0.9 2 ± 0.8*** 5.4 ± 1.1*** 
V50 (mV) -17 ± 1.7 -15 ± 1.9* -21 ± 1.4* -2.5 ± 2.6 -0.82  ± 1.9 -2.2  ± 2.7 
Kslope (mV) 3.5 ± 0.3 4.2 ± 0.5 4.3 ± 0.9 3.5  ± 0.7 2.4  ± 0.5* 4.4  ± 1.1* 
 
 
Table. 1. Average values of the activation curves for  I peak and Iss calcium 
currents fitted by Boltzmann equation (n=4 preparations from separate worms, 
*** p ≤ 0.005; ** p ≤ 0.01;* p ≤ 0.05). These averages are for the experiments 
where AF3 was used to trigger the recovery of PF1 inhibited calcium-currents 
(n=5). 
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Chapter 5.  Effects of the muscarinic agonist,  
5-methylfurmethiodide, on contraction and electrophysiology of 
Ascaris suum muscle. 
International J Parasitology (2008) Jul;38 (8-9):945-57. Epub 2007 Dec 8. 
Sasa M. Trailovic*, Saurabh Verma*, Cheryl L. Clark, Alan P. Robertson, 
and Richard J.  Martin.  (* Joint first authors.) 
Department of Biomedical Sciences, Iowa State University, IA 50011, USA 
 
5.1 Abstract 
Contraction and electrophysiological effects of 5-methylfurmethiodide (MFI), a 
selective muscarinic agonist in mammals, were tested on Ascaris suum muscle 
strips.  In a contraction assay, MFI produced weak contraction and was less potent 
than levamisole and acetylcholine.  Atropine (3 µM) a non-selective muscarinic 
antagonist in mammalian preparations, did not affect contractions produced by MFI.  
Mecamylamine (3 µM) a nicotinic antagonist in A. suum preparations blocked the 
MFI contractions indicating that MFI had weak nicotinic agonist actions.  In two-
micropipette current-clamp experiments MFI, at concentrations greater than 10 µM, 
produced concentration-dependent depolarizations and small increases in 
membrane conductance. The depolarizing effects were not abolished by perfusing 
the preparation in a calcium-free Ascaris Ringer solution to block synaptic 
transmission, suggesting that MFI effects were mediated by receptors on the muscle 
and were calcium-independent.  A high concentration of mecamylamine, 30 µM, only 
reduced the depolarizing responses by 42%, indicating that MFI also had effects on 
non-nicotinic receptors.  Three non-nicotinic effects in the presence of 30 µM 
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mecamylamine were identified using voltage-clamp: 1) MFI produced opening of 
mecamylamine-resistant non-selective-cation channel currents; 2) MFI inhibited 
opening of voltage-activated potassium currents; and 3) MFI increased the threshold 
of voltage-activated calcium currents.   We suggest that a drug that is more selective 
for voltage-activated potassium currents, without effects on other channels like MIF, 
may be exploited pharmacologically as a novel anthelmintic or as an agent to 
potentiate the action of levamisole. In a larval migration assay we demonstrated that 
4-aminopyridine (a potassium channel blocker) potentiated the effects of levamisole 
but MFI did not.   
5.2 Introduction 
 The development of novel anthelmintics has been limited, so it is important to 
identify novel therapeutic lead compounds as well as methods for enhancing the 
potency of existing compounds that might counter drug resistance.  The methods 
may include pharmacological agents that increase responses to the existing 
anthelmintics.   Previously our studies have focused on levamisole and related 
drugs. Levamisole belongs to the ionotropic cholinergic agonist group of 
anthelmintics, that includes pyrantel, and that selectively produces muscle cell 
depolarization and spastic paralysis in parasitic nematodes (Aceves et al., 1970; 
Aubry et al., 1970). We have shown using current-clamp, voltage-clamp and patch-
clamp, that electrophysiological responses to these anthelmintics can be observed in 
body muscle cells of the nematode parasites A. suum & Oesophagostomum 
dentatum (Martin, 1982; Pennington & Martin, 1990;  Robertson & Martin, 1993;  
Robertson et al., 1994;  Dale & Martin, 1995;  Evans & Martin, 1996;  Martin et al., 
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2002;  Robertson et al., 2002;  Trailovic et al., 2002).  These studies have identified 
nematode nicotinic acetylcholine gated receptor channels (nAChRs) over the 
nematode muscle cell surface that is selectively and directly gated by these 
anthelmintics. These studies have described down to the single-channel level, the 
agonist action and channel-blocking action of the anthelmintics.   
 If it were possible to find a drug that could stimulate nematode metabotropic 
cholinergic (G-protein coupled, muscarinic-like) receptors, it might be developed as 
a stand alone anthelmintic, or it might be used with ionotropic cholinergic 
anthelmintics to increase their potency. There is evidence in A. suum of 
metabotropic cholinergic receptors on muscle cells.  Colquhoun et al. (1991) have 
tested a range of cholinergic agonists on the electrophysiology of A. suum muscle 
cells and found furtrethonium to be one of the more potent muscarinic agonists.  
Segerberg & Stretton (1993) have also found evidence of muscarinic-like receptors 
on A. suum muscle mediating depolarization and contraction; and Martin & Valkanov 
(1996) have described effects of acetylcholine potentiating the opening of 
mecamylamine-resistant non-selective cation channel currents (Ibcat) in isolated A. 
suum muscle bags.   In Caenorhabditis elegans three G-protein coupled 
acetylcholine receptors (GAR-1, GAR-2 and GAR-3) have been reported (Hwang et 
al., 1999; Lee et al., 2000).  GAR-3 is pharmacologically similar to the mammalian 
muscarinic receptor. GAR-1 and GAR-2 are pharmacologically unlike mammalian 
muscarinic receptors and are not antagonized by usual concentrations of muscarinic 
antagonists. 
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 Colquhoun et al., (1991) tested effects on membrane potential of A. suum of a 
number of mammalian cholinergic agonists including furtrethonium, muscarine, 
arecoline, pilocarpine, McN A343, bethanocol and oxtremorine and furtrethonium 
was the most potent.  We therefore selected 5-methylfurmethiodide (MFI, Fig.1 A)  
which is a potent mammalian muscarinic agonist (Newberry & Priestley, 1987) for 
further testing.  In this paper we show that MFI in A. suum has four effects:  1) it is a 
weak nicotinic agonist; 2) it opens mecamylamine-resistant non-selective cation-
channels; 3) it inhibits opening of voltage-activated potassium channels; and 4) it 
increases the threshold for activation of calcium channels.  We discuss the 
significance of: mecamylamine-resistant channels and receptor operated channels 
(ROCs: TRPs).  We also illustrate the use of inhibition of voltage-sensitive potassium 
channels as a method for potentiation of cholinergic anthelmintics.   
5.3 Materials and Methods 
 Collection of worms 
 Adult A. suum, Fig. 1 B, were obtained weekly from the Tyson pork packing 
plant at Storm Lake, Iowa.  Worms were maintained in Locke’s solution [NaCl 
(155mM), KCl (5 mM), CaCl2 (2 mM), NaHCO3 (1.5 mM) and glucose (5 mM)] at 32 
oC. The Locke’s solution was changed daily.  
Muscle contraction assay 
 A. suum were used for the contraction studies within 72 hours of collection, 
since the ability to contract vigorously to cholinergic agonists declined after this 
period. Two 1-cm body-flap preparations, one dorsal and one ventral, were made 
from each A. suum female from the region anterior to the genital pore, Fig. 1 B. Each 
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flap was monitored isometrically by attaching a force transducer in an experimental 
bath maintained at 37 oC containing 10 ml Ascaris Ringer (mM): NaCl, 23; Na-
acetate, 110; KCl, 24; CaCl2, 6; MgCl2 5; glucose, 11; HEPES, 5; pH 7.6 adjusted 
with NaOH and bubbled with nitrogen.  Eight baths were used simultaneously. After 
dissection, the preparations were allowed to equilibrate for 15 min under an initial 
tension of 2.0 g. The antagonist was then added to the preparation 15 min before 
the application of the first concentration of the agonist. We ran two controls (no 
antagonist) and three replicate antagonist concentrations during each experiment (8 
preparations). The dorsal and ventral flaps were assigned randomly in the 
experiments to reduce any potential error associated with differences in receptor 
populations. The agonists were added cumulatively with 2-3 minute intervals 
between applications and the responses were steady changes in tension. Results for 
individual flaps were rejected if the maximum change in tension, in response to 
agonist, did not exceed 0.5 g. The responses for each concentration were measured 
in grams and expressed in grams or as a % of the maximum tension produced by 
each individual flap preparation.   
 Changes in isometric muscle tension responses were monitored using a 
PowerLab System (AD Instruments) that consists of the PowerLab hardware unit 
and Chart for Windows software. The system allows for recording, displaying and 
analysis of experimental data.  Sigmoid dose-response curves for each individual 
flap preparation at each concentration of antagonist were described by the Hill 
equation and fitted using Graph Pad Prism 4 software. The fits allowed estimation of 
EC50s with 95% confidence intervals.   
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Electrophysiology 
 A 1cm long muscle tissue flap was prepared by dissecting the anterior part of 
the worm, 2-3 cm caudal to the head. The body muscle flap preparation was then 
pinned onto 3 ml Sylgard lined Petri-dish. The intestine was removed to expose the 
muscle bags. The preparation, Fig. 1 C, was continuously perfused, unless 
otherwise stated, with Ascaris Ringer solution. The preparation was maintained in 
the experimental chamber at 34 oC using a Warner Heating collar [DH 35] and 
heating the incoming perfusate with a Warner instruments (TC 324B) in-line heating 
system (Hamden, CT, USA). The perfusate was applied at 4-6 ml/min through a 19-
gauge needle placed directly over the muscle bag that was being recorded from. 
Calcium-free experiments were performed using calcium-free Ascaris Ringer 
(Composition in mM: NaCl 23, Na-acetate 110, KCl 24, MgCl2 11, glucose 11, 
HEPES 5, and EGTA 0.5, NaOH was used to adjust the pH to 7.6). The sodium  and 
calcium substitution experiments were conducted using n-methyl-d-glucamine 
Ringer  (NMDG Ringer), composition in mM : NMDG Cl 23, NMDG-acetate 110, KCl 
24, MgCl2 11 , glucose 11, HEPES 5 and 5 EGTA, CsOH was used to adjust the pH 
to 7.6.  Calcium currents were recorded using modified Ascaris Ringer (calcium-
Ringer) with added 5 mM 4-aminopyridine to reduce potassium currents.   
 Two-micropipette voltage-clamp and current-clamp techniques were 
employed to investigate whole cell currents in A. suum. Borosilicate capillary glass 
(Harvard Apparatus, Holliston, MA, USA) micropipettes were pulled on a P-97 
Flaming Brown Micropipette puller (Sutter Instrument Co., Novato, CA, USA).  The 
voltage-sensing and current-injecting micropipettes for the current–clamp and the 
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voltage-sensing micropipettes for voltage-clamp had resistances in the range 20-30 
MΩ. The current-injecting micropipette for voltage-clamp had a resistance of 4-6 MΩ 
to keep the gain high and to facilitate clamp quality.   The recordings were obtained 
by impaling both electrodes in the bag region of the A. suum muscle. All experiments 
were performed using an Axoclamp 2B amplifier, 1320A Digidata interface and 
Clampex 8.2 software (Axon Instruments, Sunnywale, CA). All data were displayed 
and analyzed on a Pentium IV based desktop computer. The amplifier gain for 
voltage-clamp was more than 100 in all recordings. The phase lag was set to 1.5 ms 
in all experiments. In addition muscles closer to nerve cord were impaled for 
experimental study as they were rounder and with shorter arms to keep the 
membrane capacitance load low and to maintain the space-clamp. Only cells with 
stable membrane potentials more negative than -30 mV and of input conductance 
less than 2.5 µS were selected for recording.  To investigate the effects of MFI on 
currents at hyperpolarized and depolarized potentials at the same times, a ramped 
voltage protocol was used from a holding potential of -35mV.  The voltage was 
stepped to -65 mV and over a period of 5 sec brought to -15 mV before stepping 
back to -35 mV.  Leak subtraction was not used for the ramped-voltage experiments.  
 To investigate effects on inward and outward voltage-activated currents, 
voltage-steps of 5 mV each were used. The step potentials were: -25 mV, -20 mV, -
15 mV, -10 mV, -5 mV, 0 mV, +5 mV, +10 mV, +15 mV and + 20 mV.   Step 
potentials up to 150 ms were used for observing the outward potassium currents; 
step potential up to 50 ms were used for the inward calcium currents.  The holding 
potential was -35 mV and leak subtraction was used to display the voltage-activated 
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currents (Verma et al., 2007). Outward potassium currents were observed using 3 M 
potassium acetate in the recording micropipettes.  Calcium currents were observed 
using a combination of 1.5 M potassium acetate and 1.5 M cesium acetate in 
recording micropipettes; the cesium acetate was included in pipette solution to block 
outward potassium currents. For all voltage-clamp experiments, the drug 
applications were done in current-clamp for a minimum of 2 minutes before moving 
onto voltage-clamp. For current-clamp experiments a hyperpolarizing pulse of 40 nA 
was injected for 500 ms at 0.28 Hz frequency through the current-injecting 
micropipette and the other micropipette recorded the change in membrane potential.  
Larval migration studies 
 Levamisole-sensitive O. dentatum were originally supplied by the Royal 
Veterinary and Agricultural School, Frederiksberg, Copenhagen and then 
reproduced at 6-9 month intervals by passage in pigs at Iowa State University, 
Ames, Iowa. The L3 larvae isolates were maintained between passages in tap water 
refrigerated at 11 oC (changed every 2-4 months).   
 Between 1500-3000 L3’s were ex-sheathed by 5-10 minute incubation in 1.5 
% sodium hypochlorite solution.  The larvae were then washed three times in 
migration buffer (composition: 0.85 % NaCl, 5 mM Tris-HCl, pH to 7.0 with 1 M 
NaOH) with the aid of centrifugation (5 min 1000 g). Approximately 150 larvae were 
collected with a pipette and placed in each of the drug concentrations to be tested 
for 2 hours at 37 oC.   After this incubation, the larvae were re-suspended in fresh 
test solutions. A migration apparatus consisting of two tightly fitting plastic tubes 
(~10 mm length) that secured a 20 µm nylon filter (Small Parts Inc. Miami Lakes, Fl.) 
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was placed in each test solution of a 24-well plate.  The re-suspended larvae were 
added slowly to the top of each filter and allowed to migrate through the filters and 
into the wells during a 2 hr incubation at 37 oC.  At the end of the incubation period, 
the number of larvae remaining within each of the filter tubes was counted and the 
number of larvae entering into the 24 well plates was counted. We then calculated 
the % not migrating for each of the concentrations. The relationship between the 
concentration of levamisole and the %-inhibited larvae was then examined by fitting 
sigmoidal dose-response curves.  
Drugs  
 A 5-methylfurmethiodide (MFI), (Tocris Bioscience, Ellisville, Missouri) 3 mM 
stock solution was prepared every week and kept in 1.5 ml micro-tubes at -20 ºC. 
The MFI stock solution was thawed just before use for experiments. All other drugs 
were obtained from Sigma-Aldrich, St. Louis, MO. All the stock solutions were made 
using double distilled water.   
Statistical Analysis 
 Currents were plotted as a function of step potential to generate I-V curves. 
All the statistical analysis was done using Graph Pad Prism software (version 4.0, 
San Diego, CA, USA).  Data were fitted with Boltzmann sigmoidal equation:  I = Imax 
/ {1 + exp [(V50 –V)/Kslope]}. The EC50 concentrations for levamisole, acetylcholine 
and MFI were determined by fitting the standard sigmoidal dose-response 
relationship (slope =1) using the Graph Pad Prism software.   Paired t-tests were 
used to test significant difference in responses with control and test recordings in the 
same preparation.  Observations given are mean ± standard error of the mean.  
 161 
Minitab was used for analysis of variance using the general linear model to test the 
significance of effects of MFI and 4-AP in the larval migration studies.   
 5.4 Results 
Contraction 
 MFI was less potent than levamisole and acetylcholine in the contraction 
assay. Fig. 2 A shows the contraction-concentration plots for levamisole, 
acetylcholine (with 3 µM neostigmine to block cholinesterase) and MFI.  The EC50s 
(with 95% confidence intervals) were: levamisole: 0.7 (0.5 – 1.1, N= 18 preparations) 
µM; acetylcholine 3.1 (1.9 – 4.9, N= 24 preparations) µM; and MFI 221 (120- 410, 
N=18 preparations) µM.  MFI was not a full agonist and produced a maximum 
contraction that was around 30% of that produced by levamisole.   
 Atropine (3 µM) did not inhibit (control: N = 4 preparations; atropine N=6 
preparations) the contractile effects of MFI, Fig. 2 B, showing that the effects were 
not mediated by classic muscarinic receptors. However 3 µM mecamylamine, Fig. 2 
C, a nicotinic antagonist, completely blocked (N=4 preparations) contractions 
produced by MFI, showing that MFI has weak nicotinic effects sensitive to low 
concentrations of mecamylamine.    
 
MFI depolarizations (current-clamp) 
 Fig. 3 A shows a representative recording of the effect of application, by rapid 
microperfusion, of 300 µM MFI on the membrane potential and input conductance of 
an A. suum muscle cell. The dark central trace is the membrane potential which had 
a resting value of -35 mV; the downward deflection is the voltage response to the 
 162 
injected current showing that the resting input conductance was 2.4 µS; and the 
upward deflection is the anode break spike that followed the end of the 40 nA 
hyperpolarizing current pulse.  The response, despite rapid MFI application, was a 
slow depolarization of 13 mV associated with a very small conductance increase of 
less than 0.1 µS; the response took 75 sec from onset to reach its peak and was 
reversible on washing.  The slow nature of the response to rapidly-applied MFI to A. 
suum muscle suggests that most of the response may not be mediated directly on 
ligand-gated channels (Purcell et al., 2002).  The anode break spikes increased in 
amplitude during the application of the MFI as shown in Fig.3 A where there was an 
increase from 11 mV to 17 mV.  Similar effects on anode break spikes were 
observed in the other preparations.  One possible explanation for the effects on 
anode break spikes is an effect of MFI on voltage-sensitive currents associated with 
the spiking mechanism and this possibility is investigated subsequently in our 
manuscript.    
 Fig. 3 B shows a representative recording of the effect of different 
concentrations of MFI on the membrane potential and resting conductance of the 
muscle cell.  There was little effect at 10 µM MFI but a more noticeable effect at 30 
µM MFI; again notice the very slow onset and offset of the response.  The 
depolarizations were concentration-dependent and reversible on washing.  Fig. 3 C 
shows, for comparison, a recording from another preparation, the faster time-course 
(onset and offset) of the depolarizing response to 3 µM acetylcholine with the peak 
occurring in less that 9 sec; the MFI response was slower suggesting a different 
mechanism of action. The peak MFI concentration-depolarization relationships are 
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shown in Fig. 4; the relationships were determined in normal Ascaris Ringer and in 
Ca-free Ascaris Ringer solution and were not distinguishable. The concentration-
conductance relationship, Fig 4 inset, in normal Ascaris and in Ca-free Ascaris 
Ringer solution however suggested that the presence of calcium could increase the 
MFI-induced conductance change, but we did not analyze this effect further.  The 
fact that removal of calcium did not abolish the MFI response suggests that the 
effects of MFI are direct on muscle receptors and are not mediated trans-
synaptically because calcium is required for synaptic transmission. The EC50 in the 
presence of calcium was 151 µM (95% confidence intervals 77– 262 µM, df 23, n= 6 
preparations) which was not significantly different in calcium-free Ascaris Ringer, 
191 µM (95% confidence intervals 76 – 540 µM, df 23, 6 preparations).   We also 
determined the conductance-concentration plots in the presence and absence of 
calcium, Fig. 4 inset. The conductance changes associated with the depolarization 
responses were small, ranging up to 0.1 µS over the concentration range. The input 
conductance changes associated with nicotinic effects of acetylcholine are usually 
larger, up to 2.5 µS in A. suum muscle (Colquhoun et al., 1991), suggesting again 
that the receptor population stimulated by MFI is not entirely nicotinic. The MFI 
conductance EC50 in the presence of calcium was 71 µM and in calcium-free Ringer, 
it was 58 µM. The lack of major effects of removing calcium on membrane potential 
suggests that calcium is not the major charge carrier mediating the depolarization.  
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Effect of atropine and mecamylamine on MFI depolarizations 
 Next, we tested effects of a high concentration of atropine, 30 µM, on the MFI 
depolarization response and found that it only had a small, but statistically significant 
inhibitory effect, Fig. 5 A.  The mean response to 100 µM MFI was 9.8 ± 0.8 mV (N= 
4) and in the presence of 30 µM atropine it was 7.4 ± 0.8 mV (N=4, p < 0.001, paired 
t-test). These observations suggest that MFI did not mediate most of its effect on 
membrane potential by activating muscarinic (atropine sensitive) receptors.  
 When we tested the effects of a high concentration of mecamylamine (30 
µM), it reduced but did not block depolarizing responses to 100 µM MFI, Fig. 5 B; 
the mean response before application of mecamylamine was 6.5 ± 1.0 mV (N=4), in 
the presence of mecamylamine the mean response was 3.3 ± 0.9 (N=4, p < 0.01, 
paired t-test). Since mecamylamine is a potent nicotinic antagonist in A. suum 
(Colquhoun et al., 1991), the modest  antagonism of mecamylamine suggests that 
only part of the MFI response is mediated by nicotinic receptor channels; most of the 
response is mediated by other mecamylamine-resistant receptor ion-channel effects. 
In order to dissect out the ionic mechanisms involved we conducted voltage-clamp 
experiments to examine effects on specific voltage-activated currents.      
 
Ramp voltage-clamp experiments 
 Initial voltage-clamp experiments showed that 100 µM MFI induced a steady 
inward current at a holding potential of -35 mV (mean 57 ± 9 nA) and that this was 
significantly reduced, but not blocked, (mean 42 ± 5 nA) in the presence of 30 µM 
mecamylamine (p <0.001, paired t-test, N=7).   We used 30 µM mecamylamine 
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subsequently in the voltage-clamp experiments to block nicotinic effects and isolate 
the non-nicotinic effects of MFI.  Fig. 6 shows sections of a recording made during 
the ramp voltage-clamp experiments.  The top trace (Fig. 6. A) shows the ramp 
protocol that was used:  the potential was held at -35 mV between the ramp-
voltages, near to the normal resting membrane potential; there was then a step to -
65 mV followed by a ramped depolarization over a 5 sec period to -15 mV; the 
membrane potential was then stepped back to -35 mV.  These ramp pulses were 
repeated after 5 sec.  The middle trace (Fig. 6 B) shows current traces: 1) Control, 
just before the application of MFI; and 2) during the plateau phase of the MFI 
response.  Following washout of MFI, the currents returned towards control levels 
(data not shown).      
 
MFI opens a mecamylamine-resistant non-selective cation channel 
Fig. 6 B shows the ramp currents that were displayed without leakage 
correction.  At -35 mV during the application of MFI, there was an increase in the 
inward holding current of 9 nA (follow the upper dashed line in Fig. 6 B).  At -65 mV 
during the application of MFI, the inward current increased by 15 nA (follow the 
lower dashed line). The increases in current are plotted in Fig.6 C and extrapolated 
to estimate the reversal potential (Erev: +10 mV) of the MFI current.  The mean 
reversal potential in experiments on separate preparations was -6.0 ±  5.8 mV (N=5). 
Additionally, the current associated with the -35 mV to -65 mV voltage-step 
increased from -107 nA (control) to 113 nA in the presence of 100 µM MFI and 30 
µM mecamylamine. In similar experiments on 5 different preparations, the mean 
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increase in the current step was 12.2 ±  3.6 nA and statistically significant (paired t-
test, p<0.05, N=5).  For a 30 mV step, the increased current step seen in the ramp 
experiments corresponds to a mean membrane conductance increase of 0.4 µS. 
The increased conductance and mean Erev of -6 mV can be explained by MFI 
opening non-selective cation channels (Martin & Valkanov, 1996) which are 
mecamylamine-resistant.  We also considered the possibility that the effect could be 
mediated by an increase in chloride channel conductance but this is unlikely since 
the estimated reversal potential would be more negative than -32 mV [based on an 
intracellular chloride concentration less than 20 mM (Brading and Caldwell, 1971), 
and an extracellular concentration of 69 mM as used in our experiments]. Thus one 
effect of MFI is to open mecamylamine-resistant, non-selective cation channels.   
 
MFI also inhibits voltage-activated channel currents 
  Further inspection of the ramp currents, Fig. 7A, shows that the current step 
associated with the -15 mV to -35mV voltage-step decreased from 58 nA in the 
control to 46 nA in the presence of MFI.  In experiments on 5 separate preparations, 
the mean reduction in the current step was 9.0 ± 1.1 nA and statistically significant 
(paired t-test, p<0.05, N=5). For the 20 mV step, the reduction in current step 
corresponds to a reduction in membrane conductance of 0.45 µS.   Depolarization is 
known to activate voltage-sensitive potassium and voltage-sensitive calcium 
channels in A. suum muscle (Martin et al., 1992).  The reduced current step 
(decreased membrane conductance) from -15 mV suggests that additional effects of 
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MFI are to inhibit opening of voltage-sensitive potassium and/or voltage-sensitive 
calcium channels.  We investigated this possibility in the next series of experiments.  
 
MFI inhibits opening of voltage-activated potassium currents 
 To isolate effects of MFI on voltage-activated potassium currents, we used a 
NMDG- Ringer to block voltage-activated inward currents (Martin et al., 1992; Verma 
et al., 2007) in the presence of 30 µM mecamylamine.  Fig. 7 B shows the inhibitory 
effect of MFI on voltage-activated potassium currents activated by rectangular 
depolarizing step potential from a holding potential of -35 mV.  Fig. 7 C plots peak 
outward currents against the step potential for the control and in the presence of 100 
µM MFI. The plots were described by the Boltzmann equation (1):  
   I = Imax / {1 + exp [(V50 -V)/Kslope]}……………….(1),  
where I the peak current, Imax the maximum current V50 is the potential that produced 
the half-maximum effect, V is the step potential and Kslope is the slope of the plot.  
Table 1 shows the values estimated for the Boltzmann equation for the control and 
in the presence of MFI for the experiment shown if Fig 7 C. When the data from 5 
different preparations were pooled we found that: (i) the V50  significantly increased 
(p<0.05, paired t-test N=5)  from a mean of 7.7  ±  0.9 mV to 11.1 ± 1.2 mV; (ii) the  
Imax  significantly decreased (p<0.05, paired t-test N=5) from a mean of 495 ± 138 
to  311 ± 114 nA; and (iii) that Slope decreased significantly (p<0.05, paired t-test, 
N=5)  from 6.4 ± 0.4 nA.mV-1 to 4.9 ± 0.6 nA.mV-1.  Imax V50 and Kslope were all 
changed by MFI.  
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Table 1.   The constant values for equation (1), the Boltzmann equation, obtained by fitting 
the activation curve for the voltage-activated potassium currents. Note that 100 µM MFI 
reduced the maximum activated current and raised the, V50, threshold for activation of the 
current.  
 
MFI also raises the threshold for activation of voltage-activated calcium currents 
 Fig. 8 A shows the reversible effect of 100 µM MFI on the voltage-activated 
calcium currents. Fig. 8 B shows the current-voltage relationships of the calcium 
currents and that the effect of 100 µM MFI was to increase the threshold for 
activation of the calcium current so that a greater depolarization was normally 
required to activate the same currents.   Notice that between -20 mV and -5 mV that 
the calcium current is reduced by MFI but at 0 mV the current is the same.  Similar 
increases in the threshold for activation of the calcium currents produced by MFI 
were observed in experiments on 4 separate preparations. The mean voltage-
activated calcium current activated by a step from a holding potential of -35 mV to a 
step potential of -5 mV was -99.9  ± 10.6 nA; in the presence of 100 µM MFI it was 
reduced significantly (p< 0.05, paired t-test, N= 4) to -75 .1 ± 13.1 nA, Fig 8 C, and 
this returned to - 97.6 ± 11.0 nA on washout.  
 
 Control 100 µM MFI 
Imax 745 nA. 427 nA 
V50 8.3 mV 11.3 mV 
Kslope 5.6 nA. mV-1 4.9  nA.mV-1 
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Effects of MFI and 4-aminopyridine (4-AP) on levamisole inhibition of larval migration 
 One of our longer-term aims has been to identify pharmacological 
mechanisms that could be used to design novel therapeutic agents or to potentiate 
the effects of levamisole.  However, MFI produced a number of effects on channel 
currents which were mutually antagonistic: the effect on inhibiting potassium 
channels would be excitatory, but the effects on calcium currents would be inhibitory. 
We were therefore interested to with see if the anthelmintic effects of levamisole 
could be potentiated by addition of a selective potassium channel blocker and to 
compare effects of MFI.  Fig. 9 shows the effects of 100 µM MFI and 1 mM 4-AP 
(selective potassium channel blocker) on levamisole concentration-response plot in 
larval migration assays. The effect of MFI was statistically significantly: it inhibited 
the effects of levamisole (p<0.001, f-test, df 1, 62). The effects of 4-AP were also 
statistically significantly and it potentiated the effect of levamisole (p<0.001, f-test, df 
1, 62). The levamisole control had an EC50 of 173 µM (134 – 222 µM: 95% 
confidence interval, N= 3 separate experiments); in the presence of MFI the 
levamisole EC50 was 1062 µM (531 – 2124 µM: 95% confidence interval N= 3 
separate experiments); in the presence of 1 mM 4-aminopyridine, the levamisole 
EC50 was 47 µM (29 – 75 µM 95% confidence interval, N= 3 separate experiments). 
The EC50s were significantly different, with non-overlapping confidence intervals. We 
found that 1 mM 4-AP was near threshold for inhibitory effects on migration. At low 
concentrations of levamisole, MFI had little effect but at higher levamisole 
concentrations it acted as a levamisole antagonist.  The antagonism may be due to 
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MFI acting as partial (weak) nicotinic agonist or due to inhibition of calcium currents 
and these actions appear to limit the ability of MFI to potentiate the actions of 
levamisole. However, it was clear that 4-aminopyridine potentiated the effects of 
levamisole. Addition of 4-aminopyridine made levamisole 3.7 x s more potent, when 
comparing the EC50s due to antagonism of the potassium current.   
5.5 Discussion 
MFI effects in A. suum 
 We found evidence of effects of MFI in A. suum on four types of ion-channels, 
summarized in Fig. 10.  In our muscle strip experiments we observed that MFI was a 
weak agonist producing contraction with a relative potency of 0.014 of acetylcholine. 
MFI did not produce a maximum contraction like acetylcholine or levamisole. The 
contraction appears to be mediated by nicotinic cholinergic receptors rather than 
muscarinic receptors because it was inhibited by a low concentration of 
mecamylamine (3 µM),  in A. suum  (Colquhoun et al., 1991).  
  MFI also activated a mecamylamine-resistant non-selective cation channel 
current, inhibited voltage-activated potassium channel currents and raised the 
threshold of voltage-activated calcium channel currents, Fig. 10.  The nicotinic 
channel currents, the non-selective cation channel currents and inhibition of the 
potassium current would contribute to depolarization and contraction, but the 
increase in the calcium current threshold would not. The calcium current effect 
probably limited the contractile effects of MFI in the muscle strip experiments.    
 Three subtypes of nicotinic acetylcholine receptor channels have been 
described in A. suum (Robertson et al., 2002;  Qian et al., 2006).  There is the N-
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type, which is activated preferentially by nicotine; there is the L-type, which is 
activated preferentially by levamisole; and there is the B-type, which is activated 
preferentially by bephenium.   It is possible that one nicotinic receptor subtype was 
not inhibited by mecamylamine. This is unlikely because of the potency of 
mecamylamine as a nicotinic antagonist in Ascaris (Colquhoun et al., 1991).  We 
checked the potency of mecamylamine as antagonist of nicotine, levamisole and 
bephenium using our contraction assay to obtain contraction concentration plots in 
the absence of mecamylamine and then 0.03, 0.3 and 3.0 µM mecamylamine (at 
least 4 preparations for each agonist) were obtained. The pA2 were calculated using 
standard methods (Robertson et al. 2002). Table 2 shows the pA2 and IC50 (µM) 
values.  The potency of mecamylamine against the three agonists makes it unlikely 
that the mecamylamine- resistant cation-channels are due to a nicotinic receptor 
subtype.  
Agonist pA2 µM value of pA2 
nicotine 7.2 0.062 
levamisole 6.6 0.235 
bephenium 6.7 0.191 
 Table 2.   The pA2 and IC50 (µM) values obtained for mecamylamine with nicotine, 
 levamisole or bephenium as agonist.   Agonist contraction concentration  plots in the 
 absence of mecamylamine and then 0.03, 0.3 and 3.0 µM  mecamylamine (4 or 
 more preparations were used for each agonist) were obtained 
 
 
Non-selective cation-channels and ROCs (TRP-channels)  
 The significance and function of the nicotinic cholinergic channels that 
mediate muscle contraction and the effects of ionotropic cholinergic anthelmintics 
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like levamisole have been described  (Martin & Robertson, 2007),  but the function of 
the MFI activated mecamylamine-resistant cation-channels is uncertain.  Martin & 
Valkanov (1996) have described activation by acetylcholine of an atropine-resistant, 
mecamylamine-resistant non-selective cation channel current (Ibcat) which has slow 
kinetics and that this current may underlie the slow depolarization waves seen in A. 
suum muscle (Weisblat et al., 1976).    Receptor operated channels (ROCs) which 
are non-selective cation channels are activated by a variety of ligands including 
muscarinic agonists and belong to the TRP group of channels (Albert and Large, 
2006; Ramsey et al., 2006). The permeability properties of the mecamylamine-
resistant non-selective cation channel, channels of the slow waves, Ibcat (Martin & 
Valkanov, 1996) and TRP-channels have some similarities.  These similarities give 
rise to the possibility that the slow waves and Ibcat  are conducted by a TRP-like 
channel (Zholos et al., 2004;Takai et al., 2004) that is activated by MFI. Interestingly, 
Arevalo & Saz (1992) have already demonstrated the activation of phospholipase C 
and production of diacylglycerol by acetylcholine in A suum which activate ROCs 
(Beech et al., 2004) .  
 
Effects on potassium and calcium currents 
 We have examined, in A. suum muscle, the effects of MFI, which is known to 
activate M1 receptors in rat cervical ganglion neurons. Mammalian muscarinic 
acetylcholine receptors are seven transmembrane receptors of the rhodopsin-like 
family where the natural agonist is acetylcholine (Caulfield et al., 1994).  They are 
divided into five pharmacological subtypes, M1 - M5. MFI produces depolarization in 
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rat cervical ganglion cells (Newberry and Priestley, 1987; Roberts and Newberry, 
1990) by stimulation of receptors that produces closure of an inwardly rectifying 
potassium channel current known as the M-current (Caulfield et al., 1994).  We have 
shown here that MFI also produces depolarization and inhibition of voltage-activated 
potassium currents in A. suum.   
 In other mammalian preparations stimulation of the M1 receptor can also 
inhibit N- and R-type calcium currents (Melliti et al., 2001). We saw both inhibition of 
potassium currents and an increase in the threshold for calcium currents in A. suum 
muscle cells.   It is not clear why MFI produces mutually opposing effects in A. 
suum.  It is possible that the extrasynaptic location of MFI application is stimulating a 
mixture of cholinergic receptors that would not occur physiologically with synaptic 
release of acetylcholine.  We also point out that we have not tested for any role of G-
proteins in this study and it remains a possibility that the effect of MFI in A. suum 
may be via a direct action of MFI on the potassium or calcium channels. The slow 
speed of the MFI response however, suggests an indirect action on the ion-channels 
mediated by a second messenger (Purcell et al., 2002).   
 
C. elegans muscarinic receptors (GARs)  
 In the model nematode C. elegans, three main categories of G-protein linked 
acetylcholine receptors have been described that are known as GARs (Hwang et al., 
1999; Lee et al., 2000). GAR-1, GAR-2 and GAR-3 are molecular homologues of 
mammalian muscarinic acetylcholine receptors (Lee et al 2000).  GAR-1 and GAR-2 
are pharmacologically separable from mammalian muscarinic receptors: they are not 
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sensitive to all muscarinic antagonists. GAR-3 is molecularly and pharmacologically 
more like mammalian muscarinic receptors and is sensitive to atropine. In C. 
elegans the GAR-3 receptor is coupled to and inhibits opening of a potassium 
channel and enhances nicotinic receptor function via a Gαq protein in the male 
spicule muscle (Liu et al., 2007) but in the pharyngeal muscle GAR-3 stimulation 
enhances a calcium current (Steger & Avery, 2004).   
 
Muscarinic-like receptors in Ascaris suum 
 There is much less molecular information available concerning A. suum 
GARs but homologues to GAR-1 are in EST data bases (BM281808 & BM 281722: 
NCBI) and their function and pharmacology remains to be characterized.  At this 
stage we do not have enough information to determine which G-protein coupled 
acetylcholine receptors are coupled to potassium or other channels in A. suum.   
 There are a number of physiological and pharmacological reports indicating 
the presence of muscarinic-like receptors on A. suum body muscle.  Colquhoun et 
al., (1999) have described the relative potency of a range of selective muscarinic 
agonists in Ascaris suum:  furmethiodide (furtrethonium) had a relative potency of 
0.007 (compared to acetylcholine); arecoline had a relative potency of 0.001 but 
oxtremorine was without effect.  In an isolated muscle bag preparation of A. suum, 
Martin & Valkanov (1996) observed evidence of a mecamylamine-resistant 
cholinergic receptor, stimulation of which increased the opening of a non-selective 
cation channel, an effect that was not blocked by atropine, mecamylamine or 
tubocurarine.  In addition Segerberg & Stretton (1993) reported that pilocarpine, a 
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muscarinic agonist, produced a concentration-dependent depolarization in A. suum 
muscle that was not antagonized by a muscarinic antagonist (N-methyl-
scopolamine) nor the nicotinic antagonist, tubocurarine.  The lack of effect of 
oxtremorine and atropine in previous A. suum studies together with the modest 
effect of atropine in our studies suggests that a GAR-3-like receptor is not involved 
in mediating the effects of MFI.     
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5.8 Legends to figures 
 
Fig 1.   A: The chemical structure of 5-methylfurmethiodide.   
B: A. suum muscle strip preparations are dissected from the anterior region of the worm and 
mounted in a water bath for the contraction assay.   
C: Diagram of the two micro-pipette current-clamp and voltage-clamp recording from the 
bag region of the A. suum muscle cell and the application of solutions by microperfusion.  
The current-injecting micropipette (I) and voltage-sensing micropipette (V) are illustrated. 
  
Fig. 2.  A: Effect of MFI (■), acetylcholine with 3 µM neostigmine to block cholinesterase 
(○) and levamisole (●) on contraction of A. suum muscle strips.  EC50s:  MFI 221 µM; 
acetylcholine, 3.1 µM, levamisole, 0.7 µM.   Mean ± S. E. maximum contractions are shown.  
MFI is not a full agonist and does not produce a maximum contraction.   
B: Atropine (3 µM applied 10 minutes before and maintained in the presence of the agonist) 
had no inhibitory effect on MFI muscle contractions.  Control (■); 3 µM atropine (□).    
C: Mecamylamine (3 µM) completely antagonizes the contractions of MFI.   Control (●); 3 
µM atropine (○).    
 
Fig 3.  Effect of MFI on membrane potential and conductance.   
A: Effect of 300 µM MFI in the presence of 6 mM calcium.  A 2-minute application of MFI 
produces a 10 mV depolarization and a small change in input conductance (downward 
pulses) but a clear increase in the anode break spikes produced at the end of each 
hyperpolarizing potential response to the injected current pulse.   The central trace is the 
membrane potential, -35 mV; the downward deflection is the voltage response to injected 
current. The resting input conductance was 2.4 µS; and the upward deflection is the anode 
break spike that followed the end of the 40 nA hyperpolarizing current pulse.  There was a 
slow 13 mV depolarization associated with a very small conductance increase of 0.1 µS; the 
response took 75 sec form onset to reach its peak.  The anode break spikes increased in 
amplitude during MFI application from 11mV to 17 mV.   
B: Lower time-resolution recording of a representative recording of applying increasing 
concentrations of MFI on the membrane potential and resting conductance of the muscle cell.  
There was little effect at 10 µM MFI but a noticeable effect at 30 µM MFI; again notice the 
very slow onset and offset of the response.  
C: Representative recordings of the effect acetylcholine on membrane potential.  Note that 
the time course is faster than that of MFI.  The faster time-course (onset and offset) of the 
depolarizing response to 3 µM acetylcholine with the peak occurring with our application 
method within 9 sec after onset.     
 
Fig 4.   Peak MFI depolarization-concentration relationships. The relationships were 
determined in normal Ascaris Ringer and in Ca-free Ascaris Ringer.  The EC50 in the 
presence of calcium was 151 µM and in calcium-free, it was 191µM.  Number of 
preparations, N=6.  
Inset:  MFI-conductance-concentration plots in the presence and absence of calcium. The 
conductance change associated with the depolarization responses was small, up to 0.1 µS 
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over the concentration range. The MFI EC50 in the presence of calcium was 71 µM and in 
calcium-free, it was 58 µM.   
 
Fig 5.  A: 30 µM atropine has a small but significant effect on the depolarizing responses to 
100µM MFI.  Representative trace and bar chart (N=8). Control, 9.8 ± 0.8 mV; + atropine, 
7.4 ± 0.8 mV.  
B: 30 µM mecamylamine reduces, but does not completely block depolarizing responses to 
100 µM MFI.  Representative trace and bar chart (N=4). Control, 6.5 ± 1.0 mV; + 
mecamylamine, 3.3 ± 1.0 mV.  
  
Fig. 6.    A: Ramp-voltage protocol used to view effects of MFI on bag currents. The holding 
potential was -35 mV; the start of the ramp began at -65 mV and increased to -15 mV and 
then returned to -35 mV. 
B:  Effect of 100 µM MFI on voltage-ramp activated currents under voltage-clamp in the 
presence of 30 µM mecamylamine to block nicotinic effects. The holding current increased 
by -9nA at -35 mV and by -15 nA at -65 mV.  The current record in B shows that the current-
step associated with the voltage-step, -35mV to -65mV increased from 107 nA in the control 
to 113 nA in the presence of 100 µM MFI showing that MFI increased the membrane 
conductance at -35 mV.  At –15 mV the current step associated with the -15 mV to -35mV 
voltage-step decreased from 58 nA in the control to 46 nA in the presence of MFI showing 
that MFI decreased the conductance of the membrane at -15 mV that could be associated 
with potassium channel block.   The effect was reversible on washout (data not shown).   
C:   Estimation of the reversal potential (Erev) of the MFI current induced at potential more 
negative than -35 mV.  Extrapolation of the MFI induced currents at -35 and -65 mV gave 
+10mV as the reversal potential.  Because of the composition of the intracellular and 
extracellular ions, the reversal potential is consistent with the current being due to opening of 
a non-selective cation channel.  The high concentration of mecamylamine present suggests 
that this is not due to a nicotinic channel.   
 
 
 
Fig. 7.  Effect of MFI on depolarization-activated potassium currents in NMDG Ringer.  
A: Ramp currents from experiment shown in Fig 6 B.  Note that there is a reduction from 58 
nA to 46 nA in the current step associated with the voltage step -15 to -35 mV indicating that 
100 µM MFI limits opening of voltage-activated currents at depolarized potentials.   
 B: The muscle cell was held at -35 mV and rectangular depolarizing steps made to different 
potentials in 5 mV steps to activate the potential dependent potassium channels.  The control 
currents are reduced in the presence of 100 µM MFI and increase again on wash.     
C: Peak outward current-voltage plots, control (●), in the presence of 100 µM MFI (○).  The 
plots are fitted with the Boltzmann equation (equation-1) to obtain estimates of the constants 
(see Table 1).  MFI inhibits the outward current by reducing the maximum current and 
decreasing the half-activation potential.    
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Fig 8.  100 µM MFI increases the threshold for activation of the voltage-activated calcium 
currents.   
A: Control currents (left) activated by step potentials from a holding potential of -35 mV.  
Currents in the presence of 100 µM MFI (middle) and following washout (right).   
B: Plot of the peak inward calcium current at different step potentials.  Control (●).   100µM 
MFI (∆).  Wash (□).   Note that it takes a greater depolarization step to activate the current. 
C: Bar chart of the peak calcium current at -5 mV in the control, presence of 100 µM MFI, 
and following washout.  MFI had a significant (P<0.05 paired t-test N=4) effect when 
compared to the control and wash.  
 
Fig 9. Potentiation effect of 100 µM 4-aminopyridine (4-AP) and antagonistic effect of 100 
µM MFI on levamisole inhibition of larval migration. O. dentatum ex-sheathed L3 larval 
migration assay.   Control, levamisole response (●).  Levamisole with 1 mM 4-AP (□).  
Levamisole with 100 µM MFI (∆).  MFI reduces the effect of levamisole at higher doses.  
N=3.   
 
Fig 10.  Summary diagram of the effects of MFI on the membrane ion-channels of A.  suum 
muscle. MFI is a weak agonist of the nicotinic acetylcholine channels on the bag (up arrow: 
nAChR). MFI activates mecamylamine-resistant non-selective cation channels (up arrow: 
MRCAT: TRP?).  MFI raises the threshold of voltage-activated calcium currents (down 
arrow: VACC).  MFI inhibits opening of voltage-activated potassium currents (down arrow: 
K channels) 
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5.9 Figures 
 
Fig 1.   A: The chemical structure of 5-methylfurmethiodide. B: A. suum muscle strip 
preparation for the contraction assay.  C: Diagram of the two micro-pipette current-
clamp and voltage-clamp recording from the bag region of the A. suum muscle cell. 
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Fig. 2.  A: Effect of MFI (■), acetylcholine (○) and levamisole (●) on contraction of A. 
suum muscle strips. 
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Fig 3.  Effect of MFI on membrane potential and conductance.   
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Fig 4. Peak MFI depolarization-concentration relationships. 
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Fig.5 Effect of atropine on MFI response. 
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Fig. 6.    Ramp-voltage study. 
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Fig. 7.  Effect of MFI on depolarization-activated potassium currents in NMDG Ringer.  
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Fig 8.  100 µM MFI increases the threshold for activation of the voltage-activated 
calcium currents.   
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Fig 9.  Summary diagram of the effects of MFI on the membrane ion-channel of the A.  
suum muscle. MFI is a weak agonist of the nicotinic acetylcholine channels on the bag 
(up arrow: nAChR). 
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Fig 10.  Potentiation effect of 100 µM 4-aminopyridine (4-AP) and antagonistic effect of 
100 µM MFI on levamisole inhibition of larval migration. O. dentatum ex-sheathed L3 
larval migration assay.  
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Chapter 6. General Discussion  
As outlined previously in introduction I have investigated three hypotheses. Based 
on the results and observations I have come to certain conclusions for each 
hypothesis as mentioned below:  
1. Entry of calcium from extracellular sources is responsible for muscle 
contraction in A. suum somatic muscle cells. It is assumed that spikes and slow 
waves induced under current clamp in A. suum muscles are calcium dependent. 
These spikes are potentiated by the excitatory neuropeptide, AF2. Our first 
hypothesis was that spiking is due to the opening of voltage-activated calcium 
channels. AF2 increased the spiking and therefore AF2 will positively modulate the 
voltage-activated calcium currents.  
 We were able to isolate the voltage-activated calcium currents from somatic 
muscle cells of A. suum. There were two distinct calcium currents isolated under 
voltage-clamp: transient peak currents (Ipeak) and steady-state currents (Iss). These 
currents were reduced in the absence of calcium demonstrating that majority of the 
current is carried by calcium. Also cobalt, a calcium channel blocker, abolished the 
inward calcium currents. These observations suggest that the calcium channels in 
nematodes are not exclusively permeable to calcium, but may also be permeable to 
other monovalent cations including sodium and potassium. The A. suum calcium 
current was most likely to be carried by calcium. A short duration application of AF2 
produced long lasting potentiation of the Ipeak currents. The increase in the inward 
current suggests that AF2 was responsible for the increase in spontaneous spiking 
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and depolarization. AF2 increased the frequency of large and small spikes under 
current-clamp.  
 
2. There are two distinct calcium currents in A. suum somatic muscle cells. The 
two currents are pharmacologically different. The second hypothesis was that the 
two currents can be modulated, negatively and positively, by FLPs. We investigated 
the effects of excitatory (AF3) and inhibitory (PF1) neuropeptide FLPs on the two 
calcium currents.  
 The voltage-activated calcium currents were potentiated in the presence of AF3. 
The biggest effect of AF3 was on steady-state currents (Iss) but as mentioned 
previously AF2 has its biggest effect on Ipeak. The different actions by these two 
neuropeptides on the two currents imply that they can be modulated separately.  
The inhibitory neuropeptide PF1 inhibited both, Ipeak and Iss, calcium currents. We 
also found that PF1 in the presence of calcium increased the potassium currents. 
The effect on potassium currents was abolished in absence of calcium and at higher 
concentrations of PF1. The effects of PF1 are important as a novel anthelmintic, 
emodepside, has been proposed to mimic the effect or induce the release of PF1. 
Emodepside has also been shown to produce its effect by modulation of a calcium-
activated potassium channel (SLO-1). The effect of PF1 on calcium channels is also 
calcium dependent. It will be of interest to investigate the mechanism of action of 
emodepside on calcium channels to further elucidate the mechanism of action of 
emodepside (see Appendix).  
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3. The third hypothesis was aimed at investigating the role of muscarinic 
receptors in muscle contraction. Our hypothesis was that muscarinic receptors play 
some role in somatic muscle contraction and muscarinic AChR’s in nematodes 
modulate voltage-activated currents in the somatic muscle cells of A. suum. 
Colquhoun et al, (1991) tested effects of different mammalian cholinergic agonists 
including furtrethonium, muscarine, pilocarpine, arecoline, McN A343, bethanecol 
and oxtremorine, on A. suum somatic muscle cells. They found that furtrethonium 
was the most potent. We therefore selected 5-methylfurmethiodide (MFI), which is a 
potent muscarinic agonist for further study on muscle contraction in A. suum. We 
studied the effect of the muscarinic agonist, MFI along with levamisole and 
acetylcholine on contraction and electrophysiology of the somatic muscle cells in A. 
suum.  
 MFI was a weak agonist producing muscle contraction. MFI did not produce a 
maximum contraction like ACh or levamisole but it acted as a weak nicotinic agonist 
in inducing muscle contraction.  More importantly MFI lead to the opening of 
mecamylamine-resistant-non-selective cation channel and inhibition of voltage-
activated potassium channels. MFI did not inhibit but raised the threshold of voltage-
activated calcium channel currents. The properties of mecamylamine-resistant-non-
selective currents (Ibcat) currents are similar to receptor operated channels of 
transient receptor potential channel (TRP) group. The similarities imply that the slow 
waves and Ibcat are conducted by MFI sensitive TRP-like channels. In mammalian 
preparations MFI has been shown to produce closure of an inwardly rectifying 
potassium channel current. MFI is known to activate M1 muscarinic receptors in rat 
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cervical ganglion (Caulfield et al., 1994). We have demonstrated similar results 
where MFI induced depolarization and inhibition of voltage-activated potassium 
currents in A. suum. 
  The development of anthelmintic resistance against existing drugs is a cause 
for concern for human and animal health alike. Our approach was to investigate the 
actions of cholinergic anthelmintics (levamisole), to understand better mode of action 
of these drugs and to develop a pharmacological strategy for countering resistance 
to these compounds. The neuromuscular system is the target for some of the most 
effective classes of anthelmintics. Muscle cells are very closely associated with 
proper functioning of the parasitic worms as they are involved in feeding, locomotion 
and reproduction. The calcium channels in the nematode, A. suum are different from 
vertebrate as they are not blocked by vertebrate calcium channel blockers. These 
channels are modulated by nematode specific endogenous neuropeptides (FLPs). 
Some of the FLPs are cross species reactive but not in mammals. These qualities 
make the FLP receptors attractive targets for the development of anthelmintic drugs. 
Also the effects of cholinergic anthelmintics are potentiated by the excitatory FLP, 
AF2. These properties suggest that a synthetic FLP ligand could be used to 
potentiate the effects of cholinergic anthelmintics like levamisole. Modulation of the 
voltage-activated channels by muscarinic agonists also offers an alternative to 
increase the potency of cholinergic anthelmintics. Inhibition of voltage-sensitive 
potassium channels by the muscarinic agonist, MFI demonstrates a way to increase 
the efficacy of cholinergic anthelmintics.  
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 For further investigation of these observations I suggest the study of the 
voltage-activated currents at single channel level. Also calcium imaging is another 
option to further characterize and locate these calcium channels in somatic muscle 
cells. Another future study which holds potential is to investigate these currents in C. 
elegans. A PCR-based cDNA approach has been widely successful in C. elegans 
similar methodologies can be applied to A. suum to characterize the voltage-
activated channel currents. Once identified these channels could be expressed in C. 
elegans for further analysis as it offers the possibility of detailed electrophysiological 
studies. These results in future will contribute to a better understanding of the role 
and interaction of these peptides with different physiological systems in nematodes. 
Also, a better understanding of the mechanism of action of the existing anthelmintics 
will allow us to develop strategies to counter the development of resistant more 
effectively.  
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Appendix  
 In this portion of my dissertation I summarize the results and 
observations of experiments which are in preliminary stages and need further 
work. These experiments are a step towards the future line of work as I 
suggested in the general discussion.  
Profender and emodepside 
  Profender, the brand name of a product from Bayer, is a topical solution 
for cats. Profender is a mixture of emodepside (15 mg) and praziquantel (60.1 
mg) in each 0.7 ml tube. To check the effects of emodepside on voltage-
activated currents we did preliminary studies with Profender for two reasons: i) 
unavailability of emodpeside and ii) to investigate the effects of other 
compounds in solution. The study so far is at a preliminary stage and we 
cannot conclude the results with absolute certainty. I am presneting the results 
and observations I have obtained so far.  
Effects of Profender on voltage-activated potassium and calcium currents 
 Fig. 7.1A shows currents activated by steps from the holding potential of   
-35 mV to 0 mV and to +20 mV. The step potential of 0 mV (Fig. 7.1A, Ipeak) 
shows activation of the calcium transient current (Verma et al., 2007). The step 
potential to +20 mV (Fig. 3A, O) shows activation of the outward potassium 
current (Thorn et al., 1987).  
 10 µM Profender produced an effect on both the currents that increased 
slowly over a period of 10 minutes. In the representative recording, Fig. 7.1A, 
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Profender decreased the potassium current from 700 nA to 531 nA and the 
Ipeak 
 
Figure 7.1 Effects of Profender on voltage-activated currents.  
(A) Outward potassium currents (O) and calcium currents (Ipeak) were suppressed 
in presence of Profender.  
(B) Effects on calcium currents were irreversible.  
(C) Outward potassium currents recovered post wash.  
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decreased from -173 nA to -112 nA. After 20 minutes of continuous wash, the 
potassium current increased to 680 nA but in contrast, the calcium transient 
current reduced to -103nA. 
  The effect on the potassium currents is reversed on washing but the 
effect on the calcium current is not reversed on washing. This difference in 
wash-out suggests that the two currents may be regulated differently. Fig. 7.1B 
& C summarizes the time dependent effects of Profender on the potassium 
and the calcium currents in 6 different preparations. It can be observed by 
comparing Fig. 7.1 B & C that the percentage decrease in the potassium 
currents, for the 6 recordings after 9 minutes application of Profender was 21 ± 
2 %  (p=0.003, n=5),  which was bigger than the percentage decrease of the 
calcium currents, 14 ± 8 % (p=0.04, n=5).  We can also see that during the 
wash period the potassium current returned to close to control levels; but the 
decrease in the calcium currents is maintained. Thus, we observed the effects 
of Profender on the two currents and that the effect on the potassium currents 
was proportionately bigger than on the calcium. The effect on calcium currents 
was not reversible.   
Effects of Emodepside on voltage-activated potassium and calcium currents 
 Fig. 7.2A, shows a typical recording of the effects of emodepside on 
membrane potential; in this cell the resting membrane potential was -29 mV 
and input conductance was 3 µS. Application of 1µM emodepside produced a 
hyperpolarization of 3 mV and conductance increase of 0.4 µS. The effect was 
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not completely washed off even after 20 mins. Similar results were obtained in 
a total of 6 preparations. Fig. 7.2B summarizes the effects of emodepside on 
membrane potential. The effect of 1µM emodepside on membrane potential 
was statistically significant and the mean hyperpolarization was 2.6 ± 1 mV (p 
= 0.04).  
 Effect of emodepside on voltage-activated currents is different from the 
effects of profender. Fig. 7.2C shows currents activated by steps from the 
holding potential of -35 mV to 0 mV and to +20 mV. The step potential of 0 mV 
(Fig. 7.2C, Ipeak) shows activation of the calcium transient current. The step 
potential to +20 mV (Fig. 7.2C, O) shows activation of the outward potassium 
current. 1 µM Emodepside produced an effect on the currents that increased 
slowly over a period of 8 minutes. In the representative recording, Fig. 7.2C, 
unlike Profender , emodepside increased the potassium current from 577 nA to 
726 nA and decreased the Ipeak calcium currents from -101 nA to -75 nA. After 
20 minutes of continuous wash, the potassium current decreased to 704 nA 
but in contrast, the calcium transient current reduced to -18 nA.  
 The effect on the potassium currents is reversed on washing but the 
effect on the calcium current is not reversed on washing these effects are 
similar to the effects seen previously with Profender. This difference in wash-
out again demonstrates the possible different regulation of the two currents. 
Fig. 7.2B & C summarizes the time dependent effects on the potassium 
currents and the calcium currents in 6 different preparations. It can be seen by 
comparing Fig. 7.2 B & C that the percentage increase in the potassium 
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currents for the 6 recordings after 9 minutes application of emodepside was 
4.2 ± 4 %  (p=0.5, n=6) and was not significant. Whereas, percentage 
decrease of the calcium currents, 12 ± 8 % (p=0.02, n=5) and was significant.  
Interestingly potassium currents decreased to close to normal levels post-
wash; but the decrease in the calcium currents is increased with time. Thus, 
we observed the effects of emodepside on the two currents and that the effect 
on the potassium currents was smaller than on the calcium but the effects on 
potassium currents was reversible.   
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Figure 7.2 Emodepside (A) on membrane potential induced (B) hyperpolarization. 
Two effects of Emodepside on (C) Voltage-activated currents (paired t-test, n =6, * P≤ 
0.05); (D)  calcium currents were suppressed and (E) outward potassium currents 
potentiated.   
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AF1  
  AF1 is an excitatory FMRFamide peptide. I tested AF1 to compare the 
results of AF2 with other excitatory peptides. As mentioned effects of AF1 
although encouraging were not consistent and weaker as compared to AF2.  
Effect of AF1 on transient inward currents 
 Fig. 7.3 A demonstrates the effects of AF1 on membrane potential and 
conductance. AF1 produced depolarization of 1 mV with no change in 
conductance in 5 different recordings.  
 Fig 7.3 B shows a representative experiment of effects following a 2-
minute application of 1 µM AF1 on the peak transient inward current. We 
followed the same analytical approach as we did previously to prepare the 
activation curves and to test the effect of AF2.  Fig. 7.3 B, C & D show that 
AF1 increased the current by shifting the activation curve to the left and 
increasing the maximum conductance change.  The peak current at the 0 mV 
step increased from -141 nA in the control to -156 nA after AF1 application, 
Fig. 7.3 B.  The control activation curve had a V50 of -12 ± 0.7 mV and a Gmax 
of 3.2 ± 0.05 µS.  After AF1, V50 was -16 ± 2.8 mV and the Gmax was 6.05 ± 0.2 
µS, Fig 7.3 D.  Thus, there was an hyperpolarizing shift of 4 mV in V50 and a 
53% increase in Gmax in the representative experiment. The slope factor for the 
curve changed from the control 5.8 ± 0.7 mV to 6.4 ± 1.7 mV after application 
of AF1. 
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Figure 7.3 Effects of AF1 on voltage-activated currents. (A) Effect of AF1 on 
membrane potential.  (B) AF1 potentiated calcium currents (Ipeak). (C) Activation curve 
(D) AF1 significantly potentiated the inward current and the effect was reversible 
(paired t-test, n =6, * P≤ 0.05). 
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 It was clear from the experiment described in Fig. 7.3 B-C and from 
similar observations in 10 other experiments that AF1 increased the transient 
inward current. We found that the potentiation took 4 minutes to reach a 
maximum and lasted for less then 15 minutes after washing the AF1. Fig.7C 
shows the mean ± S.E. % increases from 5 experiments.   The average 
potentiation for the 5 recordings after 5 minutes was 12 ± 4 % and was 
significant. The results from different preparations ranged from 21 % - 2%.  In 
addition, we also examined the effect of continuous application of AF1 and the 
effects were not significantly different from control (5 preparations). The results 
demonstrate the possibility that the effects of AF1 were produced in a similar 
fashion as AF2. The effects of AF2 on calcium currents are much bigger and 
long lasting when compared with AF1.    
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Table 7.4  (McVeigh et al., 2006) Distribution of flp genes across the phylum Nematoda.  
aFor further details see (5). bx, a variable hydrophilic residue; xg, a variable hydrophobic residue; cysteine has 
not been reported in any FLP. cNematodes are classified into five clades. Clade II is not shown because no 
genetic data are available for any Clade II species. dE, expressed sequence tag(s) (EST) is known; C, a complete 
propeptide open reading frame eDNA is available. All sequences are available on Genbank 
(http://www.ncbi.nlm.nih.gov), except e(C.L. Moffett, PhD Thesis, Queen’s University Belfast, 2001) and i(I. 
Miskelly, PhD, Thesis, Queen’s University, Belfast, 2006). gThe flp-32 transcript is distinct from the flp-11 
cDNA in Teladorsagia circumcincta; flp-32 is also present in the C. elegans genome. In C. elegans, flp-11 and 
flp-32 map to different chromosomesm even thought they encode some of the same peptides (C. Li, pers. 
commun. as reported in McVeigh et al., 2006). We therefore deduce that these represent distinct genes rather 
than splice variants. hHomologs of flp-1-20,24,26,27 have also been reported in the C. elegans genome. 
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